Document_and_Entity_Informatio
Document and Entity Information Document (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Feb. 18, 2014 | Jun. 28, 2013 | |
Entity Information [Line Items] | ' | ' | ' |
Entity Registrant Name | 'Remy International, Inc. | ' | ' |
Entity Central Index Key | '0001046859 | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Filer Category | 'Accelerated Filer | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Amendment Flag | 'false | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 32,148,470 | ' |
Entity Public Float | ' | ' | $262,600,000 |
Entity Common Stock Held by Nonaffiliates, Shares Outstanding | ' | ' | 14,138,511 |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Trading Symbol | 'REMY | ' | ' |
Statement_of_Financial_Positio
Statement of Financial Position (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $114,884 | $111,733 |
Trade accounts receivable (less allowances of $1,583 and $1,931) | 191,548 | 170,637 |
Other receivables | 21,023 | 17,203 |
Inventories | 159,340 | 158,936 |
Deferred income taxes | 36,329 | 36,315 |
Prepaid expenses and other current assets | 11,151 | 15,431 |
Total current assets | 534,275 | 510,255 |
Property, plant and equipment | 249,326 | 227,955 |
Less accumulated depreciation and amortization | -103,715 | -86,072 |
Property, plant and equipment, net | 145,611 | 141,883 |
Deferred financing costs, net of amortization | 3,802 | 4,867 |
Goodwill | 271,418 | 271,418 |
Intangibles, net | 89,909 | 99,329 |
Other noncurrent assets | 72,040 | 73,463 |
Total assets | 1,117,055 | 1,101,215 |
Current liabilities: | ' | ' |
Short-term debt | 2,369 | 9,098 |
Current maturities of long-term debt | 3,392 | 3,470 |
Accounts payable | 168,491 | 155,407 |
Accrued interest | 92 | 112 |
Accrued restructuring | 1,026 | 3,679 |
Other current liabilities and accrued expenses | 110,179 | 108,157 |
Total current liabilities | 285,549 | 279,923 |
Long-term debt, net of current maturities | 293,835 | 284,475 |
Postretirement benefits other than pensions | 1,628 | 1,969 |
Postretirement benefits other than pensions | 19,103 | 31,762 |
Deferred income taxes | 1,000 | 2,390 |
Other noncurrent liabilities | 24,783 | 29,188 |
Remy International, Inc. stockholders' equity: | ' | ' |
Common stock, par value of $0.0001; 31,981,544 shares outstanding at December 31, 2013, and 31,865,008 shares outstanding at December 31, 2012 | 3 | 3 |
Treasury stock, at cost; 267,924 treasury shares at December 31, 2013, and 133,467 treasury shares at December 31, 2012 | -1,477 | -229 |
Additional paid-in capital | 320,687 | 323,912 |
Retained earnings | 213,418 | 186,483 |
Accumulated other comprehensive loss | -41,474 | -50,307 |
Total Remy International, Inc. stockholders' equity | 491,157 | 459,862 |
Noncontrolling interest | 0 | 11,646 |
Total equity | 491,157 | 471,508 |
Total liabilities and equity | $1,117,055 | $1,101,215 |
Balance_Sheet_Parenthetical_Pa
Balance Sheet Parenthetical (Parentheticals) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, except Share data, unless otherwise specified | ||
Current assets: | ' | ' |
Allowance for doubtful accounts | $1,583 | $1,931 |
Stockholders' Equity: | ' | ' |
Common Stock, par value | $0.00 | $0.00 |
Common Stock, Shares, Outstanding | 31,981,544 | 31,865,008 |
Treasury Stock, shares outstanding | 267,924 | 133,467 |
Statement_of_Income
Statement of Income (USD $) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Consolidated statements of operations [Abstract] | ' | ' | ' |
Net sales | $1,118,580 | $1,133,547 | $1,194,953 |
Cost of goods sold | 895,610 | 895,843 | 925,052 |
Gross profit | 222,970 | 237,704 | 269,901 |
Selling, general, and administrative expenses | 134,413 | 129,520 | 139,685 |
Intangible asset impairment charges | 0 | 0 | 5,600 |
Restructuring and other charges | 4,066 | 10,271 | 3,572 |
Operating income | 84,491 | 97,913 | 121,044 |
Interest expensebnet | 19,957 | 27,757 | 30,900 |
Loss on extinguishment of debt and refinancing fees | 4,256 | 0 | 0 |
Income before income taxes | 60,278 | 70,156 | 90,144 |
Income tax expense (benefit) | 19,924 | -71,229 | 14,813 |
Net income | 40,354 | 141,385 | 75,331 |
Less net income attributable to noncontrolling interest | 659 | 2,774 | 3,445 |
Net income attributable to Remy International, Inc. | 39,695 | 138,611 | 71,886 |
Preferred stock dividends | 0 | 0 | -2,114 |
Loss on extinguishment of preferred stock | 0 | 0 | -7,572 |
Net income attributable to common stockholders | $39,695 | $138,611 | $62,200 |
Basic earnings per share: | ' | ' | ' |
Earnings per share | $1.27 | $4.53 | $2.14 |
Weighted average shares outstanding | 31,207 | 30,616 | 29,096 |
Diluted earnings per share: | ' | ' | ' |
Earnings per share | $1.26 | $4.47 | $2.10 |
Weighted average shares outstanding | 31,388 | 30,990 | 29,674 |
Dividends declared per common share | $0.40 | $0.30 | $0 |
Statement_of_Comprehensive_Inc
Statement of Comprehensive Income (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Net income | $40,354 | $141,385 | $75,331 |
Other comprehensive income (loss): | ' | ' | ' |
Foreign currency translation adjustments | 1,955 | 2,799 | -4,309 |
Employee benefit plans, net of tax | 7,114 | -2,822 | -15,002 |
Total other comprehensive income (loss), net of tax | 9,033 | 15,458 | -44,000 |
Comprehensive income | 49,387 | 156,843 | 31,331 |
Less: Comprehensive income attributable to noncontrolling interest | 659 | 2,774 | 3,445 |
Less: Other Comprehensive income attributable to noncontrolling interest- foreign currency translation | 200 | 35 | 373 |
Comprehensive income attributable to Remy International, Inc. | 48,528 | 154,034 | 27,513 |
Foreign Exchange Contract | ' | ' | ' |
Other comprehensive income (loss): | ' | ' | ' |
Derivative contracts, net of tax | -906 | 12,939 | -10,225 |
Commodity Contract | ' | ' | ' |
Other comprehensive income (loss): | ' | ' | ' |
Derivative contracts, net of tax | -16 | 2,542 | -14,464 |
Interest Rate Contract | ' | ' | ' |
Other comprehensive income (loss): | ' | ' | ' |
Derivative contracts, net of tax | $886 | $0 | $0 |
Statement_of_Shareholders_Equi
Statement of Shareholders' Equity (USD $) | Total | Common stock | Treasury stock | Additional paid-in capital | Retained earnings (accumulated deficit) | Accumulated other comprehensive income (loss) | Total Remy International, Inc. stockholders' equity | Noncontrolling interest |
In Thousands | ||||||||
Beginning Balance at Dec. 31, 2010 | ' | $1 | $0 | $103,932 | ($14,453) | ($21,357) | $68,123 | $9,350 |
Net income | 75,331 | ' | ' | ' | 75,331 | ' | 75,331 | 3,445 |
Less net income attributable to noncontrolling interest | -3,445 | ' | ' | ' | -3,445 | ' | -3,445 | ' |
Foreign currency translation | ' | ' | ' | ' | ' | -4,682 | -4,682 | 373 |
Unrealized gains (losses) on derivative instruments, net of tax | ' | ' | ' | ' | ' | -24,689 | -24,689 | ' |
Defined benefit plans, net of tax | -15,002 | ' | ' | ' | ' | -15,002 | -15,002 | ' |
Comprehensive income attributable to Remy International, Inc. | 27,513 | ' | ' | ' | ' | ' | 27,513 | 3,818 |
Issuance of common stock, net of proceeds | ' | 2 | ' | 215,710 | ' | ' | 215,712 | ' |
Reclassification of restricted stock award to liability award | ' | ' | ' | -39 | ' | ' | -39 | ' |
Less distribution to noncontrolling interest | ' | ' | ' | ' | ' | ' | 0 | -4,331 |
Stock-based compensation | ' | ' | ' | 6,884 | ' | ' | 6,884 | ' |
Preferred stock dividends | ' | ' | ' | -2,114 | ' | ' | -2,114 | ' |
Loss on extinguishment of preferred stock | -7,572 | ' | ' | -7,572 | ' | ' | -7,572 | ' |
Ending Balance at Dec. 31, 2011 | ' | 3 | 0 | 316,801 | 57,433 | -65,730 | 308,507 | 8,837 |
Net income | 141,385 | ' | ' | ' | 141,385 | ' | 141,385 | 2,774 |
Less net income attributable to noncontrolling interest | -2,774 | ' | ' | ' | -2,774 | ' | -2,774 | ' |
Foreign currency translation | ' | ' | ' | ' | ' | 2,764 | 2,764 | 35 |
Unrealized gains (losses) on derivative instruments, net of tax | ' | ' | ' | ' | ' | 15,481 | 15,481 | ' |
Defined benefit plans, net of tax | -2,822 | ' | ' | ' | ' | -2,822 | -2,822 | ' |
Comprehensive income attributable to Remy International, Inc. | 154,034 | ' | ' | ' | ' | ' | 154,034 | 2,809 |
Purchase of treasury stock | -229 | ' | -229 | ' | ' | ' | -229 | ' |
Reclassification of restricted stock award to liability award | ' | ' | ' | -150 | ' | ' | -150 | ' |
Stock-based compensation | ' | ' | ' | 7,261 | ' | ' | 7,261 | ' |
Loss on extinguishment of preferred stock | 0 | ' | ' | ' | ' | ' | ' | ' |
Common stock dividends | ' | ' | ' | ' | -9,561 | ' | -9,561 | ' |
Ending Balance at Dec. 31, 2012 | 471,508 | 3 | -229 | 323,912 | 186,483 | -50,307 | 459,862 | 11,646 |
Net income | 40,354 | ' | ' | ' | 40,354 | ' | 40,354 | 659 |
Less net income attributable to noncontrolling interest | -659 | ' | ' | ' | -659 | ' | -659 | ' |
Foreign currency translation | ' | ' | ' | ' | ' | 1,755 | 1,755 | 200 |
Unrealized gains (losses) on derivative instruments, net of tax | ' | ' | ' | ' | ' | -36 | -36 | ' |
Defined benefit plans, net of tax | 7,114 | ' | ' | ' | ' | 7,114 | 7,114 | ' |
Comprehensive income attributable to Remy International, Inc. | 48,528 | ' | ' | ' | ' | ' | 48,528 | 859 |
Purchase of treasury stock | -1,248 | ' | -1,248 | ' | ' | ' | -1,248 | ' |
Reclassification of restricted stock award to liability award | ' | ' | ' | -1,026 | ' | ' | -1,026 | ' |
Stock-based compensation | ' | ' | ' | 6,561 | ' | ' | 6,561 | ' |
Loss on extinguishment of preferred stock | 0 | ' | ' | ' | ' | ' | ' | ' |
Excess tax benefits from stock-based compensation | ' | ' | ' | 428 | ' | ' | 428 | ' |
Common stock dividends | ' | ' | ' | ' | -12,760 | ' | -12,760 | ' |
Purchase of and distributions to noncontrolling interest | ' | ' | ' | -9,188 | ' | ' | -9,188 | -12,505 |
Ending Balance at Dec. 31, 2013 | $491,157 | $3 | ($1,477) | $320,687 | $213,418 | ($41,474) | $491,157 | $0 |
Statement_of_Cash_Flows
Statement of Cash Flows (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cash Flows from Operating Activities: | ' | ' | ' |
Net income | $40,354 | $141,385 | $75,331 |
Adjustments to reconcile net income to cash provided by operating activities: | ' | ' | ' |
Depreciation and amortization | 33,770 | 38,060 | 35,252 |
Amortization of debt issuance costs and original issue discount | 1,122 | 1,773 | 1,800 |
Stock-based compensation | 6,561 | 7,261 | 6,884 |
Loss on extinguishment of debt and refinancing fees | 4,256 | 0 | 0 |
Intangible asset impairment charges | 0 | 0 | 5,600 |
Deferred income taxes | 3,720 | -88,967 | -2,845 |
Accrued pension and postretirement benefits, net | -1,606 | -3,056 | -4,311 |
Restructuring and other charges | 4,066 | 10,271 | 3,572 |
Cash payments for restructuring charges | -6,719 | -6,957 | -1,237 |
Other | -1,353 | -2,747 | -1,469 |
Changes in operating assets and liabilities, net of restructuring charges: | ' | ' | ' |
Accounts receivable | -23,104 | 20,534 | 210 |
Inventories | 259 | -5,732 | -10,708 |
Accounts payable | 9,210 | -1,032 | -4,705 |
Other current assets and liabilities, net | 7,607 | -21,437 | -15,027 |
Other noncurrent assets and liabilities, net | -18,236 | -23,581 | -18,800 |
Net cash provided by operating activities | 59,907 | 65,775 | 69,547 |
Cash Flows from Investing Activities: | ' | ' | ' |
Net proceeds on sale of assets | 599 | 268 | 0 |
Purchases of property, plant and equipment | -21,830 | -24,467 | -21,167 |
Government grant proceeds related to capital expenditures | 0 | 1,485 | 2,186 |
Net cash used in investing activities | -21,231 | -22,714 | -18,981 |
Cash Flows from Financing Activities: | ' | ' | ' |
Change in short-term debt and revolver | -6,685 | -5,738 | -25,233 |
Proceeds from issuance of long-term debt | 299,250 | 0 | 0 |
Payments made on long-term debt, including capital leases | -290,861 | -10,403 | -3,347 |
Purchase of and distributions to noncontrolling interest | -21,771 | 0 | -4,331 |
Net proceeds from common stock rights offering | 0 | 0 | 122,177 |
Dividend payments on preferred stock | 0 | 0 | -37,399 |
Cash payments on redemption of preferred stock | 0 | 0 | -44,869 |
Purchase of treasury stock | -1,248 | -229 | 0 |
Dividend payments on common stock | -12,669 | -9,226 | 0 |
Payments of Debt Issuance Costs | -3,476 | 0 | -141 |
Other | 428 | 143 | 0 |
Net cash (used in) provided by financing activities | -37,032 | -25,453 | 6,857 |
Effect of exchange rate changes on cash and cash equivalents | 1,507 | 2,441 | -3,253 |
Net increase in cash and cash equivalents | 3,151 | 20,049 | 54,170 |
Cash and cash equivalents at beginning of period | 111,733 | 91,684 | 37,514 |
Cash and cash equivalents at end of period | 114,884 | 111,733 | 91,684 |
Accounts Payable | ' | ' | ' |
Noncash investing and financing activities | ' | ' | ' |
Purchases of property, plant and equipment in accounts payable | 3,851 | 2,338 | 4,252 |
Assets Held under Capital Leases | ' | ' | ' |
Noncash investing and financing activities | ' | ' | ' |
Purchases of property, plant and equipment in accounts payable | $56 | $939 | $0 |
Description_of_the_Business
Description of the Business | 12 Months Ended |
Dec. 31, 2013 | |
Description of the business [Abstract] | ' |
Business Description and Basis of Presentation | ' |
1. Description of the business | |
Business | |
Remy International, Inc. (together with its subsidiaries, “we”, “our”, “us”, “Remy” or the “Company”) is a leading global vehicular parts designer, manufacturer, remanufacturer, marketer and distributor of aftermarket and original equipment electrical components for automobiles, light trucks, heavy-duty trucks and other vehicles. We sell our products worldwide primarily under the “Delco Remy”, “Remy”, “World Wide Automotive”, and "USA Industries" brand names and our customers' widely recognized private label brand names. Our products include new and remanufactured, light-duty and heavy-duty starters and alternators for both original equipment and aftermarket applications, hybrid power technology, and multi-line products, such as constant velocity ("CV") axles, disc brake calipers, and steering gears. These products are principally sold or distributed to original equipment manufacturers (“OEMs”) for both original equipment manufacture and aftermarket operations, as well as to warehouse distributors and retail automotive parts chains. We sell our products principally in North America, Europe, Latin America and Asia-Pacific. | |
We are one of the largest producers in the world of remanufactured starters and alternators for the aftermarket. Our remanufacturing operations obtain failed products, commonly known as cores, from our customers as returns. These cores are an essential material needed for the remanufacturing operations. We have expanded our operations to become a low cost, global manufacturer and remanufacturer with a more balanced business mix between the aftermarket and the original equipment market, especially in the heavy duty OEM market, since we separated from General Motors Corporation (“GM”) in 1994, when we were essentially an original equipment supplier predominantly to GM. | |
In general, our business is influenced by the underlying trends in the automobile, light truck, and heavy-duty truck, construction and industrial markets. We have been able to reduce the cyclical nature of some of our businesses with the diversity of OEM markets between the automotive, heavy-duty truck and industrial markets by focusing on our remanufacturing capabilities and our aftermarket business. | |
The automotive parts market is highly competitive. Competition is based primarily on quality of products, service, delivery, technical support and price. Most OEMs and aftermarket distributors source parts from one or two suppliers and we compete with a number of companies who supply automobile manufacturers throughout the world. | |
On August 14, 2012, Fidelity National Special Opportunities, Inc., a wholly-owned subsidiary of Fidelity National Financial, Inc. or "FNF," a leading provider of title insurance, mortgage services and restaurant and diversified services, purchased additional shares of our common stock, thereby increasing its ownership position in us above 50%. As a result, FNF began consolidating our financial results in the third quarter of 2012. As of December 31, 2013 and 2012, FNF held a 51% ownership interest in us, respectively, comprised of 16,342,508 shares of our common stock. Additionally, FNF and related subsidiaries participated in our Amended and Restated Term B Loan Credit Agreement on March 5, 2013 and held $29,700,000 principal amount of our Amended and Restated Term B loan as of December 31, 2013. FNF and related subsidiaries held $28,698,000 of the principal amount of our Term B Loan as of December 31, 2012. | |
As of December 31, 2011, FNF held a 47% ownership interest in Remy, comprised of 14,805,195 shares of our common stock. Additionally, FNF and related subsidiaries held $29,700,000 principal amount of our Term B Loan as of December 31, 2011. | |
During the year ended December 31, 2011, FNF acquired an additional 9,870,130 shares of our common stock in our rights offering. In connection with the rights offering, FNF exchanged 42,359 shares of our Series A and Series B preferred shares and board members exchanged 565 shares of our Series B preferred shares for common stock. The remaining 435 shares of Series B preferred shares owned by the board members were redeemed on January 31, 2011. |
Significant_Accounting_Policie
Significant Accounting Policies | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Summary of significant accounting policies [Abstract] | ' | |||||||||
Significant Accounting Policies | ' | |||||||||
2. Summary of significant accounting policies | ||||||||||
Basis of presentation and principles of consolidation | ||||||||||
The consolidated financial statements include the accounts of Remy International, Inc., all wholly-owned subsidiaries, and any partially-owned subsidiary that we have the ability to control. Control generally equates to ownership percentage, whereby investments that are more than 50% owned are consolidated. Investments in companies in which we hold an ownership interest of 20% to 50% over which we exercise significant influence are accounted for by the equity method. Currently, we account for all 20% to 50% owned entities under the equity method. Investments in companies in which we hold an ownership interest of less than 20% are accounted for on the cost basis. Such investments were not material at December 31, 2013 and 2012. All significant intercompany accounts and transactions have been eliminated. | ||||||||||
Use of estimates | ||||||||||
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the year. Actual results could differ from these estimates. | ||||||||||
Revenue recognition | ||||||||||
Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, ownership has transferred, the seller's price to the buyer is fixed and determinable, and collectability is reasonably assured. Sales are recorded upon shipment of product to customers and transfer of title and risk of loss under standard commercial terms (typically, F.O.B. shipping point). We recognize shipping and handling costs as costs of goods sold with the related amounts billed to customers as sales. Accruals for sales returns, price protection, and other allowances are provided at the time of shipment based upon past experience. Adjustments to such returns and allowances are made as new information becomes available. We accrue for rebates, price protection, and other customer sales allowances in accordance with specific customer arrangements. Such rebates are recorded as a reduction of sales. | ||||||||||
Accounting for remanufacturing operations | ||||||||||
Core deposits | ||||||||||
Remanufacturing is the process where failed or used components, commonly known as cores, are disassembled into subcomponents, cleaned, inspected, tested, combined with new subcomponents and reassembled into saleable, finished products. With many customers, a deposit is charged for the core. Upon return of a core, we grant the customer a credit based on the core deposit value. Deposits charged by us totaled $91,318,000, $87,866,000, and $113,670,000 for the years ended December 31, 2013, 2012, and 2011, respectively. Core deposits are excluded from revenue. We generally limit core returns to the quantity of similar, remanufactured cores previously sold to the customer. | ||||||||||
Core liability | ||||||||||
We record a liability for core returns based on cores expected to be returned. This liability is recorded in “Other current liabilities and accrued expenses” in the accompanying consolidated balance sheets. The liability represents the difference between the core deposit value to be credited to the customer and the estimated core inventory value of the core to be returned. Revisions to these estimates are made periodically to consider current costs and customer return trends. | ||||||||||
Core inventory | ||||||||||
Upon receipt of a core, we record inventory at lower of cost or fair market value. The value of a core declines over its estimated useful life (ranging from 4 to 30 years) and is devalued accordingly. Carrying value of the core inventory is evaluated by comparing current prices obtained from core brokers to carrying cost. The devaluation of core carrying value is reflected as a charge to cost of goods sold. Core inventory that is deemed to be obsolete or in excess of current and future projected demand is written down to the lower of cost or market and charged to cost of goods sold. Core inventories are classified as “Inventories” in the accompanying consolidated balance sheets. | ||||||||||
Customer contract intangibles | ||||||||||
Upon entering into new or extending existing contracts, we may be required to purchase certain cores and inventory from our customers at retail prices, or be obligated to provide certain agreed support. The excess of the prices paid for the cores and inventory over fair value, and the value of any agreed support, are recorded as contract intangibles and amortized as a reduction to revenue on a method to reflect the pattern of economic benefit consumed. Customer contract intangibles that are determined in accordance with the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 805, Business Combinations, and which are not paid to the customers, are amortized and recorded in cost of goods sold. Contract intangibles are included in “Intangibles, net” in the noncurrent asset section of the accompanying consolidated balance sheets. | ||||||||||
Customer obligations | ||||||||||
Customer obligations relate to liabilities when we enter into new or amend existing customer contracts. These contracts designate us to be the exclusive supplier to the respective customer, product line or distribution center and require us to compensate these customers over several years. | ||||||||||
In addition, we have entered into arrangements with certain customers where we purchased the cores held in their inventory. Credits to be issued to these customers for these arrangements are recorded at net present value and are reflected as “Customer obligations.” These obligations are included in “Other current liabilities and accrued expenses” and “Other noncurrent liabilities” in the accompanying consolidated balance sheets. Subsequent to the arrangements, the inventory owned by these customers only represents the exchange value of the remanufactured product. | ||||||||||
Right of core return | ||||||||||
When we enter into arrangements to purchase certain cores held in a customer's inventory or when the customer is not charged a deposit for the core, we have the right to receive a core from the customer in return for every exchange unit supplied to them. We classify such rights as “Core return rights” in “Other noncurrent assets” in the accompanying consolidated balance sheets. The core return rights are valued based on the underlying core inventory values. Devaluation of these rights is charged to cost of goods sold. On a periodic basis, we settle with a customer for cores that have not been returned. | ||||||||||
Government grants | ||||||||||
We record government grants when there is reasonable assurance that the grant will be received and we will comply with the conditions attached to the grants received. Grants related to income are recorded as an offset to the related expense in the accompanying statements of operations. Grants related to assets are recorded as deferred revenue and recognized on a straight-line basis over the useful life of the related asset. We continue to evaluate our compliance with the conditions attached to the related grants. | ||||||||||
The U.S. Department of Energy, or the DOE, awarded us a grant in 2009, pursuant to which it agreed to match up to $60,200,000 of eligible expenditures we make through 2012 for the commercialization of hybrid electric motor technology. We obtained agreements from the DOE to extend the period of eligibility for the grant through 2013. As of December 31, 2012, we have completed the first phase of the grant award and have received $36,000,000 of the total grant. As a number of our hybrid customers have delayed launches of their products or cancelled their programs, we are now moderating our investments in hybrid until the market develops. On July 10, 2013, we formally notified the DOE that we have elected not to pursue the second phase of the grant. | ||||||||||
In addition, we received various grants and subsidies from foreign jurisdictions during the three year period ended December 31, 2013. The amounts recognized in the accompanying consolidated statements of operations as government grants were as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Reduction of cost of goods sold | $ | 2,427 | $ | 4,820 | $ | 5,529 | ||||
Reduction of selling, general, and administrative expenses | $ | 743 | $ | 6,491 | $ | 7,691 | ||||
We had deferred revenue of $6,283,000 and $7,414,000 related to government grants as of December 31, 2013 and 2012, respectively. | ||||||||||
Research and development | ||||||||||
We conduct research and development programs that are expected to contribute to future earnings. Such costs are included in selling, general and administrative expenses in the consolidated statements of operations. Company-funded research and development expenses were approximately $15,543,000, $26,004,000, and $26,548,000, for the years ended December 31, 2013, 2012, and 2011, respectively. The decrease in research and development programs in 2013 correlate with the end of the DOE grant in December 2012 as noted above. | ||||||||||
Customer-funded research and development expenses, recorded as an offset to research and development expense in selling, general and administrative expenses, were approximately $969,000, $967,000, and $405,000, for the years ended December 31, 2013, 2012, and 2011, respectively. | ||||||||||
Cash and cash equivalents | ||||||||||
All cash balances and highly liquid investments with maturities of ninety days or less when acquired are considered cash and cash equivalents. The carrying amount of cash equivalents approximates fair value. | ||||||||||
Trade accounts receivable and allowance for doubtful accounts | ||||||||||
Trade accounts receivable is stated at net realizable value, which approximates fair value. Substantially all of our trade accounts receivable are due from customers in the original equipment and aftermarket automotive industries, both domestically and internationally. Trade accounts receivable include notes receivables of $27,154,000 and $29,091,000 as of December 31, 2013 and 2012, respectively. Trade accounts receivable is reduced by an allowance for amounts that are expected to become uncollectible in the future and for disputed items. We perform periodic credit evaluations of our customers' financial condition and generally do not require collateral. We maintain allowances for doubtful customer accounts for estimated losses resulting from the inability of our customers to make required payments. The allowance for doubtful accounts is developed based on several factors including customers' credit quality, historical write-off experience and any known specific issues or disputes which exist as of the balance sheet date. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. | ||||||||||
Inventories other than core inventory | ||||||||||
Inventories other than core inventory are carried at the lower of cost or market determined on the first-in, first-out (FIFO) method. We evaluate inventories on a regular basis to identify inventory on hand that may be obsolete or in excess of current and future projected market demand. For inventory deemed to be obsolete or in excess of current and future projected market demand, we record an inventory reserve and a charge to cost of goods sold to reduce carrying cost to lower of cost or market. | ||||||||||
Property, plant and equipment | ||||||||||
Property, plant and equipment are recorded at cost. Major expenditures that significantly extend the useful life or enhance the usability of the property, plant or equipment are capitalized. Depreciation is calculated primarily using the straight-line method over the estimated useful lives of the related assets (15 to 40 years for buildings, and 3 to 15 years for tooling, machinery and equipment). Capital leases and leasehold improvements are amortized over the shorter of the lease term or their estimated useful life. | ||||||||||
Valuation of long-lived assets | ||||||||||
When events or circumstances indicate a potential impairment to the carrying value, we evaluate the carrying value of long-lived assets, including certain intangible assets, for recoverability through an undiscounted cash flow analysis. When such events or circumstances arise which indicate the long-lived asset is not recoverable, fair market value is determined by asset, or the appropriate grouping of assets, and is compared to the asset's carrying value to determine if impairment exists. Asset impairments are recorded as a charge to operations, based on the amount by which the carrying value exceeds the fair market value. Long-lived assets to be disposed of other than by sale are considered held and used until such time the asset is disposed. | ||||||||||
Tooling | ||||||||||
Tooling, which is included in machinery and equipment in the accompanying consolidated balance sheets, includes the costs to design and develop tools, dies, jigs and other items owned by us and used in the manufacture of products sold under long-term supply agreements. Tooling is amortized over the tool's expected life. Tooling that involves new technology not covered by a customer supply agreement is expensed as incurred. Engineering, testing and other costs incurred in the design and development of products and product components are expensed as incurred. | ||||||||||
Goodwill and other intangible assets | ||||||||||
Goodwill and indefinite-lived intangible assets are not amortized, but are tested for impairment at least annually. We perform our annual impairment test in the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. We determine goodwill impairment charges by comparing the carrying value of each reporting unit to the fair value of the reporting unit. In determining fair value of reporting units, we utilize discounted cash flow analyses and guideline company market multiples. Where the carrying value exceeds the fair value for a particular reporting unit, goodwill impairment charges may be recognized. | ||||||||||
Definite-lived intangible assets have been stated at estimated fair value as a result of fresh-start reporting. The values of other intangible assets with determinable useful lives are amortized on a basis to reflect the pattern of economic benefit consumed. Prior to the application of fresh-start, intangible assets were stated at cost. Certain amortization of intangibles associated with specific customers in the aftermarket business is recorded as a reduction of sales. | ||||||||||
Foreign currency translation | ||||||||||
Each of our foreign subsidiaries' functional currency as of December 31, 2013, is its local currency, with the exception of our subsidiaries in Mexico, for which the U.S. dollar is the functional currency since substantially all of the purchases and sales are denominated in U.S. dollars, and in Hungary, for which the Euro is the functional currency as substantially all of the purchases and sales are denominated in Euro. Financial statements of foreign subsidiaries for which the functional currency is their local currency are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and at the average exchange rate for each year for revenue and expenses. Translation adjustments are recorded as a separate component of stockholders' equity and reflected in other comprehensive income (loss) (“OCI”). For each of our foreign subsidiaries, gains and losses arising from transactions denominated in a currency other than the functional currency are included in the accompanying consolidated statements of operations. We evaluate our foreign subsidiaries' functional currency on an ongoing basis. | ||||||||||
Derivative financial instruments | ||||||||||
In the normal course of business, our operations are exposed to continuing fluctuations in foreign currency values, interest rates and commodity prices that can affect the cost of operating, investing and financing. Accordingly, we address a portion of these risks through a controlled program of risk management that includes the use of derivative financial instruments. We have historically used derivative financial instruments for the purpose of hedging currency, interest rate, and commodity exposures, which exist as a part of ongoing business operations. | ||||||||||
As a policy, we do not engage in speculative or leveraged transactions, nor do we hold or issue derivative financial instruments for trading purposes. Our objectives for holding derivatives are to minimize risks using the most effective and cost-efficient methods available. Management routinely reviews the effectiveness of the use of derivative financial instruments. | ||||||||||
We recognize all of our derivative instruments as either assets or liabilities at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated, and is effective, as a hedge and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation. Gains and losses related to a hedge are either recognized in income immediately to offset the gain or loss on the hedged item or are deferred and reported as a component of “Accumulated other comprehensive income (loss)” (“AOCI”) and subsequently recognized in earnings when the hedged item affects earnings. The change in fair value of the ineffective portion of a financial instrument, determined using the change in fair value method, is recognized in earnings immediately. The gain or loss related to financial instruments that are not designated as hedges is recognized immediately in earnings. | ||||||||||
Warranty | ||||||||||
We provide certain warranties relating to quality and performance of our products. An allowance for the estimated future cost of product warranties and other defective product returns is based on management's estimate of product failure rates and customer eligibility. If these factors differ from management's estimates, revisions to the estimated warranty liability may be required. The specific terms and conditions of the warranties vary depending upon the customer and the product sold. | ||||||||||
Income taxes | ||||||||||
We account for income taxes in accordance with FASB ASC Topic 740, Income Taxes, which requires deferred tax assets and liabilities to be recognized using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. FASB ASC Topic 740 also requires deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. | ||||||||||
We assess the need to maintain a valuation allowance for deferred tax assets based on an assessment of whether it is more likely than not that deferred tax benefits will be realized through the generation of future taxable income. Appropriate consideration is given to all available evidence, both positive and negative, in assessing the need for a valuation allowance. | ||||||||||
Failure to achieve forecasted taxable income may affect the ultimate realization of certain deferred tax assets arising from net operating losses. Factors that may affect our ability to achieve sufficient forecasted taxable income include, but are not limited to, general economic conditions, increased competition or other market conditions, costs incurred or delays in product availability. | ||||||||||
Pension and postretirement plans | ||||||||||
We maintain limited defined benefit pension plans and other postretirement benefit plans, as well as a supplemental employee retirement plan covering certain executives. Costs associated with these plans are based on actuarial computations. Inherent in these valuations are key assumptions regarding discount rates, expected return on plan assets, rates of compensation increases, and the rates of health care benefit increases. If future trends in these assumptions prove to differ from management's assumptions, revisions to the plan assets and benefit obligations may be required. | ||||||||||
Earnings per share | ||||||||||
Basic earnings per share are calculated by dividing net income attributable to common stockholders by the weighted average shares outstanding during the period. Diluted earnings per share are based on the weighted average number of shares outstanding plus the assumed issuance of common shares and related adjustment to net income attributable to common stockholders related to all potentially dilutive securities. For the years ended December 31, 2013, 2012 and 2011, in applying the treasury stock method, equivalent shares of unvested restricted stock and restricted stock units of 181,603, 374,288 and 578,288, respectively, were included in the weighted average shares outstanding in the diluted calculation. Anti-dilutive stock options of 218,050 were excluded from the calculation of dilutive earnings per share for the year ended December 31, 2013. | ||||||||||
Stock-based compensation | ||||||||||
We account for stock-based compensation plans using the fair value method. Using the fair value method of accounting, compensation expense is measured based on the fair value of the award at the grant date, using the Black-Scholes Model for stock options and the fair market value of our common stock for restricted stock, and recognized straight line over the service period. Performance awards are adjusted for the estimated percentage attainment related to those awards granted with performance conditions. | ||||||||||
Restricted stock unit awards that are to be settled in cash are subject to liability accounting. Accordingly, the fair value for such awards are calculated each reporting period based on our most recent closing stock price. As such, the liability is adjusted, and expense is recognized, based on changes to the fair value and the percentage of time vested. | ||||||||||
Recent accounting adoptions | ||||||||||
In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220), Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. ASU No. 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. We adopted this guidance on January 1, 2013. The adoption of this guidance increased our disclosures, but did not have an impact on our consolidated financial position, results of operations or cash flows. | ||||||||||
In December 2011, the FASB issued ASU No. 2011-11, Balance Sheet (Topic 210), Disclosures about Offsetting Assets and Liabilities, which requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. In January 2013, the FASB issued ASU No. 2013-01, Clarifying the Scope of Disclosures About Offsetting Assets and Liabilities, that limits the scope of the new balance sheet offsetting disclosures to derivatives, repurchase agreements and securities lending transactions to the extent they are offset in the financial statements or subject to an enforceable master netting arrangement or similar agreement. ASU No. 2011-11, as clarified by ASU No. 2013-01, is effective for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. We adopted this guidance on January 1, 2013. The adoption of this guidance had an immaterial impact. | ||||||||||
In July 2012, the FASB issued ASU No. 2012-02, Intangibles-Goodwill and Other (Topic 350), Testing Indefinite-Lived Intangible Assets for Impairment, which permits an entity to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test. ASU No. 2012-02 is effective for annual reporting periods beginning on or after September 15, 2012 and interim periods within those annual periods. The adoption of this guidance did not have an impact on our consolidated financial position, results of operations or cash flows. | ||||||||||
New accounting pronouncements | ||||||||||
In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists to provide guidance on the presentation of unrecognized tax benefits. ASU 2013-11 requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with certain limited exceptions. ASU 2013-11 is effective for annual reporting periods beginning on or after December 15, 2013 and interim periods within those annual periods with earlier adoption permitted. This guidance is effective January 1, 2014. ASU 2013-11 should be applied prospectively with retroactive application permitted. The adoption of this guidance is not expected to have a material impact on our consolidated financial position, results of operations or cash flows. |
Fair_Value_Measurement
Fair Value Measurement | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Fair value measurements [Abstract] | ' | |||||||||||||||
Fair Value Disclosures | ' | |||||||||||||||
3. Fair value measurements | ||||||||||||||||
FASB ASC Topic 820, Fair Value Measurements and Disclosures, clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based upon assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, FASB ASC Topic 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: | ||||||||||||||||
Level 1: | Observable inputs such as quoted prices in active markets; | |||||||||||||||
Level 2: | Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and | |||||||||||||||
Level 3: | Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. | |||||||||||||||
An asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. | ||||||||||||||||
Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques noted in FASB ASC Topic 820: | ||||||||||||||||
A. | Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. | |||||||||||||||
B. | Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost). | |||||||||||||||
C. | Income approach: Techniques to convert future amounts to a single present amount based upon market expectations (including present value techniques, option-pricing and excess earnings models). | |||||||||||||||
Assets and liabilities remeasured and disclosed at fair value on a recurring basis as of December 31, 2013 and 2012, are set forth in the table below: | ||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | |||||||||||||||
(In thousands) | Asset/ | Level 2 | Valuation | Asset/ | Level 2 | Valuation | ||||||||||
(liability) | technique | (liability) | technique | |||||||||||||
Interest rate swap contracts | $ | 727 | $ | 727 | C | $ | (2,218 | ) | $ | (2,218 | ) | C | ||||
Foreign exchange contracts | 3,417 | 3,417 | C | 5,328 | 5,328 | C | ||||||||||
Commodity contracts | (1,333 | ) | (1,333 | ) | C | (1,315 | ) | (1,315 | ) | C | ||||||
We calculate the fair value of our interest rate swap contracts, commodity contracts and foreign currency contracts using quoted interest rate curves, quoted commodity forward rates and quoted currency forward rates. For contracts which, when aggregated by counterparty, are in a liability position, the discount rates are adjusted by the credit spread that market participants would apply if buying these contracts from our counterparties. | ||||||||||||||||
The following table presents our defined benefit plan assets measured at fair value on a recurring basis as of December 31, 2013: | ||||||||||||||||
(In thousands of dollars) | Total | Level 1 | Valuation | |||||||||||||
technique | ||||||||||||||||
U.S. Plans: | ||||||||||||||||
Interest-bearing cash and equivalents | $ | 2,563 | $ | 2,563 | A | |||||||||||
Investments with Registered Investment Companies: | ||||||||||||||||
Fixed income securities | 14,550 | 14,550 | A | |||||||||||||
Equity securities | 25,798 | 25,798 | A | |||||||||||||
42,911 | 42,911 | |||||||||||||||
Non U.S. Plans: | ||||||||||||||||
Interest-bearing cash and equivalents | 6,417 | 6,417 | A | |||||||||||||
Investments with Registered Investment Companies: | ||||||||||||||||
Fixed income securities | 3,858 | 3,858 | A | |||||||||||||
Equity securities | 6,800 | 6,800 | A | |||||||||||||
17,075 | 17,075 | |||||||||||||||
Total | $ | 59,986 | $ | 59,986 | ||||||||||||
The following table presents our defined benefit plan assets measured at fair value on a recurring basis as of December 31, 2012: | ||||||||||||||||
(In thousands of dollars) | Total | Level 1 | Valuation | |||||||||||||
technique | ||||||||||||||||
U.S. Plans: | ||||||||||||||||
Interest-bearing cash and equivalents | $ | 2,329 | $ | 2,329 | A | |||||||||||
Investments with Registered Investment Companies: | ||||||||||||||||
Fixed income securities | 12,838 | 12,838 | A | |||||||||||||
Equity securities | 22,732 | 22,732 | A | |||||||||||||
37,899 | 37,899 | |||||||||||||||
Non U.S. Plans: | ||||||||||||||||
Interest-bearing cash and equivalents | 89 | 89 | A | |||||||||||||
Investments with Registered Investment Companies: | ||||||||||||||||
Fixed income securities | 3,792 | 3,792 | A | |||||||||||||
Equity securities | 5,569 | 5,569 | A | |||||||||||||
9,450 | 9,450 | |||||||||||||||
Total | $ | 47,349 | $ | 47,349 | ||||||||||||
Investments with registered investment companies are valued at the closing price reported on the active market on which the funds are traded. | ||||||||||||||||
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities that are measured at fair value on a nonrecurring basis. As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets (see Notes 6, 7 and 15). We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on our assumptions as observable inputs are not available. As such, we have determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. |
Financial_Instruments
Financial Instruments | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||
Financial Instruments Disclosure | ' | ||||||||||||||||
4. Financial instruments | |||||||||||||||||
Foreign currency risk | |||||||||||||||||
We manufacture and sell our products primarily in North America, South America, Asia, Europe and Africa. As a result our financial results could be significantly affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets in which we manufacture and sell our products. We generally try to use natural hedges within our foreign currency activities, including the matching of revenues and costs, to minimize foreign currency risk. Where natural hedges are not in place, we consider managing certain aspects of our foreign currency activities through the use of foreign exchange contracts. We primarily utilize forward exchange contracts with maturities generally within eighteen months to hedge against currency rate fluctuations, and are designated as hedges. | |||||||||||||||||
As of December 31, 2013 and 2012, we had the following outstanding foreign currency contracts that were entered into to hedge forecasted purchases and revenues, respectively: | |||||||||||||||||
(In thousands) | Currency denomination | ||||||||||||||||
as of December 31, | |||||||||||||||||
Foreign currency contract | 2013 | 2012 | |||||||||||||||
South Korean Won Forward | $ | 74,368 | $ | 55,546 | |||||||||||||
Mexican Peso Contracts | $ | 73,520 | $ | 66,674 | |||||||||||||
Brazilian Real Forward | $ | 11,427 | $ | 18,055 | |||||||||||||
Hungarian Forint Forward | € | 14,416 | € | 13,565 | |||||||||||||
Great Britain Pound Forward | £ | 3,735 | £ | 1,370 | |||||||||||||
Accumulated unrealized net gains of $2,520,000 and $3,426,000 were recorded in AOCI as of December 31, 2013 and 2012, respectively. As of December 31, 2013, gains of $2,562,000 are expected to be reclassified to the consolidated statement of operations within the next twelve months. Any ineffectiveness during the years ended December 31, 2013, 2012, and 2011, respectively was immaterial. The Mexican Peso contracts with 2011 settlements were undesignated hedges and the changes in the fair value were recorded as cost of goods sold in the consolidated statement of operations. | |||||||||||||||||
Interest rate risk | |||||||||||||||||
During 2010, we entered into an interest rate swap agreement in respect to 50% of the outstanding principal balance of our Term B Loan under which we swapped a variable LIBOR rate with a floor of 1.75% to a fixed rate of 3.345%. Due to the significant value of terminated swaps which were rolled into this Term B Loan swap, this Term B Loan interest rate swap was an undesignated hedge and changes in the fair value were recorded as interest expense-net in the accompanying consolidated statements of operations. | |||||||||||||||||
On March 27, 2013, we terminated our undesignated Term B Loan interest rate swap and transferred the value into a new undesignated interest rate swap agreement of $72,000,000 of the outstanding principal loan balance under which we swap a variable LIBOR rate with a floor of 1.25% to a fixed rate of 4.045% with an effective date of December 30, 2016 and expiration date of December 31, 2019. The notional value of this interest rate swap is $72,000,000, and is reduced by $187,500 quarterly from the effective date. Due to the significant value of the terminated swaps which were transferred into this new swap, this interest rate swap is an undesignated hedge and changes in the fair value are recorded as interest expense-net in the accompanying consolidated statements of operations. | |||||||||||||||||
On March 27, 2013, we also entered into a designated interest rate swap agreement for $72,000,000 of the outstanding principal balance of our long term debt. Under the terms of the new interest rate swap agreement, we swap a variable LIBOR rate with a floor of 1.25% to a fixed rate of 2.75% with an effective date of December 30, 2016 and expiration date of December 31, 2019. The notional value of this interest rate swap is $72,000,000, and is reduced by $187,500 quarterly from the effective date. This interest rate swap has been designated as a cash flow hedging instrument. Accumulated unrealized gains of $1,455,000, excluding the tax effect, were recorded in AOCI as of December 31, 2013, and there were none recorded as of December 31, 2012. As of December 31, 2013, no gains are expected to be reclassified to the consolidated statement of operations within the next twelve months. Any ineffectiveness during the years ended December 31, 2013, 2012, and 2011, respectively was immaterial. | |||||||||||||||||
The interest rate swaps reduce our overall interest rate risk. However, due to the remaining outstanding borrowings on the Amended and Restated Term B Loan and other borrowing facilities that continue to have variable interest rates, management believes that interest rate risk to us could be material if there are significant adverse changes in interest rates. | |||||||||||||||||
Commodity price risk | |||||||||||||||||
Our production processes are dependent upon the supply of certain components whose raw materials are exposed to price fluctuations on the open market. The primary purpose of our commodity price forward contract activity is to manage the volatility associated with forecasted purchases. We monitor our commodity price risk exposures regularly to maximize the overall effectiveness of our commodity forward contracts. The principal raw material hedged is copper. Forward contracts are used to mitigate commodity price risk associated with raw materials, generally related to purchases forecast for up to twenty-four months in the future. Additionally, we purchase certain commodities during the normal course of business which result in physical delivery and are excluded from hedge accounting. | |||||||||||||||||
We had thirty-two commodity price hedge contracts outstanding at December 31, 2013, and thirty-six commodity price hedge contracts outstanding at December 31, 2012, with combined notional quantities of 6,368 and 6,566 metric tons of copper, respectively. These contracts mature within the next eighteen months. These contracts were designated as cash flow hedging instruments. Accumulated unrealized net losses of $1,319,000 and $1,288,000, excluding the tax effect, were recorded in AOCI as of December 31, 2013 and 2012, respectively. As of December 31, 2013, pre-tax losses of $1,511,000 are expected to be reclassified to the accompanying consolidated statement of operations within the next 12 months. Hedge ineffectiveness during the years ended December 31, 2013, 2012, and 2011, was immaterial. | |||||||||||||||||
Other | |||||||||||||||||
We present our derivative positions and any related material collateral under master netting agreements on a gross basis. We have entered into International Swaps and Derivatives Association agreements with each of its significant derivative counterparties. These agreements provide bilateral netting and offsetting of accounts that are in a liability position with those that are in an asset position. These agreements do not require us to maintain a minimum credit rating in order to be in compliance with the terms of the agreements and do not contain any margin call provisions or collateral requirements that could be triggered by derivative instruments in a net liability position. As of December 31, 2013, we have not posted any collateral to support its derivatives in a liability position. | |||||||||||||||||
For derivatives designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness. Unrealized gains and losses associated with ineffective hedges, determined using the change in fair value method, are recognized in the accompanying consolidated statements of operations. Derivative gains and losses included in AOCI for effective hedges are reclassified into the accompanying consolidated statements of operations upon recognition of the hedged transaction. | |||||||||||||||||
Any derivative instrument designated initially, but no longer effective as a hedge, or initially not effective as a hedge, is recorded at fair value and the related gains and losses are recognized in the accompanying consolidated statements of operations. Our undesignated hedges are primarily our interest rate swaps whose fair value at inception of the instrument due to the roll over of existing interest rate swaps resulted in ineffectiveness. The following table discloses the fair values and balance sheet locations of our derivative instruments: | |||||||||||||||||
Asset derivatives | Liability derivatives | ||||||||||||||||
(In thousands) | Balance sheet location | December 31, 2013 | December 31, 2012 | Balance sheet location | December 31, 2013 | December 31, 2012 | |||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||
Commodity contracts | Prepaid expenses and other current assets | $ | 257 | $ | 427 | Other current liabilities and accrued expenses | $ | — | $ | 2,009 | |||||||
Commodity contracts | Other noncurrent assets | 195 | 267 | Other noncurrent liabilities | 1,785 | — | |||||||||||
Foreign currency contracts | Prepaid expenses and other current assets | 3,630 | 5,537 | Other current liabilities and accrued expenses | 141 | 26 | |||||||||||
Foreign currency contracts | Other noncurrent assets | 108 | 127 | Other noncurrent liabilities | 180 | 310 | |||||||||||
Interest rate swap contracts | Other noncurrent assets | 1,455 | — | Other noncurrent liabilities | — | — | |||||||||||
Total derivatives designated as hedging instruments | $ | 5,645 | $ | 6,358 | $ | 2,106 | $ | 2,345 | |||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||
Interest rate swap contracts | Prepaid expenses and other current assets | $ | — | $ | — | Other current liabilities and accrued expenses | $ | — | $ | 2,218 | |||||||
Interest rate swap contracts | Other noncurrent assets | — | — | Other noncurrent liabilities | 728 | — | |||||||||||
Total derivatives not designated as hedging instruments | $ | — | $ | — | $ | 728 | $ | 2,218 | |||||||||
The following tables disclose the effect of our derivative instruments on the accompanying consolidated statement of operations for the year ended December 31, 2013 (in thousands): | |||||||||||||||||
Derivatives designated as cash | Amount of gain (loss) recognized in OCI on derivatives (effective portion) | Location of gain (loss) reclassified from AOCI into income (effective portion) | Amount of gain (loss) reclassified from AOCI into income (effective portion) | Location of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | Amount of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | ||||||||||||
flow hedging instruments | |||||||||||||||||
Commodity contracts | $ | (3,987 | ) | Cost of goods sold | $ | (3,956 | ) | Cost of goods sold | $ | (54 | ) | ||||||
Foreign currency contracts | 4,594 | Cost of goods sold | 5,751 | Cost of goods sold | — | ||||||||||||
Interest rate swap contracts | 1,455 | Interest expense–net | — | Interest expense–net | — | ||||||||||||
$ | 2,062 | $ | 1,795 | $ | (54 | ) | |||||||||||
Derivatives not designated as hedging instruments | Location of gain (loss) recognized in income on derivatives | Amount of gain (loss) recognized in income on derivatives | |||||||||||||||
Interest rate swap | Interest expense–net | $ | 1,490 | ||||||||||||||
The following tables disclose the effect of our derivative instruments on the accompanying consolidated statement of operations for the year ended December 31, 2012 (in thousands): | |||||||||||||||||
Derivatives designated as | Amount of | Location of gain | Amount of | Location of gain | Amount of gain | ||||||||||||
cash flow hedging | gain (loss) | (loss) reclassified from | gain | (loss) recognized in | (loss) | ||||||||||||
instruments | recognized | AOCI into income | (loss) | income on derivatives | recognized | ||||||||||||
in | (effective portion) | reclassified | (ineffective portion | in income on | |||||||||||||
OCI on | from AOCI | and amount excluded | derivatives | ||||||||||||||
derivatives | into | from effectiveness | (ineffective | ||||||||||||||
(effective | income | testing) | portion and | ||||||||||||||
portion) | (effective | amount | |||||||||||||||
portion) | excluded from | ||||||||||||||||
effectiveness | |||||||||||||||||
testing) | |||||||||||||||||
Commodity contracts | $ | (5 | ) | Cost of goods sold | $ | (4,043 | ) | Cost of goods sold | $ | (7 | ) | ||||||
Foreign currency | 12,809 | Cost of goods sold | (2,965 | ) | Cost of goods sold | — | |||||||||||
contracts | |||||||||||||||||
$ | 12,804 | $ | (7,008 | ) | $ | (7 | ) | ||||||||||
Derivatives not designated as hedging instruments | Location of gain | Amount of gain | |||||||||||||||
(loss) recognized in | (loss) recognized | ||||||||||||||||
income on | in income on | ||||||||||||||||
derivatives | derivatives | ||||||||||||||||
Interest rate swap contracts | Interest expense–net | $ | (466 | ) | |||||||||||||
The following tables disclose the effect of our derivative instruments on the accompanying consolidated statement of operations for the year ended December 31, 2011 (in thousands): | |||||||||||||||||
Derivatives designated as | Amount of | Location of gain | Amount of | Location of gain | Amount of gain | ||||||||||||
cash flow hedging | gain (loss) | (loss) reclassified from | gain | (loss) recognized in | (loss) | ||||||||||||
instruments | recognized | AOCI into income | (loss) | income on derivatives | recognized | ||||||||||||
in | (effective portion) | reclassified | (ineffective portion | in income on | |||||||||||||
OCI on | from AOCI | and amount excluded | derivatives | ||||||||||||||
derivatives | into | from effectiveness | (ineffective | ||||||||||||||
(effective | income | testing) | portion and | ||||||||||||||
portion) | (effective | amount | |||||||||||||||
portion) | excluded from | ||||||||||||||||
effectiveness | |||||||||||||||||
testing) | |||||||||||||||||
Commodity contracts | $ | (7,722 | ) | Cost of goods sold | $ | 6,742 | Cost of goods sold | $ | (91 | ) | |||||||
Foreign currency | (7,567 | ) | Cost of goods sold | 2,658 | Cost of goods sold | — | |||||||||||
contracts | |||||||||||||||||
$ | (15,289 | ) | $ | 9,400 | $ | (91 | ) | ||||||||||
Derivatives not designated as hedging instruments | Location of gain | Amount of gain | |||||||||||||||
(loss) recognized in | (loss) recognized | ||||||||||||||||
income on | in income on | ||||||||||||||||
derivatives | derivatives | ||||||||||||||||
Foreign currency contracts | Cost of goods sold | $ | (2,213 | ) | |||||||||||||
Interest rate swap contracts | Interest expense–net | $ | (1,659 | ) | |||||||||||||
Concentrations of credit risk | |||||||||||||||||
Financial instruments, which potentially subject us to concentrations of credit risk, consist primarily of accounts receivable and cash investments. We require placement of cash in financial institutions evaluated as highly creditworthy. Our customer base includes global light and commercial vehicle manufacturers and a large number of retailers, distributors and installers of automotive aftermarket parts. Our credit evaluation process and the geographical dispersion of sales transactions help to mitigate credit risk concentration. We conduct a significant amount of business with GM, Hyundai Motor Corporation ("Hyundai"), and three large automotive parts retailers. Net sales to these customers in the aggregate represented 48.3%, 50.1%, and 49.1% of consolidated net sales for the years ended December 31, 2013, 2012, and 2011, respectively. | |||||||||||||||||
GM represents our largest customer and accounted for approximately 16.2%, 20.7%, and 20.7% of our net sales for the years ended December 31, 2013, 2012, and 2011, respectively. Net sales to Hyundai accounted for approximately 10.4%, 8.8%, and 7.9% of our net sales for the year ended December 31, 2013, 2012, and 2011, respectively. | |||||||||||||||||
Accounts receivable factoring arrangements | |||||||||||||||||
We have entered into factoring agreements with various domestic, Korean and European financial institutions to sell our accounts receivable under nonrecourse agreements. These are treated as a sale. The transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. We do not service any domestic accounts after the factoring has occurred. We do not have any servicing assets or liabilities. We utilize factoring arrangements as an integral part of financing for us. The cost of factoring such accounts receivable is reflected in the accompanying consolidated statements of operations as interest expense with other financing costs. The cost of factoring such accounts receivable for the years ended December 31, 2013, 2012, and 2011, was $5,710,000, $5,472,000 and $6,501,000, respectively. Gross amounts factored under these facilities as of December 31, 2013 and 2012, were $244,940,000 and $183,547,000, respectively. Any change in the availability of these factoring arrangements could have a material adverse effect on our financial condition. |
Inventory
Inventory | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Inventory [Abstract] | ' | ||||||
Inventory Disclosure | ' | ||||||
5. Inventories | |||||||
Net inventories consisted of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Raw materials | $ | 42,322 | $ | 47,972 | |||
Core inventory | 36,581 | 31,191 | |||||
Work-in-process | 8,398 | 9,934 | |||||
Finished goods | 72,039 | 69,839 | |||||
$ | 159,340 | $ | 158,936 | ||||
Raw materials also include materials consumed in the manufacturing and remanufacturing process, but not directly incorporated into the finished products. |
PPE
PP&E | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
PP&E [Abstract] | ' | ||||||
Property, Plant and Equipment Disclosure | ' | ||||||
6. Property, plant and equipment | |||||||
Property, plant and equipment consisted of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Land and buildings | $ | 44,762 | $ | 43,272 | |||
Machinery and equipment | 204,564 | 184,683 | |||||
$ | 249,326 | $ | 227,955 | ||||
Depreciation and amortization expense of property, plant, and equipment, including assets recorded under capital leases, for the years ended December 31, 2013, 2012, and 2011 was $19,107,000, $19,161,000, and $19,110,000, respectively. |
Goodwill_and_Other_Intangible_
Goodwill and Other Intangible Assets | 12 Months Ended | ||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||
Goodwill and other intangible assets [Abstract] | ' | ||||||||||||||||||
Goodwill and Intangible Assets Disclosure | ' | ||||||||||||||||||
7. Goodwill and other intangible assets | |||||||||||||||||||
The following table represents the carrying value of other intangible assets: | |||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | ||||||||||||||||||
(In thousands) | Carrying | Accumulated | Net | Carrying | Accumulated | Net | |||||||||||||
value | amortization | value | amortization | ||||||||||||||||
Definite-life intangibles: | |||||||||||||||||||
Intellectual property | $ | 16,810 | $ | 4,583 | $ | 12,227 | $ | 14,370 | $ | 4,082 | $ | 10,288 | |||||||
Customer relationships | 35,500 | 17,746 | 17,754 | 35,500 | 15,150 | 20,350 | |||||||||||||
Customer contract | 97,789 | 86,061 | 11,728 | 95,389 | 74,898 | 20,491 | |||||||||||||
Total | 150,099 | 108,390 | 41,709 | 145,259 | 94,130 | 51,129 | |||||||||||||
Indefinite-life intangibles: | |||||||||||||||||||
Trade names | 48,200 | — | 48,200 | 48,200 | — | 48,200 | |||||||||||||
Intangible assets, net | $ | 198,299 | $ | 108,390 | $ | 89,909 | $ | 193,459 | $ | 94,130 | $ | 99,329 | |||||||
Goodwill | $ | 271,418 | $ | — | $ | 271,418 | $ | 271,418 | $ | — | $ | 271,418 | |||||||
Intellectual property primarily consists of patent filing costs, purchases of intellectual property, and $9,000,000 assigned as a result of applying fresh-start accounting in 2007 for the value of trade secrets, patents, and regulatory approvals. The value assigned in fresh-start accounting is based on the relief from royalty method utilizing the forecasted revenue and applying a royalty rate based on similar arm's length licensing transactions. The weighted average useful life of intellectual property intangibles as of December 31, 2013 was 12.3 years. In 2013 and 2012, we added $2,440,000 and $1,665,000 of intellectual property, respectively, at cost with a weighted average life of approximately 15 years. | |||||||||||||||||||
Customer relationships consist of $35,500,000 assigned during fresh-start in 2007 based on the value of our relationship with certain customers and the ability to generate future recurring income. The amortization period is 10 years based on an estimate of the remaining useful life. | |||||||||||||||||||
Customer contract intangibles consist of the excess of the prices paid for the cores and inventory over fair value, and the value of any agreed support for new contracts with customers and $29,800,000 assigned as a result of applying fresh-start accounting in 2007 based on our contracts with certain customers and the associated revenue streams. The weighted average useful life of the customer contract intangibles is 4.0 years. During 2013, and 2012, we had additions of approximately $2,741,000 and $4,985,000, respectively, with a weighted average useful life of 4.0 years and 4.0 years, respectively, based on the estimated useful lives of the contracts. We do not typically assume a renewal or extension of the terms in determining the amortization period. | |||||||||||||||||||
As a result of fresh-start accounting, we recorded $59,700,000 of trade names based on the earnings potential and relief of costs associated with licensing the trade names. Our trade names were assigned an indefinite life. As a result of the change in economic conditions in 2010, we reassessed the useful life of a certain indefinite life trade name. On December 31, 2010, we assigned a 10-year useful life to the trade name which had a value of $6,000,000. | |||||||||||||||||||
In the fourth quarter of 2013, 2012, and 2011, the Company performed our annual quantitative impairment analysis of goodwill, which indicated that the estimated fair value of each reporting unit substantially exceeded its corresponding carrying amount, and as such, no reporting unit was at risk of impairment. We also performed our annual impairment analysis for our indefinite-lived trademarks in the fourth quarter of 2013, 2012, and 2011 using a quantitative assessment, and concluded that no impairment existed as of the testing dates. In the third quarter of 2011, we fully impaired our defined-life intangible trade name by $5,600,000. The impairment was the result of a change in revenue being generated by the products sold under our trade name to products sold under our customer's private label brand. Our Level 3 estimated fair value analysis was based on a relief from royalty methodology utilizing the projected future revenues, and applying a royalty rate based on similar arm's length licensing transactions for the related margins. The intangible asset impairment was recorded in the accompanying consolidated statements of operations in “Intangible asset impairment charges.” | |||||||||||||||||||
We have entered into several transactions and agreements with GM and certain of its subsidiaries related to their respective businesses. Pursuant to a Trademark License Agreement between us and GM, GM granted us an exclusive license to use the “Delco Remy” trademark on and in connection with automotive starters and heavy-duty starters and alternators initially until July 31, 2004, and extendable indefinitely upon payment of a fixed $100,000 annual licensing fee to GM. The “Delco Remy” and “Remy” trademarks are registered in the U.S., Canada and Mexico and in major markets worldwide. We own the “Remy” trademark. GM has agreed that upon our request, they will register the “Delco Remy” trademark in any jurisdiction where they are not currently registered. | |||||||||||||||||||
Definite-lived intangible assets are being amortized to reflect the pattern of economic benefit consumed. We do not assume any residual value in our intangible assets. Amortization expense of definite-lived intangibles for the years ended December 31, 2013, 2012, and 2011 was $14,663,000, $18,899,000, and $22,448,000, respectively. Estimated future amortization, in thousands, for intangibles with definite lives at December 31, 2013, is: | |||||||||||||||||||
2014 | $ | 12,125 | |||||||||||||||||
2015 | 7,315 | ||||||||||||||||||
2016 | 8,092 | ||||||||||||||||||
2017 | 9,665 | ||||||||||||||||||
2018 | 521 | ||||||||||||||||||
Other_Noncurrent_Assets
Other Noncurrent Assets | 12 Months Ended |
Dec. 31, 2013 | |
Other noncurrent assets [Abstract] | ' |
Other Assets Disclosure | ' |
8. Other noncurrent assets | |
Other noncurrent assets primarily consisted of core return rights of $37,250,000 and noncurrent deferred tax assets of $22,113,000 as of December 31, 2013. Other noncurrent assets primarily consisted of core return rights of $33,908,000 and noncurrent deferred tax assets of $32,907,000 as of December 31, 2012. |
Other_Current_Liabilities_and_
Other Current Liabilities and Accrued Expenses | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Other current liabilities and accrued expenses [Abstract] | ' | |||||||||
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current | ' | |||||||||
9. Other current liabilities and accrued expenses | ||||||||||
Other current liabilities and accrued expenses consist of the following: | ||||||||||
As of December 31, | ||||||||||
(In thousands) | 2013 | 2012 | ||||||||
Accrued warranty | $ | 27,083 | $ | 23,374 | ||||||
Accrued wages and benefits | 20,016 | 18,531 | ||||||||
Current portion of customer obligations | 4,560 | 9,326 | ||||||||
Rebates, stocklifts, discounts and returns | 18,922 | 15,865 | ||||||||
Current deferred revenue | 2,270 | 2,882 | ||||||||
Other | 37,328 | 38,179 | ||||||||
$ | 110,179 | $ | 108,157 | |||||||
Changes to our current and noncurrent accrued warranty were as follows: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Balance at beginning of period | $ | 27,194 | $ | 30,278 | $ | 32,510 | ||||
Provision for warranty | 44,215 | 36,281 | 45,597 | |||||||
Payments and charges against the accrual | (40,628 | ) | (39,365 | ) | (47,829 | ) | ||||
Balance at end of period | $ | 30,781 | $ | 27,194 | $ | 30,278 | ||||
Other_Noncurrent_Liabilities
Other Noncurrent Liabilities | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Other noncurrent liabilities [Abstract] | ' | ||||||
Other Noncurrent Liabilities | ' | ||||||
10. Other noncurrent liabilities | |||||||
Other noncurrent liabilities consist of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Customer obligations, net of current portion | $ | — | $ | 3,689 | |||
Noncurrent deferred revenue | 4,755 | 5,755 | |||||
Other | 20,028 | 19,744 | |||||
$ | 24,783 | $ | 29,188 | ||||
Debt
Debt | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Debt [Abstract] | ' | ||||||
Debt Disclosure | ' | ||||||
11. Debt | |||||||
Borrowings under long-term debt arrangements, net of discounts, consisted of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Asset-Based Revolving Credit Facility, First Amendment- Maturity date of September 5, 2018 | $ | — | $ | — | |||
Term B Loan- Maturity date of December 17, 2016 | — | 284,892 | |||||
Amended and Restated Term B Loan- Maturity date of March 5, 2020 | 295,001 | — | |||||
Total Senior Credit Facility and Notes | 295,001 | 284,892 | |||||
Capital leases | 2,226 | 3,053 | |||||
Less current maturities | (3,392 | ) | (3,470 | ) | |||
Long-term debt less current maturities | $ | 293,835 | $ | 284,475 | |||
Future maturities of long-term debt outstanding at December 31, 2013, including capital lease obligations, and excluding original issue discount, in thousands, consist of the following: | |||||||
2014 | $ | 3,392 | |||||
2015 | 3,407 | ||||||
2016 | 3,421 | ||||||
2017 | 3,353 | ||||||
2018 | 3,255 | ||||||
Thereafter | 282,398 | ||||||
On March 5, 2013, we entered into a First Amendment to our existing ABL Revolver Credit Agreement ("ABL First Amendment") to extend the maturity date of the Asset-Based Revolving Credit Facility ("ABL") from December 17, 2015 to September 5, 2018 and reduce the borrowing rate. The ABL First Amendment bears an interest rate to a defined Base Rate plus 0.50%-1.00% per year or, at our election, at an applicable LIBOR Rate plus 1.50%-2.00% per year and is paid monthly. The ABL First Amendment maintains the current availability at $95,000,000, but may be increased, under certain circumstances, by $20,000,000. The ABL First Amendment is secured by substantially all domestic accounts receivable and inventory. At December 31, 2013, the revolver balance was zero. Based upon the collateral supporting the ABL First Amendment, the amount borrowed, and the outstanding letters of credit of $2,535,000, there was additional availability for borrowing of $72,521,000 on December 31, 2013. We will incur an unused commitment fee of 0.375% on the unused amount of commitments under the ABL First Amendment. | |||||||
On March 5, 2013, we entered into a $300,000,000 Amended and Restated Term B Loan Credit Agreement (“Amended and Restated Term B Loan”) to refinance the existing $286,978,000 Term B Loan, extend the maturity from December 17, 2016 to March 5, 2020, and reduce the borrowing rate. The Amended and Restated Term B Loan bears an interest rate consisting of LIBOR (subject to a floor of 1.25%) plus 3.0% per year with an original issue discount of $750,000. The Amended and Restated Term B Loan also contains an option to increase the borrowing provided certain conditions are satisfied, including maintaining a maximum leverage ratio. The Amended and Restated Term B Loan is secured by a first priority lien on the stock of our subsidiaries and substantially all domestic assets other than accounts receivable and inventory pledged to the ABL First Amendment. Principal payments in the amount of $750,000 are due at the end of each calendar quarter with termination and final payment no later than March 5, 2020. The Amended and Restated Term B facility is subject to an excess cash flow calculation, which may require the payment of additional principal on an annual basis. As of December 31, 2013, the excess cash flow calculation was zero. At December 31, 2013, the average borrowing rate, including the impact of the interest rate swaps, was 4.25%. As a result of the refinancing of our Term B Loan syndication, we recorded a loss on extinguishment of debt and refinancing fees of $4,256,000 during the quarter ended March 31, 2013. | |||||||
As of December 31, 2013, the estimated fair value of our Amended and Restated Term B Loan was $300,157,000, which was $5,156,000 more than the carrying value. As of December 31, 2012, the estimated fair value of our previous Term B Loan was $290,029,000, which was $5,137,000 more than the carrying value. The Level 2 fair market values were based on established market prices as of December 31, 2013 and 2012. The fair value estimates do not necessarily reflect the values we could realize in the current markets. Because of their short-term nature or variable interest rate, we believe the carrying value for short-term debt and the revolving credit agreement closely approximates their fair value. | |||||||
All credit agreements contain various covenants and representations that are customary for transactions of this nature. We are in compliance with all covenants as of December 31, 2013. The credit agreements contain various restrictive covenants, which include, among other things: (i) a maximum leverage ratio; (ii) a minimum interest coverage ratio; (iii) mandatory prepayments upon certain asset sales and debt issuances; and (iv) limitations on the payment of dividends in excess of a specified amount. The term loan also includes events of default customary for a facility of this type, including a cross-default provision under which the lenders may declare the loan in default if we (i) fail to make a payment when due under any debt having a principal amount greater than $5 million or (ii) breach any other covenant in any such debt as a result of which the holders of such debt are permitted to accelerate its maturity. | |||||||
Short-term debt | |||||||
We have revolving credit facilities with four Korean banks with a total facility amount of approximately $17,057,000 of which $2,369,000 is borrowed at average interest rates of 3.46% at December 31, 2013. In Hungary, there are two revolving credit facilities with two separate banks for a total facility amount of approximately of $4,316,000 of which nothing is borrowed at December 31, 2013. | |||||||
Capital leases | |||||||
Capital leases have been capitalized using nominal interest rates ranging from 4.0% to 15.1% as determined by the dates we entered into the leases. We had assets under capital leases of approximately $3,050,000 at December 31, 2013 and approximately $3,883,000 at December 31, 2012, net of accumulated amortization. |
Redeemable_Preferred_Stock
Redeemable Preferred Stock | 12 Months Ended |
Dec. 31, 2013 | |
Preferred Stock [Abstract] | ' |
Preferred Stock [Text Block] | ' |
12. Redeemable preferred stock | |
Series A Preferred Stock- As of December 31, 2010, 27,000 shares of Series A preferred stock, with a par value of $0.0001 per share, were issued and outstanding in the amount of $27,000,000, the liquidation preference amount. Preferred stockholders received a “Backstop Fee” of $500,000, which has been netted against the issuance proceeds. Series A preferred stockholders have no voting rights, except as defined in Exhibit A of the Amended and Restated Certificate of Incorporation as in effect on December 31, 2010. Dividends are cumulative whether or not declared by the board of directors and have been accrued in the amount of $739,000 for the year ended December 31, 2011. | |
Series B Preferred Stock- As of December 31, 2010, 60,000 shares of Series B preferred stock, with par value of $0.0001 per share, were issued and outstanding in the amount of $60,000,000, the liquidation preference amount. Preferred stockholders received a “Backstop Fee” of $1,200,000, which has been netted against the issuance proceeds. Series B preferred stockholders have no voting rights, except as defined in Exhibit B of the Amended and Restated Certificate of Incorporation as in effect on December 31, 2010. Dividends are cumulative whether or not declared by the board of directors and have been accrued in the amount of $1,375,000 for the year ended December 31, 2011. | |
The holders of the preferred stock were entitled to dividends which accrued on a daily basis at an annual rate of three month LIBOR plus 20% on the liquidation preference amount. If not declared and paid quarterly, such dividends were added to the liquidation preference and accrue and compound at such dividend rate (i.e. compounded quarterly with PIK). The dividends accrued and remained unpaid until conversion or liquidation, prior and in preference to any declaration or payment of any dividend on the common stock. Any partial payments, for dividends or in liquidation, were made pro rata among the holders of the preferred stock. No dividend or distribution to common stockholders could be made unless all prior dividends on the preferred stock, since the closing date, are paid or declared and sufficient funds for the payment have been set aside. | |
January 2011 Series A and Series B preferred stock redemption | |
On January 14, 2011, we received the requisite two-thirds common stockholder vote approving the amendment to our Amended and Restated Certificate of Incorporation as in effect on December 31, 2010 to allow us to redeem our Series A preferred stock and Series B preferred stock at our option. The amendment to the Amended and Restated Certificate of Incorporation allowed for us to redeem the Series A and Series B Preferred Stock at a redemption price equal to 115% of the liquidation preference plus accrued and unpaid dividends to the date of payment of the redemption proceeds. | |
On January 19, 2011, the Board of Directors declared a dividend of $37,246,000 on the shares of Series A and Series B preferred stock to stockholders of record on January 20, 2011, and issued a notice of redemption of the remaining Series A and Series B preferred stock. On January 31, 2011, we redeemed our outstanding shares of Series A and Series B preferred stock for $45,022,000, which included $5,872,000 premium of liquidation preference at redemption and accrued dividends of $153,000. In January 2011, we recorded a loss on extinguishment of our preferred stock shares of $7,572,000 related to the premium on liquidation preference at redemption and $1,700,000 related to the “Backstop Fees.” |
Stockholders_Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2013 | |
Stockholders' Equity Attributable to Parent [Abstract] | ' |
Stockholders' Equity Note Disclosure [Text Block] | ' |
13. Stockholders' equity | |
Common stock | |
On December 12, 2012, we amended our Amended and Restated Certificate of Incorporation. The amendment authorizes the Company to issue 280,000,000 shares, consisting of 240,000,000 shares of common stock, par value $0.0001 per share, and 40,000,000 shares of preferred stock, par value $0.0001 per share. As of December 31, 2013, there are 31,981,544 common stock shares outstanding and no preferred stock shares outstanding. | |
The holders of common stock are entitled to one vote on all matters properly submitted on which the common stockholders are entitled to vote. | |
December 2012 employee stock purchase plan | |
On December 21, 2012, we completed our Employee Stock Purchase plan which resulted in the issuance of 11,107 shares of common stock. The offering was for shares of common stock in a subscription offering to eligible employees of Remy and certain of their immediate family members. This is the initial public offering of the common stock of Remy. The initial public offering price was $17.00 per share. | |
Any person purchasing shares in this offering received extra shares for no additional consideration (“additional shares”) at a rate of 15 shares for every 100 shares purchased, with any fraction of an additional share rounded down. | |
The minimum number of shares that a person could have subscribed to purchase in this offering was 100 shares and the maximum (not including additional shares that would be issued) was 200 shares. | |
January 2011 common stock rights offering | |
On January 14, 2011, we received the requisite two-thirds common stockholder vote approving the rights offering with certain related parties and the proposed amendment to our certificate of incorporation which allowed us to redeem our Series A preferred stock and Series B preferred stock at our option. | |
Pursuant to the terms of the January 2011 rights offering, we offered shares of common stock at a price of $11.00 per share to existing holders of common stock as of November 12, 2010, who certified to the Company that they are accredited investors or institutional accredited investors. | |
Eligible stockholders exercised rights for 19,723,786 shares of common stock for $216,961,000, consisting of cash proceeds of approximately $123,426,000, and the cancellation of 48,004 shares of preferred stock having an aggregate liquidation preference and accrued dividends of approximately $93,535,000. Subsequent to the January 2011 rights offering, we had 31,467,367 shares of common stock issued. We utilized the proceeds from the January 2011 rights offering to redeem our remaining outstanding Series A and Series B preferred shares as discussed in Note 12. | |
Treasury stock | |
During 2013, we withheld 67,087 shares at cost, or $1,248,000, to satisfy tax obligations for vesting of restricted stock granted to our employees under the Remy International, Inc. Omnibus Incentive Plan, or "Omnibus Incentive Plan". During 2012, we withheld 15,276 shares at cost, or $229,000, to satisfy tax obligations for our Employee Stock Purchase Plan and certain vesting of restricted stock under the Omnibus Incentive Plan. | |
Dividend payment | |
Since May 2012, our Board of Directors have declared quarterly cash dividends of ten cents ($0.10) per share, and paid amounts totaling $12,669,000 and $9,226,000 for the years ended December 31, 2013 and 2012, respectively. As of December 31, 2013 and 2012, a dividend payable of $425,000 and $335,000, respectively, was recorded for unvested restricted stock and is payable upon vesting. | |
On January 30, 2014, our Board of Directors declared a quarterly cash dividend of ten cents ($0.10) per share. The dividend will be payable in cash on February 28, 2014 to stockholders of record as of the close of business February 14, 2014. |
Accumulated_Other_Comprehensiv
Accumulated Other Comprehensive Income (Loss) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
Accumulated other comprehansive income (loss) [Abstract] | ' | ||||||||||||||||||||||||
Comprehensive Income (Loss) Note | ' | ||||||||||||||||||||||||
14. Accumulated other comprehensive income (loss) | |||||||||||||||||||||||||
The following table discloses the changes in each component of accumulated other comprehensive income (loss), net of tax for the year ended December 31, 2013, 2012 and 2011 (in thousands): | |||||||||||||||||||||||||
Foreign currency translation adjustment | Unrealized gains (losses) on currency hedges | Unrealized gains (losses) on commodity hedges | Interest rate swaps | Employee benefit plan adjustment | Accumulated other comprehensive income (loss) | ||||||||||||||||||||
Balances at December 31, 2010 | $ | (17,942 | ) | $ | 712 | $ | 5,606 | $ | (1,574 | ) | $ | (8,159 | ) | $ | (21,357 | ) | |||||||||
Other comprehensive income (loss) before reclassifications | (4,682 | ) | (8,014 | ) | (7,813 | ) | — | (12,682 | ) | (33,191 | ) | ||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | — | (2,211 | ) | (6,651 | ) | — | (2,320 | ) | (11,182 | ) | |||||||||||||||
Other comprehensive income (loss) | (4,682 | ) | (10,225 | ) | (14,464 | ) | — | (15,002 | ) | (44,373 | ) | ||||||||||||||
Balances at December 31, 2011 | (22,624 | ) | (9,513 | ) | (8,858 | ) | (1,574 | ) | (23,161 | ) | (65,730 | ) | |||||||||||||
Other comprehensive income (loss) before reclassifications | 2,764 | 10,277 | 76 | — | (2,304 | ) | 10,813 | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | — | 2,662 | 2,466 | — | (518 | ) | 4,610 | ||||||||||||||||||
Other comprehensive income (loss) | 2,764 | 12,939 | 2,542 | — | (2,822 | ) | 15,423 | ||||||||||||||||||
Balances at December 31, 2012 | (19,860 | ) | 3,426 | (6,316 | ) | (1,574 | ) | (25,983 | ) | (50,307 | ) | ||||||||||||||
Other comprehensive income (loss) before reclassifications | 1,755 | 3,495 | (2,458 | ) | 886 | 6,284 | 9,962 | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | — | (4,401 | ) | 2,442 | — | 830 | (1,129 | ) | |||||||||||||||||
Other comprehensive income (loss) | 1,755 | (906 | ) | (16 | ) | 886 | 7,114 | 8,833 | |||||||||||||||||
Balances at December 31, 2013 | $ | (18,105 | ) | $ | 2,520 | $ | (6,332 | ) | $ | (688 | ) | $ | (18,869 | ) | $ | (41,474 | ) | ||||||||
The following table discloses the effect of reclassifications of accumulated other comprehensive income on the accompanying consolidated statement of operations (in thousands): | |||||||||||||||||||||||||
Details about Accumulated Other Comprehensive Income (Loss) Components | Years ended December 31, | Affected Line Item in the Statement Where Net Income is Presented | |||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Gains (losses) on cash flow hedges: | |||||||||||||||||||||||||
Foreign currency contracts | $ | 5,751 | $ | (2,965 | ) | $ | 2,658 | Cost of goods sold | |||||||||||||||||
Commodity contracts | (4,010 | ) | (4,050 | ) | 6,651 | Cost of goods sold | |||||||||||||||||||
1,741 | (7,015 | ) | 9,309 | Total before tax | |||||||||||||||||||||
218 | 1,887 | (447 | ) | Tax benefit (expense) | |||||||||||||||||||||
1,959 | (5,128 | ) | 8,862 | Net of tax | |||||||||||||||||||||
Amortization of employee benefit plan costs: | |||||||||||||||||||||||||
Prior service costs | $ | 1,816 | $ | 1,674 | $ | 7,928 | Selling, general and administrative expenses | ||||||||||||||||||
Net actuarial loss | (3,187 | ) | (795 | ) | (5,608 | ) | Selling, general and administrative expenses | ||||||||||||||||||
(1,371 | ) | 879 | 2,320 | Total before tax | |||||||||||||||||||||
541 | (361 | ) | — | Tax benefit (expense) | |||||||||||||||||||||
(830 | ) | 518 | 2,320 | Net of tax | |||||||||||||||||||||
Total reclassifications for the period | $ | 1,129 | $ | (4,610 | ) | $ | 11,182 | Net of tax | |||||||||||||||||
Restructuring_and_Other_Charge
Restructuring and Other Charges | 12 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||
Restructuring and other charges [Abstract] | ' | |||||||||||||||||||
Restructuring and Related Activities Disclosure | ' | |||||||||||||||||||
15. Restructuring and other charges | ||||||||||||||||||||
We account for restructuring costs in accordance with FASB ASC Topic 420, Exit or Disposal Cost Obligations, and FASB ASC Topic 712, Compensation - Nonretirement Postemployment Benefits. Restructuring costs consist of costs associated with business realignment and streamlining activities and entail exit costs such as lease termination costs, certain operating costs relating to closed leased facilities, employee severance and related costs, and certain other related costs. Such costs are recorded when the liability is incurred in accordance with the prescribed accounting at the then estimated amounts. These estimates are subject to the inherent risk of uncertainty in the estimation process, especially as to the accrual of future net rental charges on exited facilities. Subsequent changes to such estimates are recorded as restructuring charges in the year the change in the estimate is made. | ||||||||||||||||||||
Most of our restructuring activities over the last three years relate to management's ongoing plan for capacity realignment and streamlining of operations to meet the demands of the various markets we serve and the current economic conditions, and to make us more cost competitive. The restructuring activities primarily relate to the following categories: | ||||||||||||||||||||
• | Capacity alignment and streamlining of both our facilities and our workforce to become more cost competitive through consolidation of excess capacity, movement of operations to lower cost facilities, and reductions of our workforce; | |||||||||||||||||||
• | Streamlining of our workforce in facilities that were not consolidated to become more cost competitive; and | |||||||||||||||||||
• | Management realignment in efforts to simplify the structure. | |||||||||||||||||||
Significant components of restructuring and other charges for the approved activities are (in thousands): | ||||||||||||||||||||
Total | Expense incurred in | Estimated | ||||||||||||||||||
expected | Year ended December 31, 2013 | Year ended December 31, 2012 | Year ended December 31, 2011 | future | ||||||||||||||||
costs | expense | |||||||||||||||||||
2013 Activities | ||||||||||||||||||||
Severance | $ | 1,756 | $ | 1,756 | $ | — | $ | — | $ | — | ||||||||||
Exit costs | 692 | 692 | — | — | — | |||||||||||||||
$ | 2,448 | $ | 2,448 | $ | — | $ | — | $ | — | |||||||||||
2012 Activities | ||||||||||||||||||||
Severance | $ | 4,533 | $ | 795 | $ | 3,738 | $ | — | $ | — | ||||||||||
Exit costs | 1,479 | 823 | 410 | — | 246 | |||||||||||||||
Other charges | 1,687 | — | 1,687 | — | — | |||||||||||||||
$ | 7,699 | $ | 1,618 | $ | 5,835 | $ | — | $ | 246 | |||||||||||
2011 Activities | ||||||||||||||||||||
Severance | $ | 4,518 | $ | — | $ | 1,635 | $ | 2,883 | $ | — | ||||||||||
Exit costs | 801 | — | 241 | 560 | — | |||||||||||||||
$ | 5,319 | $ | — | $ | 1,876 | $ | 3,443 | $ | — | |||||||||||
We intend to fund the future restructuring expenses from our existing revolver facility and funds generated from operations. Restructuring charges and asset impairments are as follows: | ||||||||||||||||||||
Years ended December 31, | ||||||||||||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||||||||||||
Severance and termination benefits | $ | 2,551 | $ | 5,373 | $ | 2,995 | ||||||||||||||
Exit costs | 1,515 | 651 | 577 | |||||||||||||||||
Other charges | — | 1,687 | — | |||||||||||||||||
Asset impairments | — | 2,560 | — | |||||||||||||||||
Total restructuring and other charges | $ | 4,066 | $ | 10,271 | $ | 3,572 | ||||||||||||||
During 2013, the severance charges and exit costs were related to the closure of our Mezokovesd, Hungary plant, restructuring actions in our China operations in association with our acquisition of our noncontrolling interest in our majority-owned Chinese joint venture (see Note 24), reductions in force in our North American facilities, and lease termination costs. | ||||||||||||||||||||
During 2012, the restructuring charges related to reductions in force related to further management realignment, the closure of our Matehuala, Mexico facility and Europe operations, and exit costs related to our Mexico, Europe and Virginia facilities. During the second quarter of 2012, the company engaged a consulting firm to assist in the analysis of the North America operations. The other charges are related to these consulting fees and other related expenses. The fixed asset impairment charges primarily relate to the closure of our facilities in Matehuala, Mexico and Mezokovesd, Hungary. These impairment charges for our land and buildings for the anticipated closure of our Mezokovesd, Hungary facility were based on real estate appraisals based on Level 3 fair value. Machinery and equipment impairment was based on estimated salvage values for equipment based on Level 3 fair value approach. | ||||||||||||||||||||
During 2011, restructuring charges for severance costs related to a management realignment, reductions in force in both Europe and the United States, and exit costs in Europe and continued consolidation of our North American facilities, including the closure of our operations in Virginia. | ||||||||||||||||||||
Accrued restructuring | ||||||||||||||||||||
The following table summarizes the activity in our restructuring accrual: | ||||||||||||||||||||
(In thousands) | Termination | Exit | Other charges | Total | ||||||||||||||||
benefits | costs | |||||||||||||||||||
Accrual at January 1, 2012 | $ | 2,539 | $ | 386 | $ | — | $ | 2,925 | ||||||||||||
Provision in 2012 | 5,373 | 651 | 1,687 | 7,711 | ||||||||||||||||
Payments in 2012 | (4,339 | ) | (931 | ) | (1,687 | ) | (6,957 | ) | ||||||||||||
Accrual at December 31, 2012 | 3,573 | 106 | — | 3,679 | ||||||||||||||||
Provision in 2013 | 2,551 | 1,515 | — | 4,066 | ||||||||||||||||
Payments in 2013 | (5,143 | ) | (1,576 | ) | — | (6,719 | ) | |||||||||||||
Accrual at December 31, 2013 | $ | 981 | $ | 45 | $ | — | $ | 1,026 | ||||||||||||
During 2014, we expect to pay substantially all of the termination benefits and the majority of the exit costs accrued as of December 31, 2013. |
Income_Taxes
Income Taxes | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Income taxes [Abstract] | ' | |||||||||
Income Tax Disclosure | ' | |||||||||
16. Income taxes | ||||||||||
Income before income taxes was taxed in the following jurisdictions: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
U.S. | $ | 25,815 | $ | 46,078 | $ | 45,053 | ||||
Non-U.S. | 34,463 | 24,078 | 45,091 | |||||||
$ | 60,278 | $ | 70,156 | $ | 90,144 | |||||
The following is a summary of the components of the provision for income tax expense (benefit): | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Current: | ||||||||||
Federal | $ | 764 | $ | 5,637 | $ | 1,798 | ||||
State and local | (215 | ) | 1,078 | 804 | ||||||
Non-U.S. | 15,655 | 11,023 | 14,230 | |||||||
Deferred: | ||||||||||
Federal | 8,332 | (70,643 | ) | (1,527 | ) | |||||
State and local | 1,352 | (13,076 | ) | (179 | ) | |||||
Non-U.S. | (5,964 | ) | (5,248 | ) | (313 | ) | ||||
Income tax expense (benefit) | $ | 19,924 | $ | (71,229 | ) | $ | 14,813 | |||
For the year ended December 31, 2013, the U.S. federal and state deferred tax expense relates to the utilization of net operating loss carryforwards, R&D credits and alternative minimum tax credits. For the year ended December 31, 2012, the U.S. federal and state deferred tax expense relates to the utilization of net operating loss carryforwards and a release of the valuation allowance. For the year ended December 31, 2011, the U.S. federal and state deferred tax expense relates to goodwill amortization for tax purposes creating tax loss carryforwards to which a full valuation allowance has been recorded. | ||||||||||
A reconciliation of income taxes at the United States federal statutory rate to the effective income tax rate follows: | ||||||||||
Years ended December 31, | ||||||||||
2013 | 2012 | 2011 | ||||||||
Federal statutory income tax rate | 35 | % | 35 | % | 35 | % | ||||
State and local income taxes, net of Federal tax benefit, if applicable | (0.4 | ) | (0.2 | ) | 0.6 | |||||
Permanent items and other | 5.7 | 9.3 | 2.2 | |||||||
Non-U.S. operations | (1.7 | ) | 2.4 | 2.4 | ||||||
Goodwill | — | — | 0.7 | |||||||
Valuation allowance changes affecting the provision | (5.5 | ) | (148.0 | ) | (24.5 | ) | ||||
Effective income tax rate | 33.1 | % | (101.5 | )% | 16.4 | % | ||||
The following table summarizes the total provision for income taxes by component: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Income tax expense (benefit) | $ | 19,924 | $ | (71,229 | ) | $ | 14,813 | |||
Allocated to other comprehensive income (loss): | ||||||||||
Financial instruments | (303 | ) | 4,331 | (2,044 | ) | |||||
Pensions | (4,196 | ) | (599 | ) | — | |||||
The following is a summary of the significant components of our deferred income tax assets and liabilities. | ||||||||||
As of December 31, | ||||||||||
(In thousands) | 2013 | 2012 | ||||||||
Deferred tax assets: | ||||||||||
Restructuring charges | $ | 289 | $ | 245 | ||||||
Employee benefits | 11,472 | 14,394 | ||||||||
Inventories | 2,875 | 2,042 | ||||||||
Warranty | 10,194 | 9,714 | ||||||||
Alternative minimum tax and other credits | 16,356 | 17,118 | ||||||||
Net operating loss carryforwards | 55,855 | 65,039 | ||||||||
Customer contracts & other intangibles | 1,428 | 388 | ||||||||
Rebates, stock, discounts and returns | 5,898 | 4,814 | ||||||||
Unrealized gain/(loss) on financial instruments | 1,150 | 1,382 | ||||||||
Other | 5,062 | 8,453 | ||||||||
Total deferred tax assets | 110,579 | 123,589 | ||||||||
Valuation allowance | (11,917 | ) | (16,044 | ) | ||||||
Deferred tax assets, net of valuation allowance | 98,662 | 107,545 | ||||||||
Deferred tax liabilities: | ||||||||||
Depreciation | (3,462 | ) | (2,088 | ) | ||||||
Goodwill and other intangibles | (8,371 | ) | (10,936 | ) | ||||||
Trade names | (18,846 | ) | (18,846 | ) | ||||||
Other | (10,704 | ) | (10,375 | ) | ||||||
Total deferred tax liabilities | (41,383 | ) | (42,245 | ) | ||||||
Net deferred tax asset | $ | 57,279 | $ | 65,300 | ||||||
At December 31, 2013, we had unused U.S. federal net operating loss carryforwards of approximately $101,500,000 that expire during 2023 through 2026. Pursuant to Internal Revenue Code Section 382, we are limited to approximately $10,555,000 use in any one year of the pre-bankruptcy net operating loss carryforward and credit equivalents in our federal income tax return. We also had unused U.S. alternative minimum tax credit carryforwards of $3,256,000 that may be carried forward indefinitely. In addition, we had research and development credit carry forwards for federal and state purposes of $12,893,000 that will expire during 2017 through 2030. | ||||||||||
At December 31, 2013, and 2012, we had unused Non-U.S. loss carryforwards totaling $63,728,000 and $54,576,000, respectively. No Non-U.S. net operating loss carryforwards will expire during 2014, foreign net operating loss carryforwards totaling $11,867,000 will expire during 2015 through 2022, and foreign net operating loss carryforwards totaling $51,861,000 have no expiration. | ||||||||||
We review the likelihood that the Company will realize the benefit of its deferred tax assets and, therefore, the need for valuation allowances on a quarterly basis, or more frequently if events indicate that a review is required. In determining whether or not it is more likely than not that a valuation allowance is required, the historical and projected financial results of the legal entity or consolidated group recording the net deferred tax asset is considered, along with all other available positive and negative evidence. The factors considered by management in its determination of the probability of the realization of the deferred tax assets include but are not limited to: recent adjusted historical financial results, historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. If, based upon the weight of available evidence, it is more likely than not the deferred tax assets will not be realized, a valuation allowance is recorded. | ||||||||||
In performing our analysis of whether a valuation allowance is required, we utilize a rolling twelve quarters of pre-tax book results adjusted for significant permanent book to tax differences as a measure of cumulative results in recent years. In certain states in the United States and foreign jurisdictions, our analysis indicates that we have cumulative three year historical losses on this basis. This is considered significant negative evidence which is difficult to overcome. Therefore, we maintain a valuation allowance in those jurisdictions. However, the three year loss position is not solely determinative and, accordingly, management considers all other available positive and negative evidence in its analysis. | ||||||||||
There is no corresponding income tax benefit recognized with respect to losses incurred and no corresponding income tax expense recognized with respect to earnings generated in jurisdictions with a valuation allowance. This causes variability in our effective tax rate. We intend to maintain the valuation allowances until it is more likely than not that the net deferred tax assets will be realized. If operating results improve or deteriorate on a sustained basis, our conclusions regarding the need for a valuation allowance could change, resulting in either the reversal or initial recognition of a valuation allowance in the future, which could have a significant impact on income tax expense in the period recognized and subsequent periods. | ||||||||||
During 2012, as part of our review in determining the need for a valuation allowance, we assessed the potential release of existing valuation allowances. Based upon this assessment during the third quarter of 2012, the valuation allowance previously recorded against the net deferred tax assets in the United States has been reversed resulting in a discrete income tax benefit of $84,705,000 during the third quarter of 2012. Our conclusion was based on cumulative three year pretax income for United States federal taxes, consecutive years of pretax income for United States federal taxes, and the anticipation of continuing profitability based on existing contractual arrangements which are expected to produce more than enough taxable income to realize the deferred tax assets based on existing sales prices and cost structure and our current Internal Revenue Code Section 382 limitations. As of December 31, 2012, the Company has retained a valuation allowance of approximately $5,598,000 on certain United States deferred tax assets. If a release of the remaining U.S. valuation allowance occurs, it will have a significant impact on net income in the period in which it occurs. | ||||||||||
At December 31, 2013, the Company has retained a valuation allowance of approximately $4,997,000 on certain United States tax credits. During 2013, there was a release of a valuation allowance in the amount of $2,703,000 due to the expiration of a capital loss which had a full valuation allowance. During 2013, an increase of $2,102,000 was made to the United States valuation allowance against the utilization of state tax credits. | ||||||||||
During 2013 and 2012, the Company concluded that certain Non-U.S. locations no longer needed a valuation allowance and recorded the release of $2,733,000 and $4,708,000, respectively, of valuation allowance, which was recognized as an income tax benefit. The release was due to either effects of the change in tax law or the three year cumulative and consecutive year income before tax for certain foreign tax jurisdictions as well as anticipation of continuing profitability. | ||||||||||
The change in the tax rates resulted in a tax benefit of $1,068,000 for the year ended December 31, 2013. There was no impact to rate changes in the years ended December 31, 2012 and 2011, respectively. | ||||||||||
Income tax payments, net of refunds including state taxes, were $7,355,000, $13,019,000, and $17,778,000 for the years ended December 31, 2013, 2012, and 2011, respectively. | ||||||||||
FASB ASC Topic 740 clarifies the accounting for uncertainty in income taxes recognized in companies' financial statements. As a result, we apply a more-likely-than-not recognition threshold for all tax uncertainties. It only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. | ||||||||||
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Balance at January 1, | $ | 9,164 | $ | 4,592 | $ | 2,806 | ||||
Additions based on tax positions related to the current year | 987 | 2,697 | 672 | |||||||
Additions for tax positions of prior years | 457 | 1,875 | 1,561 | |||||||
Reductions for tax positions of prior years | (116 | ) | — | (447 | ) | |||||
Settlements | (654 | ) | — | — | ||||||
Balance at December 31, | $ | 9,838 | $ | 9,164 | $ | 4,592 | ||||
At December 31, 2013 and 2012, we have total unrecognized tax benefits of $11,456,000 and $10,350,000, respectively, that have been recorded as other noncurrent liabilities, and we are uncertain as to if or when such amounts may be settled. We recognized interest and penalties accrued related to unrecognized tax benefits in income tax expense. As of December 31, 2013 and 2012, we accrued approximately $1,618,000 and $1,186,000, respectively, for the payment of interest and penalties. During the years ended December 31, 2013, 2012, and 2011, we expensed $432,000, $398,000, and $79,000, respectively, for penalties and interest. During the next twelve months, $4,738,000 of unrecognized tax benefits will reverse due to expiration of the statute of limitations. | ||||||||||
United States income taxes have not been provided on accumulated but undistributed earnings of approximately $172,901,000 of our Non-U.S. subsidiaries as these earnings are considered to be indefinitely reinvested and, accordingly, no provision for U.S. federal or state income taxes or Non-U.S. withholding taxes has been made. Upon distribution of those earnings, the Company would be subject to U.S. income taxes (subject to a reduction for Non-U.S. tax credits) and withholding taxes payable to the various Non-U.S. countries. Determination of the unrecognized deferred tax liability related to these undistributed earnings is not practicable because of the complexities of its hypothetical calculation. | ||||||||||
We operate in multiple jurisdictions throughout the world. We are no longer subject to U.S. federal tax examinations for years before 2007 or state and local for years before 2007, with limited exceptions. For federal purposes, the tax attributes carried forward could be adjusted through the examination process and are subject to examination 3 years from the date of utilization. Furthermore, we are no longer subject to income tax examinations in major Non-U.S. tax jurisdictions for years prior to 2006, with limited exceptions. |
Employee_Benefit_Plan
Employee Benefit Plan | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Employee benefit plans [Abstract] | ' | ||||||||||
Compensation and Employee Benefit Plans [Text Block] | ' | ||||||||||
17. Employee benefit plans | |||||||||||
Agreements with GM | |||||||||||
In connection with the sale by GM of its former Delco Remy operations, we agreed with GM to allocate the financial responsibility for employee postretirement health care and life insurance on a pro rata basis between us and them. The allocation is primarily determined upon years of service with us and aggregate years of service with GM. Effective August 1, 1994, the Company established hourly and salaried postretirement health care and life insurance plans (which were assumed by us when we emerged from bankruptcy on December 6, 2007), under which GM would reimburse us for their proportionate share of the costs we incurred under the plans. In July 2009, and in connection with GM bankruptcy proceedings, we entered into an agreement with new GM to terminate GM's reimbursement to us for GM's proportionate share of retiree health claims for our eligible hourly retirees who receive or who would receive retiree healthcare under the Remy retiree healthcare plans. | |||||||||||
Remy postretirement benefit plans | |||||||||||
We maintained certain U.S. salaried and hourly benefit plans that provided postretirement health care and life insurance to retirees and eligible dependents. The benefits were payable for life, although we retain the right to modify or terminate the plans. The salaried postretirement plan had cost sharing features such as deductibles and co-payments. Salaried employees who were not GM employees prior to 1992 are not eligible for the above described postretirement benefits. It is our policy to fund these benefits as claims are incurred. | |||||||||||
In connection with old GM's rejection of the cost-sharing arrangement of the postretirement benefit provision as part of its bankruptcy proceedings, we entered into an agreement with new GM for its portion of the postretirement cost sharing arrangement. | |||||||||||
On September 30, 2009, Remy decided to terminate the Remy postretirement healthcare benefits under the salaried and hourly postretirement plans effective December 31, 2009. In connection with the termination of these plans, we established a Voluntary Retiree Reimbursement Account Program (“VRRAP”) effective January 1, 2010. Under the VRRAP plan, participants are credited a defined lifetime capped benefit amount to cover qualifying medical expenses. The new GM agreement and plan amendment resulted in a net decrease of the benefit obligation of $2,570,000 and an increase in accumulated other comprehensive income of $10,170,000 to the Remy postretirement benefit plans in 2009. In November 2011, we entered into a settlement agreement with certain retirees and established a Retirement Reimbursement Account Program. The Retiree Reimbursement Account Program ("RRAP") is a defined lifetime capped benefit and works the same as the VRRAP plan. | |||||||||||
Pension plans | |||||||||||
Our subsidiary, Remy Inc., had defined benefit pension plans that covered certain salaried and hourly U.S. employees. The plan covering salaried employees provided benefits that were based upon years of service and final estimated average compensation. Benefits for hourly employees are based on stated amounts for each year of service. Our funding policy is to contribute amounts to provide the plans with sufficient assets to meet future benefit payment requirements consistent with actuarial determinations of the funding requirements of federal laws. Plan assets are primarily invested in mutual funds, which invest in both debt and equity instruments. In the second quarter of 2006, we notified the U.S. salaried employees and the U.S. Internal Revenue Service (“IRS”) that we had adopted an amendment to our U.S. salaried pension plan which froze the future accrual of benefits under the salaried pension plan for all eligible participants as of June 30, 2006, and provides that no new participants will be added to the plan after June 30, 2006. The plan covering hourly employees has no active employees and no current service costs. | |||||||||||
We offer a supplemental executive retirement pension plan to selected former and current executive officers of our company. The plan offers retirement benefits ranging from 30% to 50% of the participant's average salary for five consecutive years prior to receiving benefits. As of December 31, 2013, there were five participants in the plan of which none are active employees. | |||||||||||
Remy Automotive UK Ltd., a United Kingdom subsidiary, has a defined benefit pension plan. This plan covers a limited number of employees who were part of an acquisition in 1998. Remy Korea Ltd, a Korean subsidiary, has a defined benefit pension plan that covers all Korean employees. In addition, some of our non U.S. subsidiaries have other postretirement benefit plans although most participants are covered by government sponsored and administered programs. | |||||||||||
The changes in benefit obligations and plan assets, components of expense and assumptions for the postretirement healthcare and life insurance plans are as follows: | |||||||||||
Postretirement healthcare | |||||||||||
and life insurance plans | |||||||||||
Years ended December 31, | |||||||||||
(In thousands of dollars) | 2013 | 2012 | 2011 | ||||||||
Change in benefit obligations | |||||||||||
Benefit obligation at beginning of period | $ | 2,682 | $ | 2,897 | |||||||
Service cost | — | — | |||||||||
Interest cost | 77 | 97 | |||||||||
Amendments | — | — | |||||||||
Actuarial (gain) loss | (154 | ) | 22 | ||||||||
Benefits paid | (359 | ) | (334 | ) | |||||||
Benefit obligation at end of period | $ | 2,246 | $ | 2,682 | |||||||
Change in plan assets | |||||||||||
Fair value of plan assets at beginning of period | $ | — | $ | — | |||||||
Employer contributions | 359 | 334 | |||||||||
Benefits paid | (359 | ) | (334 | ) | |||||||
Fair value of plan assets at end of period | $ | — | $ | — | |||||||
Funded status | $ | (2,246 | ) | $ | (2,682 | ) | |||||
Amounts recognized in statement of financial position consist of: | |||||||||||
Current liabilities | $ | (618 | ) | $ | (713 | ) | |||||
Noncurrent liabilities | (1,628 | ) | (1,969 | ) | |||||||
Net amount recognized | $ | (2,246 | ) | $ | (2,682 | ) | |||||
Amounts recognized in accumulated other comprehensive | |||||||||||
income consist of: | |||||||||||
Net actuarial loss | $ | 3,669 | $ | 5,647 | |||||||
Prior service credit | (3,632 | ) | (5,448 | ) | |||||||
Accumulated other comprehensive loss | $ | 37 | $ | 199 | |||||||
Components of net periodic benefit cost and other amounts | |||||||||||
recognized in other comprehensive income | |||||||||||
Net Periodic Benefit Cost | |||||||||||
Service cost | $ | — | $ | — | $ | — | |||||
Interest cost | 77 | 97 | 99 | ||||||||
Amortization of prior service cost | (1,816 | ) | (1,674 | ) | (7,928 | ) | |||||
Recognized net actuarial loss | 1,824 | (492 | ) | 5,129 | |||||||
Settlement gain | — | — | — | ||||||||
Net periodic cost (benefit) | $ | 85 | $ | (2,069 | ) | $ | (2,700 | ) | |||
Other changes in plan assets and benefit obligations recognized in other comprehensive income | |||||||||||
Net actuarial (gain) loss | $ | (154 | ) | $ | 22 | $ | 68 | ||||
Prior service credit | — | — | 805 | ||||||||
Amortization of prior service cost | 1,816 | 1,674 | 7,928 | ||||||||
Recognized net actuarial (loss) gain | (1,824 | ) | 492 | (5,129 | ) | ||||||
Total recognized in other comprehensive loss (income) | (162 | ) | 2,188 | 3,672 | |||||||
Total recognized in net (benefit) cost and OCI | $ | (77 | ) | $ | 119 | $ | 972 | ||||
Weighted-average assumptions | |||||||||||
U.S. assumptions: | |||||||||||
Discount rate for benefit obligation | 4.73 | % | 3.85 | % | 4.28 | % | |||||
Discount rate for net periodic benefit cost | 3.85 | % | 4.28 | % | 5.41 | % | |||||
Rate of compensation increase | — | % | — | % | — | % | |||||
The changes in benefit obligations and plan assets and components of expense for the pension plans are as follows: | |||||||||||
Pension benefits | |||||||||||
Years ended December 31, | |||||||||||
(In thousands of dollars) | 2013 | 2012 | 2011 | ||||||||
Change in benefit obligations | |||||||||||
Benefit obligation at beginning of period | $ | 79,477 | $ | 73,182 | |||||||
Service cost | 1,035 | 291 | |||||||||
Interest cost | 3,278 | 3,143 | |||||||||
Amendments | — | — | |||||||||
Korea benefit obligation | 4,965 | — | |||||||||
Actuarial (gain) loss | (6,207 | ) | 5,692 | ||||||||
Benefits paid | (3,070 | ) | (2,831 | ) | |||||||
Benefit obligation at end of period | $ | 79,478 | $ | 79,477 | |||||||
Change in plan assets | |||||||||||
Fair value of plan assets at beginning of period | $ | 47,349 | $ | 41,765 | |||||||
Actual return on plan assets | 7,081 | 5,650 | |||||||||
Korea plan assets | 4,642 | — | |||||||||
Employer contributions | 3,984 | 2,765 | |||||||||
Benefits paid | (3,070 | ) | (2,831 | ) | |||||||
Fair value of plan assets at end of period | $ | 59,986 | $ | 47,349 | |||||||
Funded status | $ | (19,492 | ) | $ | (32,128 | ) | |||||
Amounts recognized in statement of financial position consist of: | |||||||||||
Noncurrent assets | — | — | |||||||||
Current liabilities | (389 | ) | (366 | ) | |||||||
Noncurrent liabilities | (19,103 | ) | (31,762 | ) | |||||||
Net amount recognized | $ | (19,492 | ) | $ | (32,128 | ) | |||||
Amounts recognized in accumulated other comprehensive income consist of: | |||||||||||
Net actuarial loss | $ | 17,069 | $ | 28,379 | |||||||
Prior service cost | — | — | |||||||||
Accumulated other comprehensive loss | $ | 17,069 | $ | 28,379 | |||||||
Information for pension plans with an accumulated benefit obligation in excess of plan assets | |||||||||||
Projected benefit obligation | $ | 79,478 | $ | 79,477 | |||||||
Accumulated benefit obligation | 79,478 | 79,064 | |||||||||
Fair value of plan assets | 59,986 | 47,349 | |||||||||
Components of net periodic benefit cost and other amounts recognized in other comprehensive income | |||||||||||
Net Periodic Benefit Cost | |||||||||||
Service cost | $ | 1,035 | $ | 291 | $ | 263 | |||||
Interest cost | 3,278 | 3,143 | 3,342 | ||||||||
Expected return on plan assets | (3,341 | ) | (2,622 | ) | (2,690 | ) | |||||
Amortization of prior service cost | — | — | — | ||||||||
Recognized net actuarial loss | 1,363 | 1,287 | 479 | ||||||||
Net periodic pension cost | $ | 2,335 | $ | 2,099 | $ | 1,394 | |||||
Other changes in plan assets and benefit obligations recognized in other comprehensive income | |||||||||||
Net actuarial (gain) loss | $ | (9,947 | ) | $ | 2,520 | $ | 11,807 | ||||
Prior service cost | — | — | — | ||||||||
Amortization of prior service cost | — | — | — | ||||||||
Recognized net actuarial loss | (1,363 | ) | (1,287 | ) | (479 | ) | |||||
Total recognized in other comprehensive (income) loss | (11,310 | ) | 1,233 | 11,328 | |||||||
Total recognized in net (benefit) cost and OCI | $ | (8,975 | ) | $ | 3,332 | $ | 12,722 | ||||
The assumptions for the pension plans are as follows: | |||||||||||
Pension benefits | |||||||||||
Years ended December 31, | |||||||||||
2013 | 2012 | 2011 | |||||||||
Weighted-average assumptions | |||||||||||
U.S. assumptions: | |||||||||||
Discount rate for benefit obligation | 4.73 | % | 3.85 | % | 4.28 | % | |||||
Discount rate for net periodic benefit cost | 3.85 | % | 4.28 | % | 5.41 | % | |||||
Rate of compensation increase | — | % | 5 | % | 5 | % | |||||
Expected return on plan assets | 6.5 | % | 6.5 | % | 6.5 | % | |||||
Non U.S. assumptions: | |||||||||||
Discount rate for benefit obligation | 4.27 | % | 4.1 | % | 4.7 | % | |||||
Discount rate for net periodic cost | 4 | % | 4.7 | % | 5.4 | % | |||||
Rate of compensation increase | 3.81 | % | 3.1 | % | 3.35 | % | |||||
Expected return on plan assets | 5.13 | % | 4.99 | % | 5.18 | % | |||||
Amounts in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year: | |||||||||||
(In thousands) | Pension | Postretirement | |||||||||
healthcare | |||||||||||
Amortization of actuarial losses | $ | 649 | $ | 19 | |||||||
Amortization of prior service cost | — | — | |||||||||
Total | $ | 649 | $ | 19 | |||||||
The projected benefit obligations for our non U.S. pension plans based on the actuarial present value of the vested benefits to which the employee is currently entitled but based on the employee’s expected date of separation of retirement included above are $19,477,000, and $12,557,000 as of December 31, 2013 and 2012, respectively. The fair value of the plan assets for our non U.S. pension plans included above are $17,075,000, and $9,450,000 as of December 31, 2013 and 2012, respectively. | |||||||||||
The discount rate assumptions for our U.S. pension plans and postretirement plans are based on a hypothetical yield curve and associated spot rate curve to discount the plan's projected cash flows. The yield curve utilized is the Citigroup Pension Discount Curve. Once the present value of projected benefit payments is calculated, the suggested discount rate is equal to the level rate that results in the same present value. | |||||||||||
To develop the expected long-term rate of return on assets assumption, we considered the historical returns and future expectations for returns for each asset class, as well as the target asset allocation of the present portfolio. This resulted in the selection of the 6.5% for long-term rate of return on asset assumption for U.S. plans and 5.13% for non U.S. plans. | |||||||||||
Our investment strategies with respect to U.S. pension assets are as follows: | |||||||||||
• | The assets are managed in compliance with provisions of the Employee Retirement Income Security Act. | ||||||||||
• | The assets are to be invested with expectations of achieving real growth with respect to inflation, the belief that the U.S. capital markets will remain viable, maintaining a level of liquidity to meet timely payment of benefits to participants and minimizing risk and achieving growth through prudent diversification of assets among investment categories. | ||||||||||
The 2014 target plan asset allocation is: | |||||||||||
Target allocation | |||||||||||
Equity Investments | 45% | - | 65% | ||||||||
Fixed Income Investments | 25% | - | 45% | ||||||||
Cash and Short Term Investments | 10% | - | 20% | ||||||||
The asset allocations were: | |||||||||||
As of December 31, | |||||||||||
(In thousands) | 2013 | 2012 | |||||||||
Asset Allocation for Plan Assets | |||||||||||
Interest-bearing cash | $ | 8,980 | 15 | % | $ | 2,418 | 5.1 | % | |||
Bond Mutual Funds | 18,408 | 30.7 | % | 16,630 | 35.1 | % | |||||
Equity Mutual Funds | 32,598 | 54.3 | % | 28,301 | 59.8 | % | |||||
Total plan assets | $ | 59,986 | 100 | % | $ | 47,349 | 100 | % | |||
The assumptions used in deriving our postretirement costs and the sensitivity analysis thereon are: | |||||||||||
As of December 31, | |||||||||||
2013 | 2012 | ||||||||||
Assumed Health Care Cost Trend Rates | |||||||||||
Health care cost trend rate assumed for next year | 9 | % | 9 | % | |||||||
Rate to which the cost trend is expected to decline | 5 | % | 5 | % | |||||||
Year that the rate reaches the ultimate trend rate | 2017 | 2016 | |||||||||
Sensitivity analysis | |||||||||||
An increase or decrease of one percentage point in the assumed health care trends would have the following approximate effects for the year ended December 31, 2013: | |||||||||||
(In thousands) | 1% Increase | 1% Decrease | |||||||||
Effect on total of service and interest cost components of net periodic postretirement health care benefit cost | $ | — | $ | — | |||||||
Effect on the health care component of the accumulated postretirement | $ | 7 | $ | (7 | ) | ||||||
benefit obligation | |||||||||||
Payments to pension and postretirement plans | |||||||||||
We contributed $3,984,000 to our pension plans in 2013 and $2,765,000 in 2012. In 2014, we plan to contribute approximately $3,272,000 to our U.S. pension plans and $1,497,000 to our non U.S. pension plans. The benefits of the postretirement health care plan are funded on a pay-as-you go basis and are funded on a cash basis as benefits are paid. | |||||||||||
The following reflects the estimated future benefit payments to be paid from the plans: | |||||||||||
(In thousands) | Pension | Postretirement | |||||||||
healthcare | |||||||||||
2014 | $ | 3,488 | $ | 618 | |||||||
2015 | 4,758 | 336 | |||||||||
2016 | 3,793 | 165 | |||||||||
2017 | 4,025 | 111 | |||||||||
2018 | 3,883 | 87 | |||||||||
Years 2019-2023 | 23,045 | 336 | |||||||||
Defined contribution plans | |||||||||||
We sponsor two voluntary savings plans for U.S. employees. One plan is for eligible salaried employees and the other plan is for hourly employees covered by certain labor agreements. These plans allow participants to make contributions pursuant to section 401(k) of the Internal Revenue Code. The salaried plan has Company matching contribution provisions, while the hourly plan does not. Charges were $1,594,000, $1,640,000, and $1,442,000 for the years ended December 31, 2013, 2012, and 2011, respectively. |
Stock_Based_Compensation
Stock Based Compensation | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Stock-based compensation [Abstract] | ' | |||||||||
Disclosure of Compensation Related Costs, Share-based Payments | ' | |||||||||
18. Stock-based compensation | ||||||||||
Omnibus Incentive Plan | ||||||||||
The Omnibus Incentive Plan, which is stockholder-approved, became effective on October 27, 2010, was amended on March 24, 2011 and permits our Compensation Committee of the Board of Directors to grant nonqualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units and other cash or share based awards to our employees and non-employee directors. Actual participation, as well as the terms of the awards to those participants, is determined by the Compensation Committee. The maximum number of shares authorized that may be delivered pursuant to awards under the Omnibus Incentive Plan is 5,500,000. As of December 31, 2013, there were 3,466,039 shares available to be issued under the Omnibus Incentive Plan. We generally settle our stock-based awards using a combination of new shares and treasury shares. | ||||||||||
Prior to the adoption of the Omnibus Incentive Plan, our equity-based awards granted during fiscal years 2007 and 2008 were under a long-term equity incentive plan (“Prior Plan”). As of the effective date of the Omnibus Incentive Plan, no new awards will be granted under the Prior Plan, but the Prior Plan governs the equity awards issued under the Prior Plan. | ||||||||||
Fiscal Years 2007-2008 Grants | ||||||||||
In December 2007, our executive officers received restricted stock awards of 524,737 common shares at no cost to them. An additional award of 108,335 common shares was made in April 2008, to certain other key employees. Both of the awards vest at 12% on each of the first three years' anniversaries of the grant date, and 32% each on the fourth and fifth anniversaries, based upon continuation of employment. In February and November 2008, our board of directors received restricted stock grants of 160,000 common shares that vest 50% upon the first and second anniversaries. As a nonpublic company prior to December 2012, there was not an active viable market for our common stock; accordingly, we used a calculated fair value of $3.00, $8.00, $11.55, and $11.55 on a per share basis to determine the value of the awards related to the November 2008 grant, the April 2008 grant, the February 2008, and December 2007, grants, respectively. Our calculation assumed a risk-free interest rate of 3.0%, volatility of 39.1%, and that no dividends would be paid. There were no unvested restricted stock shares outstanding under the Prior Plan as of December 31, 2013. | ||||||||||
Fiscal Year 2011 Grants | ||||||||||
During the year ended December 31, 2011, executive officers and other key employees received restricted stock awards of 744,089 common shares. The executive officers and other key employees' awards are vested 50% time based and 50% performance based. The time based shares are equally vested over a three year period. One-third of the performance based shares will be available to vest in each of the calendar years 2011, 2012, and 2013, based on a target Adjusted EBITDA, for each of the years. Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, restructuring expenses and certain items such as noncash compensation expense, loss on extinguishment of debt, intangible asset impairment charges, and reorganization items. Also during the year ended December 31, 2011, our board of directors received restricted stock awards of 340,455 common shares. One-half of the restricted stock shares granted to the board of directors vest at each anniversary of the grant date. As a nonpublic company prior to December 2012, there was not an active viable market for our common stock; accordingly, we used a calculated value of $11.00. We based this valuation primarily on the $11.00 per share price offered in the January 2011 rights offering. Since the shares sold in this rights offering were not freely tradable at issuance, the offering price includes a discount for lack of marketability, and we determined that this price approximates fair value as of the grant date. | ||||||||||
Fiscal Year 2012 Grants | ||||||||||
During the year ended December 31, 2012, executive officers and other key employees received restricted stock awards of 490,573 common shares. The executive officers and other key employees' awards are vested 50% time based and 50% performance based. The time based shares are equally vested over a three year period. One-third of the performance based shares will be available to vest for each of the calendar years 2012, 2013, and 2014 based on a target Adjusted EBITDA for each of the years. Also during the year ended December 31, 2012, our Board of Directors received restricted stock awards of 45,713 common shares. One-half of the restricted stock shares granted to the board of directors vest at each anniversary of the grant date. As a nonpublic company prior to December 2012, there was not an active viable market for our common stock; accordingly, we used a calculated value of $17.50. We based this valuation primarily on the average closing price of our shares over a 90 day period prior to the grant. | ||||||||||
Fiscal Year 2013 Grants | ||||||||||
During the year ended December 31, 2013, executive officers and other key employees received restricted stock awards of 224,507 common shares with a weighted average grant date value of $18.47, based on the closing price of our common stock on the respective grant date as reported on the NASDAQ Stock Market. These awards are 50% time based and 50% performance based. The time based restricted shares vest equally over a three-year period and one-third of the performance-based restricted shares will be available to vest for each of the calendar years 2013, 2014 and 2015 based on a target operating income for each of the years. Additionally, executive officers and other key employees were granted 234,675 stock option awards which vest equally over a three-year period with a term of seven years and a weighted average exercise price of $18.47. | ||||||||||
Also during the year ended December 31, 2013, our Board of Directors received restricted stock awards of 32,164 common shares and stock option awards of 33,618 common shares. One-half of the restricted stock shares and stock options granted to the Board of Directors vest at each anniversary of the grant date. Restricted stock granted to the Board of Directors were valued at $18.50, which was the closing price of our common stock on the grant date as reported on the NASDAQ Stock Market. Stock options granted to the Board of Directors have a term of seven years and an exercise price of $18.50. We estimated the grant date fair value of all stock options granted during the year ended December 31, 2013 using the Black-Scholes valuation model. The weighted average valuation per share was $7.58 based on the following assumptions: Risk-free interest rate was 0.86%, based on the U.S. Treasury rate that corresponds to the weighted average expected life of an option; Dividend Yield was 2.16%; Expected Volatility was 56.70% based on average volatilities of similar public companies; and Expected Term was 5 years. | ||||||||||
Fiscal Year 2014 Grants | ||||||||||
On February 18, 2014, our executive officers and other key employees received restricted stock awards of 173,568 common shares with a value of $21.98, which was the closing price of our common stock on the grant date as reported on the NASDAQ Stock Market. The executive officers and other key employees’ awards are vested 50% time based and 50% performance based. The time based shares are equally vested over a three year period. One-third of the performance based shares will be available to vest for each of the calendar years 2014, 2015 and 2016 based on a target operating income for each of the years. Additionally, executive officers and other key employees were granted 231,360 stock option awards which vest equally over a three year period with a term of seven years and exercise price of $21.98. | ||||||||||
Also on February 18, 2014, our board of directors received restricted stock awards of 27,072 common shares and stock option awards of 36,083 common shares. Restricted stock granted to the Board of Directors were valued at $21.98, which was the closing price of our common stock on the grant date as reported on the NASDAQ Stock Market. One-half of the restricted stock shares and stock options granted to the board of directors vest at each anniversary of the grant date. Stock options granted to directors have a seven year term and are based on an exercise price of $21.98. We estimated the grant date fair value of all stock options granted on February 18, 2014, using the Black-Scholes valuation model. The weighted average valuation per share was $7.07 based on the following assumptions: Risk-free interest rate was 1.53%, based on the U.S. Treasury rate that corresponds to the weighted average expected life of an option; Dividend Yield was 1.82%; Expected Volatility was 43.20% based on average volatilities of similar public companies; and Expected Term was 4.5 years. | ||||||||||
Noncash compensation expense related to the awards was recognized for the years ended December 31, as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Stock-based compensation | $ | 6,561 | $ | 7,261 | $ | 6,884 | ||||
A summary of stock option activity as of December 31, 2013 and changes for the year ended December 31, 2013 is presented below: | ||||||||||
Stock option awards | Shares | Weighted- | Weighted-average remaining contractual term | Aggregate intrinsic value (1) | ||||||
average | ||||||||||
exercise price | ||||||||||
Outstanding at January 1, 2013 | — | $ | — | |||||||
Granted | 268,293 | 18.48 | ||||||||
Exercised | — | — | ||||||||
Forfeited/Cancelled | (17,798 | ) | 18.5 | |||||||
Outstanding and expected to vest at December 31, 2013 | 250,495 | $ | 18.48 | 5.8 years | $ | 1,213,515 | ||||
Exercisable at December 31, 2013 | 13,843 | $ | 18.5 | 0.25 years | $ | 66,723 | ||||
1) The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $23.32, as reported on the NASDAQ Stock Market on December 31, 2013. This amount, which changes continuously based on the fair value of our common stock, would have been received by the option holders had all option holders had the ability to exercise their options as of the balance sheet date. | ||||||||||
A summary of the status of our nonvested restricted stock awards as of December 31, 2013, and changes during the year ended December 31, 2013, is presented below: | ||||||||||
Nonvested restricted stock awards | Shares/Units | Weighted- | ||||||||
average | ||||||||||
grant-date | ||||||||||
fair value | ||||||||||
Nonvested at January 1, 2013 | 1,124,952 | $ | 14.08 | |||||||
Granted | 256,671 | 18.48 | ||||||||
Vested | (566,027 | ) | 13.08 | |||||||
Forfeited | (67,783 | ) | 17.75 | |||||||
Nonvested at December 31, 2013 | 747,813 | $ | 15.92 | |||||||
The total fair value of shares vested during the years ended December 31, 2013, 2012, and 2011 was $9,972,000, $8,653,000 and $1,394,000, respectively. During the year ended December 31, 2013, we paid $231,000 to cash settle share-based liability awards. As of December 31, 2013, there was $5,561,000 of total unrecognized compensation cost related to nonvested restricted stock awards and stock options outstanding under the Omnibus Incentive Plan. Such cost is expected to be recognized over a weighted-average period of approximately 2 years. | ||||||||||
If factors change and we employ different assumptions, stock-based compensation expense may differ significantly from what we have recorded in the past. If there are any modifications or cancellations of the underlying unvested securities, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. Future stock-based compensation expense and unearned stock-based compensation will increase to the extent that we grant additional equity awards to employees and nonemployee directors or we assume unvested equity awards in connection with acquisitions. |
Lease_Commitments
Lease Commitments | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Lease commitments [Abstract] | ' | |||
Leases of Lessee Disclosure | ' | |||
19. Lease commitments | ||||
We occupy space and use certain equipment under operating lease arrangements. Rent expense, calculated on a straight-line basis, totaled $6,790,000, $5,599,000, and $6,858,000 for the years ended December 31, 2013, 2012, and 2011, respectively. Rental commitments at December 31, 2013, for long-term non-cancellable operating leases consummated as of December 31, 2013 (not reflected as accrued restructuring) are as follows: | ||||
(In thousands) | ||||
2014 | $ | 4,902 | ||
2015 | 3,362 | |||
2016 | 2,762 | |||
2017 | 2,371 | |||
2018 | 979 | |||
Thereafter | 1,516 | |||
Business_Segment_Geographical_
Business Segment & Geographical Information | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Business seg & geo information [Abstract] | ' | |||||||||
Segment Reporting Disclosure | ' | |||||||||
20. Business segment and geographical information | ||||||||||
We manage our business and operate in a single reportable segment. | ||||||||||
We are a multi-national corporation with operations in many countries, including the United States, Canada, Mexico, Brazil, China, Hungary, South Korea, the United Kingdom, Belgium and Tunisia. As a result, our financial results could be significantly affected by factors such as changes in foreign currency exchange rates or weak economic conditions in the foreign markets in which we distribute our products. Our operating results are exposed to changes in exchange rates between the U.S. dollar and non-U.S. currencies. Exposure to variability in foreign currency exchange rates is managed primarily through the use of natural hedges, whereby funding obligations and assets are both denominated in the local currency, and through selective currency hedges. From time to time, we enter into foreign currency agreements to manage our exposure arising from fluctuating exchange rates related to specific transactions. Refer to Note 4. Sales are attributed to geographic locations based on the point of sale. Long-lived assets included in the table below include property, plant and equipment, net, deposits and core right of return assets. Certain prior year amounts have been reclassified to conform with the current year's presentation. | ||||||||||
Information about our net sales and long-lived assets by geographic region is as follows: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Net sales to external customers: | ||||||||||
United States | $ | 735,939 | $ | 753,420 | $ | 756,824 | ||||
Europe | 89,181 | 103,303 | 115,901 | |||||||
Other Americas | 59,611 | 56,300 | 90,636 | |||||||
Asia Pacific | 233,849 | 220,524 | 231,592 | |||||||
Total net sales | $ | 1,118,580 | $ | 1,133,547 | $ | 1,194,953 | ||||
As of December 31, | ||||||||||
(In thousands) | 2013 | 2012 | ||||||||
Long-lived assets: | ||||||||||
United States | $ | 80,429 | $ | 81,451 | ||||||
Europe | 11,612 | 12,562 | ||||||||
Other Americas | 55,937 | 58,267 | ||||||||
Asia Pacific | 38,106 | 25,423 | ||||||||
Total long-lived assets | $ | 186,084 | $ | 177,703 | ||||||
Other_Commitments_and_Continge
Other Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2013 | |
Other commitments and contingencies [Abstract] | ' |
Commitments and Contingencies Disclosure | ' |
21. Other commitments and contingencies | |
We are party to various legal actions and administrative proceedings and subject to various claims arising in the ordinary course of business, including those relating to commercial transactions, product liability, safety, health, taxes, environmental and other matters. We review these matters on an ongoing basis and follow the provisions of FASB ASC Topic 450, Contingencies, when making accrual and disclosure decisions. For legal proceedings where it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and which represents our best estimate has been recorded. We believe that the ultimate liability, if any, in excess of amounts already provided for in the financial statements on the disposition of these matters and the matters discussed below would not have a material adverse effect on our financial position. | |
Remy, Inc. vs. Tecnomatic, S.p.A. | |
In September 2008, Remy International, Inc. filed suit against Tecnomatic in the U.S. District Court, Southern District of Indiana, Indianapolis Division (Civil Action No.: 1:08-CV-1227-SEB-JMS), titled Remy, Inc. vs. Tecnomatic S.p.A., for breach of contract, among other claims, with respect to a machine Tecnomatic sold to us to build stators. On December 9, 2008, Tecnomatic filed a counterclaim in the amount of $111,000. | |
In March 2011, Tecnomatic filed a lawsuit in U.S. District Court, N. D. of Illinois, against Remy International, Inc., its Mexican subsidiaries and two other entities alleging breach of contract and the misappropriation of trade secrets, and requested damages of $110,000,000. We believe this action is without merit and is an attempt to push us to settle the prior case. In June 2011, the Illinois Court granted our motion to transfer the case to U.S. District Court, Southern District of Indiana, Indianapolis Division, and the two pending actions were consolidated. | |
After multiple motions by the respective parties and rulings by the Court on the pleadings, certain original claims by Tecnomatic have been dismissed or narrowed. The Court has permitted Tecnomatic to amend its Complaint to add other new claims. Most recently, Tecnomatic was granted leave by the Court to file a Third Amended Complaint which was filed by Tecnomatic in January 2014. We moved to dismiss that complaint in part in February 2014, and the motion is currently pending with the Court. Tecnomatic filed an opposition to our pending motion to dismiss the Third Amended Complaint in February 2014. No trial date has been set, but it is anticipated to commence during the second quarter of 2015. Due to the current stage of this case, it is not possible to make a meaningful estimate of the amount or range of loss to the Company, if any, that could result from this case at this time. As such, we have no amounts accrued as of December 31, 2013 for this case. We intend to vigorously defend this case. |
Supplemental_Cash_Flow_Informa
Supplemental Cash Flow Information | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Supplemental Cash Flow Information [Abstract] | ' | |||||||||
Cash Flow, Supplemental Disclosures | ' | |||||||||
22. Supplemental cash flow information | ||||||||||
Supplemental cash flow information is as follows: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Cash paid for interest | $ | 21,479 | $ | 26,987 | $ | 29,753 | ||||
Cash paid for income taxes, net of refunds received | 7,355 | 13,019 | 17,778 | |||||||
During the year ended December 31, 2009, we entered into certain customer agreements which extinguished certain customer obligations of approximately $23,038,000 and resulted in a deferred gain of approximately $8,152,000. The gain is being deferred and recognized over the anticipated sales of the contract through December 2013. The amount recognized as a reduction of cost of goods sold during the years ended December 31, 2013, 2012, and 2011 was $1,193,000, $1,671,000 and $1,465,000, respectively. | ||||||||||
As a result of entering into new customer agreements, we recorded customer contract intangibles of $13,623,000, during the year ended December 31, 2011, by incurring customer obligations of $13,623,000. These obligations are paid monthly and quarterly over the life of the agreements. |
Executive_officer_separation
Executive officer separation | 12 Months Ended |
Dec. 31, 2013 | |
Executive officer separation [Abstract] | ' |
Other Income and Other Expense Disclosure [Text Block] | ' |
23. Executive officer separation | |
On January 31, 2013, we entered into a Transition, Noncompetition and Release Agreement with John H. Weber, our former President and Chief Executive Officer, effective February 28, 2013. Pursuant to the terms of the agreement, Mr. Weber received a lump sum cash payment of $7,000,000, resulting in a decrease to diluted earnings per share of $0.14, net of tax, for the year ended December 31, 2013. The expense related to this lump sum cash payment is included in selling, general and administrative expenses in the accompanying unaudited consolidated statement of operations for the year ended December 31, 2013. |
Purchase_of_noncontrolling_int
Purchase of noncontrolling interest (Notes) | 12 Months Ended |
Dec. 31, 2013 | |
Purchase of noncontrolling interest [Abstract] | ' |
Noncontrolling Interest Disclosure [Text Block] | ' |
24. Purchase of noncontrolling interest | |
Since 2004, we have owned a 51% controlling interest in our majority-owned Chinese joint venture, Remy Hubei Electric Co. Ltd. ("REH"). In June 2013, we acquired the remaining 49% noncontrolling ownership interest of REH for $14,628,000, consisting of cash payment of $8,107,000 and dividends declared to the noncontrolling interest holder in excess of their ownership percentage of $6,521,000. As a result of this transaction, REH became a wholly-owned subsidiary of Remy on June 24, 2013. During the year ended December 31, 2013, we recorded an adjustment to our additional paid-in capital of $9,188,000 in connection with the acquisition of the noncontrolling interest. |
Subsequent_Event_Notes
Subsequent Event (Notes) | 12 Months Ended |
Dec. 31, 2013 | |
Subsequent Events [Abstract] | ' |
Subsequent Events [Text Block] | ' |
25. Subsequent event | |
Acquisition of United Starters and Alternators Industries, Inc. | |
On January 13, 2014, we announced that we acquired substantially all of the assets of United Starters and Alternators Industries, Inc. ("USA Industries") pursuant to the terms and conditions of the Asset Purchase Agreement, effective as of January 13, 2014. USA Industries is a leading North American distributor of premium quality re-manufactured and new alternators, starters, constant velocity (CV) axles and disc brake calipers for the light-duty aftermarket. Total consideration paid was $40.5 million in cash. In connection with the closing of the transaction, the assets were placed in Remy USA Industries, L.L.C., a wholly-owned subsidiary of the Company. | |
The transaction will be accounted for in accordance with FASB ASC Topic 805, Business Combinations, where the application of purchase accounting requires that the total purchase price be allocated to the fair value of assets acquired and liabilities assumed based on their fair values at the acquisition date, with amounts exceeding the fair values recorded as goodwill. The allocation process requires, among other things, an analysis of acquired fixed assets, contracts and contingencies to identify and record the fair value of all assets acquired and liabilities assumed. We intend to utilize a third-party appraiser to assist us in allocating the purchase price to the fair value of the assets acquired and liabilities assumed. |
Quarterly_Financial_Informatio
Quarterly Financial Information | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Quarterly financial information [Abstract] | ' | |||||||||||||||
Quarterly Financial Information | ' | |||||||||||||||
26. Quarterly financial information (unaudited) | ||||||||||||||||
(In thousands, except per share information) | ||||||||||||||||
Quarter ended | ||||||||||||||||
March 31, | June 30, | September 30, | December 31, | Total year | ||||||||||||
2013 | 2013 | 2013 | 2013 | 2013 | ||||||||||||
Net sales | $ | 281,726 | $ | 282,349 | $ | 262,832 | $ | 291,673 | $ | 1,118,580 | ||||||
Gross profit | 54,979 | 54,701 | 52,232 | 61,058 | 222,970 | |||||||||||
Restructuring and other charges | 681 | 2,128 | 1,454 | (197 | ) | 4,066 | ||||||||||
Net income | 1,843 | 11,464 | 10,356 | 16,691 | 40,354 | |||||||||||
Net income attributable to common stockholders | 1,280 | 11,368 | 10,356 | 16,691 | 39,695 | |||||||||||
Basic earnings per share | $ | 0.04 | $ | 0.36 | $ | 0.33 | $ | 0.53 | $ | 1.27 | ||||||
Diluted earnings per share | $ | 0.04 | $ | 0.36 | $ | 0.33 | $ | 0.53 | $ | 1.26 | ||||||
Quarter ended | ||||||||||||||||
March 31, | June 30, | September 30, | December 31, | Total year | ||||||||||||
2012 | 2012 | 2012 | 2012 | 2012 | ||||||||||||
Net sales | $ | 293,061 | $ | 294,819 | $ | 277,401 | $ | 268,266 | $ | 1,133,547 | ||||||
Gross profit | 62,036 | 61,494 | 54,809 | 59,365 | 237,704 | |||||||||||
Restructuring and other charges | 1,698 | 1,892 | 5,374 | 1,307 | 10,271 | |||||||||||
Net income | 9,524 | 17,964 | 97,359 | 16,538 | 141,385 | |||||||||||
Net income attributable to common stockholders | 8,711 | 17,441 | 96,532 | 15,927 | 138,611 | |||||||||||
Basic earnings per share | $ | 0.29 | $ | 0.57 | $ | 3.15 | $ | 0.52 | $ | 4.53 | ||||||
Diluted earning per share | $ | 0.28 | $ | 0.56 | $ | 3.11 | $ | 0.51 | $ | 4.47 | ||||||
In June 2013, we acquired the remaining 49% noncontrolling ownership interest of REH for $14,628,000, consisting of cash payment of $8,107,000 and dividends declared to the noncontrolling interest holder in excess of their ownership percentage of $6,521,000. As a result of this transaction, REH became a wholly-owned subsidiary of Remy on June 24, 2013. See Note 24. | ||||||||||||||||
During the first quarter of 2013, we entered into a Transition, Noncompetition and Release Agreement (the "Agreement") with John H. Weber, our former President and Chief Executive Officer, effective February 28, 2013. Pursuant to the terms of the Agreement, Mr. Weber received a lump sum cash payment of $7,000,000 which is included in selling, general and administrative expenses in the accompanying consolidated statement of operations for the quarter ended March 31, 2013. See Note 23. | ||||||||||||||||
As a result of the refinancing of our Term B Loan syndication, as discussed in Note 11, we recorded a loss on extinguishment of debt and refinancing fees of $4,256,000 during the quarter ended March 31, 2013. | ||||||||||||||||
During the third quarter of 2012, we reached the conclusion that the net deferred tax asset in the United States is more likely than not to be utilized. As such, the valuation allowance previously recorded against the net deferred tax assets in the United States has been reversed resulting in an income tax benefit of $84,705,000 during the third quarter of 2012. See Note 16. Also in the third quarter of 2012, we recorded fixed asset impairment charges of $2,279,000 in restructuring and other charges related to the anticipated closure of our facilities in Matehuala, Mexico and Mezokovesd, Hungary. See Note 15. |
Valuation_and_Qualifying_Accou
Valuation and Qualifying Accounts (Notes) | 12 Months Ended | |||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||
Valuation and Qualifying Accounts [Abstract] | ' | |||||||||||||||||
Schedule of Valuation and Qualifying Accounts Disclosure | ' | |||||||||||||||||
SCHEDULE II | ||||||||||||||||||
Valuation and qualifying accounts for | ||||||||||||||||||
the years ended December 31, 2013, 2012 and 2011 | ||||||||||||||||||
(In thousands) | Balance at | Charged to | Charged | Deductions | Balance at | |||||||||||||
Beginning | Costs and | (Credited) | End of | |||||||||||||||
of Period | Expenses | to Other | Period | |||||||||||||||
Accounts | ||||||||||||||||||
Year ended December 31, 2013 | ||||||||||||||||||
Allowance for doubtful accounts | $ | 1,931 | $ | 356 | $ | 6 | (c) | $ | (710 | ) | (a) | $ | 1,583 | |||||
Allowance for excess and obsolete inventory | 5,582 | 4,114 | 61 | (c) | (2,100 | ) | (d) | 7,657 | ||||||||||
Deferred tax asset valuation allowance | 16,044 | (3,334 | ) | (793 | ) | (b) | — | 11,917 | ||||||||||
Year ended December 31, 2012 | ||||||||||||||||||
Allowance for doubtful accounts | $ | 1,612 | $ | 814 | $ | (9 | ) | (c) | $ | (486 | ) | (a) | $ | 1,931 | ||||
Allowance for excess and obsolete inventory | 6,708 | 5,115 | 86 | (c) | (6,327 | ) | (d) | 5,582 | ||||||||||
Deferred tax asset valuation allowance | 112,277 | (103,805 | ) | 7,572 | — | 16,044 | ||||||||||||
Year ended December 31, 2011 | ||||||||||||||||||
Allowance for doubtful accounts | $ | 2,364 | $ | 77 | $ | (11 | ) | (c) | $ | (818 | ) | (a) | $ | 1,612 | ||||
Allowance for excess and obsolete inventory | 8,054 | 4,611 | (74 | ) | (c) | (5,883 | ) | (d) | 6,708 | |||||||||
Deferred tax asset valuation allowance | 133,824 | (29,521 | ) | 7,974 | (b) | — | 112,277 | |||||||||||
(a) Uncollectible accounts written off | ||||||||||||||||||
(b) | Amounts related to changes in valuation allowance for deferred tax assets related to other comprehensive income and rate changes in non-U.S. jurisdictions where we have a valuation allowance | |||||||||||||||||
(c) | Other is impact of foreign currency translation | |||||||||||||||||
(d) | Deductions represent write-offs due to sales or scrap of inventory under reserve |
Significant_Accounting_Policie1
Significant Accounting Policies (Policies) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Summary of significant accounting policies [Abstract] | ' | |||||||||
Consolidation, Policy | ' | |||||||||
Basis of presentation and principles of consolidation | ||||||||||
The consolidated financial statements include the accounts of Remy International, Inc., all wholly-owned subsidiaries, and any partially-owned subsidiary that we have the ability to control. Control generally equates to ownership percentage, whereby investments that are more than 50% owned are consolidated. Investments in companies in which we hold an ownership interest of 20% to 50% over which we exercise significant influence are accounted for by the equity method. Currently, we account for all 20% to 50% owned entities under the equity method. Investments in companies in which we hold an ownership interest of less than 20% are accounted for on the cost basis. Such investments were not material at December 31, 2013 and 2012. All significant intercompany accounts and transactions have been eliminated. | ||||||||||
Use of Estimates, Policy | ' | |||||||||
Use of estimates | ||||||||||
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the year. Actual results could differ from these estimates. | ||||||||||
Revenue Recognition, Policy | ' | |||||||||
Revenue recognition | ||||||||||
Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, ownership has transferred, the seller's price to the buyer is fixed and determinable, and collectability is reasonably assured. Sales are recorded upon shipment of product to customers and transfer of title and risk of loss under standard commercial terms (typically, F.O.B. shipping point). We recognize shipping and handling costs as costs of goods sold with the related amounts billed to customers as sales. Accruals for sales returns, price protection, and other allowances are provided at the time of shipment based upon past experience. Adjustments to such returns and allowances are made as new information becomes available. We accrue for rebates, price protection, and other customer sales allowances in accordance with specific customer arrangements. Such rebates are recorded as a reduction of sales. | ||||||||||
Accounting for Remanufacturing Operations | ' | |||||||||
Accounting for remanufacturing operations | ||||||||||
Core deposits | ||||||||||
Remanufacturing is the process where failed or used components, commonly known as cores, are disassembled into subcomponents, cleaned, inspected, tested, combined with new subcomponents and reassembled into saleable, finished products. With many customers, a deposit is charged for the core. Upon return of a core, we grant the customer a credit based on the core deposit value. Deposits charged by us totaled $91,318,000, $87,866,000, and $113,670,000 for the years ended December 31, 2013, 2012, and 2011, respectively. Core deposits are excluded from revenue. We generally limit core returns to the quantity of similar, remanufactured cores previously sold to the customer. | ||||||||||
Core liability | ||||||||||
We record a liability for core returns based on cores expected to be returned. This liability is recorded in “Other current liabilities and accrued expenses” in the accompanying consolidated balance sheets. The liability represents the difference between the core deposit value to be credited to the customer and the estimated core inventory value of the core to be returned. Revisions to these estimates are made periodically to consider current costs and customer return trends. | ||||||||||
Core inventory | ||||||||||
Upon receipt of a core, we record inventory at lower of cost or fair market value. The value of a core declines over its estimated useful life (ranging from 4 to 30 years) and is devalued accordingly. Carrying value of the core inventory is evaluated by comparing current prices obtained from core brokers to carrying cost. The devaluation of core carrying value is reflected as a charge to cost of goods sold. Core inventory that is deemed to be obsolete or in excess of current and future projected demand is written down to the lower of cost or market and charged to cost of goods sold. Core inventories are classified as “Inventories” in the accompanying consolidated balance sheets. | ||||||||||
Customer contract intangibles | ||||||||||
Upon entering into new or extending existing contracts, we may be required to purchase certain cores and inventory from our customers at retail prices, or be obligated to provide certain agreed support. The excess of the prices paid for the cores and inventory over fair value, and the value of any agreed support, are recorded as contract intangibles and amortized as a reduction to revenue on a method to reflect the pattern of economic benefit consumed. Customer contract intangibles that are determined in accordance with the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 805, Business Combinations, and which are not paid to the customers, are amortized and recorded in cost of goods sold. Contract intangibles are included in “Intangibles, net” in the noncurrent asset section of the accompanying consolidated balance sheets. | ||||||||||
Customer obligations | ||||||||||
Customer obligations relate to liabilities when we enter into new or amend existing customer contracts. These contracts designate us to be the exclusive supplier to the respective customer, product line or distribution center and require us to compensate these customers over several years. | ||||||||||
In addition, we have entered into arrangements with certain customers where we purchased the cores held in their inventory. Credits to be issued to these customers for these arrangements are recorded at net present value and are reflected as “Customer obligations.” These obligations are included in “Other current liabilities and accrued expenses” and “Other noncurrent liabilities” in the accompanying consolidated balance sheets. Subsequent to the arrangements, the inventory owned by these customers only represents the exchange value of the remanufactured product. | ||||||||||
Right of core return | ||||||||||
When we enter into arrangements to purchase certain cores held in a customer's inventory or when the customer is not charged a deposit for the core, we have the right to receive a core from the customer in return for every exchange unit supplied to them. We classify such rights as “Core return rights” in “Other noncurrent assets” in the accompanying consolidated balance sheets. The core return rights are valued based on the underlying core inventory values. Devaluation of these rights is charged to cost of goods sold. On a periodic basis, we settle with a customer for cores that have not been returned. | ||||||||||
Government Grants | ' | |||||||||
Government grants | ||||||||||
We record government grants when there is reasonable assurance that the grant will be received and we will comply with the conditions attached to the grants received. Grants related to income are recorded as an offset to the related expense in the accompanying statements of operations. Grants related to assets are recorded as deferred revenue and recognized on a straight-line basis over the useful life of the related asset. We continue to evaluate our compliance with the conditions attached to the related grants. | ||||||||||
The U.S. Department of Energy, or the DOE, awarded us a grant in 2009, pursuant to which it agreed to match up to $60,200,000 of eligible expenditures we make through 2012 for the commercialization of hybrid electric motor technology. We obtained agreements from the DOE to extend the period of eligibility for the grant through 2013. As of December 31, 2012, we have completed the first phase of the grant award and have received $36,000,000 of the total grant. As a number of our hybrid customers have delayed launches of their products or cancelled their programs, we are now moderating our investments in hybrid until the market develops. On July 10, 2013, we formally notified the DOE that we have elected not to pursue the second phase of the grant. | ||||||||||
In addition, we received various grants and subsidies from foreign jurisdictions during the three year period ended December 31, 2013. The amounts recognized in the accompanying consolidated statements of operations as government grants were as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Reduction of cost of goods sold | $ | 2,427 | $ | 4,820 | $ | 5,529 | ||||
Reduction of selling, general, and administrative expenses | $ | 743 | $ | 6,491 | $ | 7,691 | ||||
Research and Development Expense, Policy | ' | |||||||||
Research and development | ||||||||||
We conduct research and development programs that are expected to contribute to future earnings. Such costs are included in selling, general and administrative expenses in the consolidated statements of operations. Company-funded research and development expenses were approximately $15,543,000, $26,004,000, and $26,548,000, for the years ended December 31, 2013, 2012, and 2011, respectively. The decrease in research and development programs in 2013 correlate with the end of the DOE grant in December 2012 as noted above. | ||||||||||
Customer-funded research and development expenses, recorded as an offset to research and development expense in selling, general and administrative expenses, were approximately $969,000, $967,000, and $405,000, for the years ended December 31, 2013, 2012, and 2011, respectively. | ||||||||||
Cash and Cash Equivalents, Policy | ' | |||||||||
Cash and cash equivalents | ||||||||||
All cash balances and highly liquid investments with maturities of ninety days or less when acquired are considered cash and cash equivalents. The carrying amount of cash equivalents approximates fair value. | ||||||||||
Trade and Other Accounts Receivable, Policy | ' | |||||||||
Trade accounts receivable and allowance for doubtful accounts | ||||||||||
Trade accounts receivable is stated at net realizable value, which approximates fair value. Substantially all of our trade accounts receivable are due from customers in the original equipment and aftermarket automotive industries, both domestically and internationally. Trade accounts receivable include notes receivables of $27,154,000 and $29,091,000 as of December 31, 2013 and 2012, respectively. Trade accounts receivable is reduced by an allowance for amounts that are expected to become uncollectible in the future and for disputed items. We perform periodic credit evaluations of our customers' financial condition and generally do not require collateral. We maintain allowances for doubtful customer accounts for estimated losses resulting from the inability of our customers to make required payments. The allowance for doubtful accounts is developed based on several factors including customers' credit quality, historical write-off experience and any known specific issues or disputes which exist as of the balance sheet date. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. | ||||||||||
Inventory, Policy | ' | |||||||||
Inventories other than core inventory | ||||||||||
Inventories other than core inventory are carried at the lower of cost or market determined on the first-in, first-out (FIFO) method. We evaluate inventories on a regular basis to identify inventory on hand that may be obsolete or in excess of current and future projected market demand. For inventory deemed to be obsolete or in excess of current and future projected market demand, we record an inventory reserve and a charge to cost of goods sold to reduce carrying cost to lower of cost or market. | ||||||||||
Property, Plant and Equipment, Policy | ' | |||||||||
Property, plant and equipment | ||||||||||
Property, plant and equipment are recorded at cost. Major expenditures that significantly extend the useful life or enhance the usability of the property, plant or equipment are capitalized. Depreciation is calculated primarily using the straight-line method over the estimated useful lives of the related assets (15 to 40 years for buildings, and 3 to 15 years for tooling, machinery and equipment). Capital leases and leasehold improvements are amortized over the shorter of the lease term or their estimated useful life. | ||||||||||
Impairment or Disposal of Long-Lived Assets, Policy | ' | |||||||||
Valuation of long-lived assets | ||||||||||
When events or circumstances indicate a potential impairment to the carrying value, we evaluate the carrying value of long-lived assets, including certain intangible assets, for recoverability through an undiscounted cash flow analysis. When such events or circumstances arise which indicate the long-lived asset is not recoverable, fair market value is determined by asset, or the appropriate grouping of assets, and is compared to the asset's carrying value to determine if impairment exists. Asset impairments are recorded as a charge to operations, based on the amount by which the carrying value exceeds the fair market value. Long-lived assets to be disposed of other than by sale are considered held and used until such time the asset is disposed. | ||||||||||
Tooling | ' | |||||||||
Tooling | ||||||||||
Tooling, which is included in machinery and equipment in the accompanying consolidated balance sheets, includes the costs to design and develop tools, dies, jigs and other items owned by us and used in the manufacture of products sold under long-term supply agreements. Tooling is amortized over the tool's expected life. Tooling that involves new technology not covered by a customer supply agreement is expensed as incurred. Engineering, testing and other costs incurred in the design and development of products and product components are expensed as incurred. | ||||||||||
Goodwill and Intangible Assets, Goodwill, Policy | ' | |||||||||
Goodwill and other intangible assets | ||||||||||
Goodwill and indefinite-lived intangible assets are not amortized, but are tested for impairment at least annually. We perform our annual impairment test in the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. We determine goodwill impairment charges by comparing the carrying value of each reporting unit to the fair value of the reporting unit. In determining fair value of reporting units, we utilize discounted cash flow analyses and guideline company market multiples. Where the carrying value exceeds the fair value for a particular reporting unit, goodwill impairment charges may be recognized. | ||||||||||
Definite-lived intangible assets have been stated at estimated fair value as a result of fresh-start reporting. The values of other intangible assets with determinable useful lives are amortized on a basis to reflect the pattern of economic benefit consumed. Prior to the application of fresh-start, intangible assets were stated at cost. Certain amortization of intangibles associated with specific customers in the aftermarket business is recorded as a reduction of sales. | ||||||||||
Foreign Currency Transactions and Translations Policy | ' | |||||||||
Foreign currency translation | ||||||||||
Each of our foreign subsidiaries' functional currency as of December 31, 2013, is its local currency, with the exception of our subsidiaries in Mexico, for which the U.S. dollar is the functional currency since substantially all of the purchases and sales are denominated in U.S. dollars, and in Hungary, for which the Euro is the functional currency as substantially all of the purchases and sales are denominated in Euro. Financial statements of foreign subsidiaries for which the functional currency is their local currency are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and at the average exchange rate for each year for revenue and expenses. Translation adjustments are recorded as a separate component of stockholders' equity and reflected in other comprehensive income (loss) (“OCI”). For each of our foreign subsidiaries, gains and losses arising from transactions denominated in a currency other than the functional currency are included in the accompanying consolidated statements of operations. We evaluate our foreign subsidiaries' functional currency on an ongoing basis. | ||||||||||
Derivatives, Policy | ' | |||||||||
Derivative financial instruments | ||||||||||
In the normal course of business, our operations are exposed to continuing fluctuations in foreign currency values, interest rates and commodity prices that can affect the cost of operating, investing and financing. Accordingly, we address a portion of these risks through a controlled program of risk management that includes the use of derivative financial instruments. We have historically used derivative financial instruments for the purpose of hedging currency, interest rate, and commodity exposures, which exist as a part of ongoing business operations. | ||||||||||
As a policy, we do not engage in speculative or leveraged transactions, nor do we hold or issue derivative financial instruments for trading purposes. Our objectives for holding derivatives are to minimize risks using the most effective and cost-efficient methods available. Management routinely reviews the effectiveness of the use of derivative financial instruments. | ||||||||||
We recognize all of our derivative instruments as either assets or liabilities at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated, and is effective, as a hedge and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation. Gains and losses related to a hedge are either recognized in income immediately to offset the gain or loss on the hedged item or are deferred and reported as a component of “Accumulated other comprehensive income (loss)” (“AOCI”) and subsequently recognized in earnings when the hedged item affects earnings. The change in fair value of the ineffective portion of a financial instrument, determined using the change in fair value method, is recognized in earnings immediately. The gain or loss related to financial instruments that are not designated as hedges is recognized immediately in earnings. | ||||||||||
Other | ||||||||||
We present our derivative positions and any related material collateral under master netting agreements on a gross basis. We have entered into International Swaps and Derivatives Association agreements with each of its significant derivative counterparties. These agreements provide bilateral netting and offsetting of accounts that are in a liability position with those that are in an asset position. These agreements do not require us to maintain a minimum credit rating in order to be in compliance with the terms of the agreements and do not contain any margin call provisions or collateral requirements that could be triggered by derivative instruments in a net liability position. As of December 31, 2013, we have not posted any collateral to support its derivatives in a liability position. | ||||||||||
For derivatives designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness. Unrealized gains and losses associated with ineffective hedges, determined using the change in fair value method, are recognized in the accompanying consolidated statements of operations. Derivative gains and losses included in AOCI for effective hedges are reclassified into the accompanying consolidated statements of operations upon recognition of the hedged transaction. | ||||||||||
Any derivative instrument designated initially, but no longer effective as a hedge, or initially not effective as a hedge, is recorded at fair value and the related gains and losses are recognized in the accompanying consolidated statements of operations. Our undesignated hedges are primarily our interest rate swaps whose fair value at inception of the instrument due to the roll over of existing interest rate swaps resulted in ineffectiveness. | ||||||||||
Standard Product Warranty, Policy | ' | |||||||||
Warranty | ||||||||||
We provide certain warranties relating to quality and performance of our products. An allowance for the estimated future cost of product warranties and other defective product returns is based on management's estimate of product failure rates and customer eligibility. If these factors differ from management's estimates, revisions to the estimated warranty liability may be required. The specific terms and conditions of the warranties vary depending upon the customer and the product sold. | ||||||||||
Income Tax, Policy | ' | |||||||||
Income taxes | ||||||||||
We account for income taxes in accordance with FASB ASC Topic 740, Income Taxes, which requires deferred tax assets and liabilities to be recognized using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. FASB ASC Topic 740 also requires deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. | ||||||||||
We assess the need to maintain a valuation allowance for deferred tax assets based on an assessment of whether it is more likely than not that deferred tax benefits will be realized through the generation of future taxable income. Appropriate consideration is given to all available evidence, both positive and negative, in assessing the need for a valuation allowance. | ||||||||||
Failure to achieve forecasted taxable income may affect the ultimate realization of certain deferred tax assets arising from net operating losses. Factors that may affect our ability to achieve sufficient forecasted taxable income include, but are not limited to, general economic conditions, increased competition or other market conditions, costs incurred or delays in product availability. | ||||||||||
FASB ASC Topic 740 clarifies the accounting for uncertainty in income taxes recognized in companies' financial statements. As a result, we apply a more-likely-than-not recognition threshold for all tax uncertainties. It only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. | ||||||||||
We review the likelihood that the Company will realize the benefit of its deferred tax assets and, therefore, the need for valuation allowances on a quarterly basis, or more frequently if events indicate that a review is required. In determining whether or not it is more likely than not that a valuation allowance is required, the historical and projected financial results of the legal entity or consolidated group recording the net deferred tax asset is considered, along with all other available positive and negative evidence. The factors considered by management in its determination of the probability of the realization of the deferred tax assets include but are not limited to: recent adjusted historical financial results, historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. If, based upon the weight of available evidence, it is more likely than not the deferred tax assets will not be realized, a valuation allowance is recorded. | ||||||||||
In performing our analysis of whether a valuation allowance is required, we utilize a rolling twelve quarters of pre-tax book results adjusted for significant permanent book to tax differences as a measure of cumulative results in recent years. In certain states in the United States and foreign jurisdictions, our analysis indicates that we have cumulative three year historical losses on this basis. This is considered significant negative evidence which is difficult to overcome. Therefore, we maintain a valuation allowance in those jurisdictions. However, the three year loss position is not solely determinative and, accordingly, management considers all other available positive and negative evidence in its analysis. | ||||||||||
There is no corresponding income tax benefit recognized with respect to losses incurred and no corresponding income tax expense recognized with respect to earnings generated in jurisdictions with a valuation allowance. This causes variability in our effective tax rate. We intend to maintain the valuation allowances until it is more likely than not that the net deferred tax assets will be realized. If operating results improve or deteriorate on a sustained basis, our conclusions regarding the need for a valuation allowance could change, resulting in either the reversal or initial recognition of a valuation allowance in the future, which could have a significant impact on income tax expense in the period recognized and subsequent periods. | ||||||||||
Pension and Other Postretirement Plans, Policy | ' | |||||||||
Pension and postretirement plans | ||||||||||
We maintain limited defined benefit pension plans and other postretirement benefit plans, as well as a supplemental employee retirement plan covering certain executives. Costs associated with these plans are based on actuarial computations. Inherent in these valuations are key assumptions regarding discount rates, expected return on plan assets, rates of compensation increases, and the rates of health care benefit increases. If future trends in these assumptions prove to differ from management's assumptions, revisions to the plan assets and benefit obligations may be required. | ||||||||||
Earnings Per Share, Policy | ' | |||||||||
Earnings per share | ||||||||||
Basic earnings per share are calculated by dividing net income attributable to common stockholders by the weighted average shares outstanding during the period. Diluted earnings per share are based on the weighted average number of shares outstanding plus the assumed issuance of common shares and related adjustment to net income attributable to common stockholders related to all potentially dilutive securities. For the years ended December 31, 2013, 2012 and 2011, in applying the treasury stock method, equivalent shares of unvested restricted stock and restricted stock units of 181,603, 374,288 and 578,288, respectively, were included in the weighted average shares outstanding in the diluted calculation. Anti-dilutive stock options of 218,050 were excluded from the calculation of dilutive earnings per share for the year ended December 31, 2013. | ||||||||||
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | ' | |||||||||
Stock-based compensation | ||||||||||
We account for stock-based compensation plans using the fair value method. Using the fair value method of accounting, compensation expense is measured based on the fair value of the award at the grant date, using the Black-Scholes Model for stock options and the fair market value of our common stock for restricted stock, and recognized straight line over the service period. Performance awards are adjusted for the estimated percentage attainment related to those awards granted with performance conditions. | ||||||||||
Restricted stock unit awards that are to be settled in cash are subject to liability accounting. Accordingly, the fair value for such awards are calculated each reporting period based on our most recent closing stock price. As such, the liability is adjusted, and expense is recognized, based on changes to the fair value and the percentage of time vested. | ||||||||||
New Accounting Pronouncements, Policy | ' | |||||||||
Recent accounting adoptions | ||||||||||
In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220), Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. ASU No. 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. We adopted this guidance on January 1, 2013. The adoption of this guidance increased our disclosures, but did not have an impact on our consolidated financial position, results of operations or cash flows. | ||||||||||
In December 2011, the FASB issued ASU No. 2011-11, Balance Sheet (Topic 210), Disclosures about Offsetting Assets and Liabilities, which requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. In January 2013, the FASB issued ASU No. 2013-01, Clarifying the Scope of Disclosures About Offsetting Assets and Liabilities, that limits the scope of the new balance sheet offsetting disclosures to derivatives, repurchase agreements and securities lending transactions to the extent they are offset in the financial statements or subject to an enforceable master netting arrangement or similar agreement. ASU No. 2011-11, as clarified by ASU No. 2013-01, is effective for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. We adopted this guidance on January 1, 2013. The adoption of this guidance had an immaterial impact. | ||||||||||
In July 2012, the FASB issued ASU No. 2012-02, Intangibles-Goodwill and Other (Topic 350), Testing Indefinite-Lived Intangible Assets for Impairment, which permits an entity to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test. ASU No. 2012-02 is effective for annual reporting periods beginning on or after September 15, 2012 and interim periods within those annual periods. The adoption of this guidance did not have an impact on our consolidated financial position, results of operations or cash flows. | ||||||||||
New accounting pronouncements | ||||||||||
In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists to provide guidance on the presentation of unrecognized tax benefits. ASU 2013-11 requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with certain limited exceptions. ASU 2013-11 is effective for annual reporting periods beginning on or after December 15, 2013 and interim periods within those annual periods with earlier adoption permitted. This guidance is effective January 1, 2014. ASU 2013-11 should be applied prospectively with retroactive application permitted. The adoption of this guidance is not expected to have a material impact on our consolidated financial position, results of operations or cash flows. | ||||||||||
Fair Value of Financial Instruments, Policy | ' | |||||||||
Investments with registered investment companies are valued at the closing price reported on the active market on which the funds are traded. | ||||||||||
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities that are measured at fair value on a nonrecurring basis. As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets (see Notes 6, 7 and 15). We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on our assumptions as observable inputs are not available. As such, we have determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. | ||||||||||
We calculate the fair value of our interest rate swap contracts, commodity contracts and foreign currency contracts using quoted interest rate curves, quoted commodity forward rates and quoted currency forward rates. For contracts which, when aggregated by counterparty, are in a liability position, the discount rates are adjusted by the credit spread that market participants would apply if buying these contracts from our counterparties. | ||||||||||
3. Fair value measurements | ||||||||||
FASB ASC Topic 820, Fair Value Measurements and Disclosures, clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based upon assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, FASB ASC Topic 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: | ||||||||||
Level 1: | Observable inputs such as quoted prices in active markets; | |||||||||
Level 2: | Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and | |||||||||
Level 3: | Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. | |||||||||
An asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. | ||||||||||
Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques noted in FASB ASC Topic 820: | ||||||||||
A. | Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. | |||||||||
B. | Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost). | |||||||||
C. | Income approach: Techniques to convert future amounts to a single present amount based upon market expectations (including present value techniques, option-pricing and excess earnings models). | |||||||||
Restructuring and Related Activities Policy | ' | |||||||||
15. Restructuring and other charges | ||||||||||
We account for restructuring costs in accordance with FASB ASC Topic 420, Exit or Disposal Cost Obligations, and FASB ASC Topic 712, Compensation - Nonretirement Postemployment Benefits. Restructuring costs consist of costs associated with business realignment and streamlining activities and entail exit costs such as lease termination costs, certain operating costs relating to closed leased facilities, employee severance and related costs, and certain other related costs. Such costs are recorded when the liability is incurred in accordance with the prescribed accounting at the then estimated amounts. These estimates are subject to the inherent risk of uncertainty in the estimation process, especially as to the accrual of future net rental charges on exited facilities. Subsequent changes to such estimates are recorded as restructuring charges in the year the change in the estimate is made. | ||||||||||
Commitments and Contingencies, Policy | ' | |||||||||
21. Other commitments and contingencies | ||||||||||
We are party to various legal actions and administrative proceedings and subject to various claims arising in the ordinary course of business, including those relating to commercial transactions, product liability, safety, health, taxes, environmental and other matters. We review these matters on an ongoing basis and follow the provisions of FASB ASC Topic 450, Contingencies, when making accrual and disclosure decisions. For legal proceedings where it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and which represents our best estimate has been recorded. We believe that the ultimate liability, if any, in excess of amounts already provided for in the financial statements on the disposition of these matters and the matters discussed below would not have a material adverse effect on our financial position. | ||||||||||
Business Combinations Policy [Policy Text Block] | ' | |||||||||
The transaction will be accounted for in accordance with FASB ASC Topic 805, Business Combinations, where the application of purchase accounting requires that the total purchase price be allocated to the fair value of assets acquired and liabilities assumed based on their fair values at the acquisition date, with amounts exceeding the fair values recorded as goodwill. The allocation process requires, among other things, an analysis of acquired fixed assets, contracts and contingencies to identify and record the fair value of all assets acquired and liabilities assumed. We intend to utilize a third-party appraiser to assist us in allocating the purchase price to the fair value of the assets acquired and liabilities assumed. |
Significant_Accounting_Policie2
Significant Accounting Policies (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Summary of significant accounting policies [Abstract] | ' | |||||||||
Schedule of Government Grants | ' | |||||||||
The amounts recognized in the accompanying consolidated statements of operations as government grants were as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Reduction of cost of goods sold | $ | 2,427 | $ | 4,820 | $ | 5,529 | ||||
Reduction of selling, general, and administrative expenses | $ | 743 | $ | 6,491 | $ | 7,691 | ||||
Fair_Value_Measurement_Tables
Fair Value Measurement (Tables) | 12 Months Ended | |||||||||||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | |||||||||||||||||||||||
Fair value measurements [Abstract] | ' | ' | ||||||||||||||||||||||
Fair Value, by Balance Sheet Grouping | ' | ' | ||||||||||||||||||||||
Assets and liabilities remeasured and disclosed at fair value on a recurring basis as of December 31, 2013 and 2012, are set forth in the table below: | ||||||||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | |||||||||||||||||||||||
(In thousands) | Asset/ | Level 2 | Valuation | Asset/ | Level 2 | Valuation | ||||||||||||||||||
(liability) | technique | (liability) | technique | |||||||||||||||||||||
Interest rate swap contracts | $ | 727 | $ | 727 | C | $ | (2,218 | ) | $ | (2,218 | ) | C | ||||||||||||
Foreign exchange contracts | 3,417 | 3,417 | C | 5,328 | 5,328 | C | ||||||||||||||||||
Commodity contracts | (1,333 | ) | (1,333 | ) | C | (1,315 | ) | (1,315 | ) | C | ||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | ' | ' | ||||||||||||||||||||||
The following table presents our defined benefit plan assets measured at fair value on a recurring basis as of December 31, 2013: | The following table presents our defined benefit plan assets measured at fair value on a recurring basis as of December 31, 2012: | |||||||||||||||||||||||
(In thousands of dollars) | Total | Level 1 | Valuation | (In thousands of dollars) | Total | Level 1 | Valuation | |||||||||||||||||
technique | technique | |||||||||||||||||||||||
U.S. Plans: | U.S. Plans: | |||||||||||||||||||||||
Interest-bearing cash and equivalents | $ | 2,563 | $ | 2,563 | A | Interest-bearing cash and equivalents | $ | 2,329 | $ | 2,329 | A | |||||||||||||
Investments with Registered Investment Companies: | Investments with Registered Investment Companies: | |||||||||||||||||||||||
Fixed income securities | 14,550 | 14,550 | A | Fixed income securities | 12,838 | 12,838 | A | |||||||||||||||||
Equity securities | 25,798 | 25,798 | A | Equity securities | 22,732 | 22,732 | A | |||||||||||||||||
42,911 | 42,911 | 37,899 | 37,899 | |||||||||||||||||||||
Non U.S. Plans: | Non U.S. Plans: | |||||||||||||||||||||||
Interest-bearing cash and equivalents | 6,417 | 6,417 | A | Interest-bearing cash and equivalents | 89 | 89 | A | |||||||||||||||||
Investments with Registered Investment Companies: | Investments with Registered Investment Companies: | |||||||||||||||||||||||
Fixed income securities | 3,858 | 3,858 | A | Fixed income securities | 3,792 | 3,792 | A | |||||||||||||||||
Equity securities | 6,800 | 6,800 | A | Equity securities | 5,569 | 5,569 | A | |||||||||||||||||
17,075 | 17,075 | 9,450 | 9,450 | |||||||||||||||||||||
Total | $ | 59,986 | $ | 59,986 | Total | $ | 47,349 | $ | 47,349 | |||||||||||||||
Financial_Instruments_Tables
Financial Instruments (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||
As of December 31, 2013 and 2012, we had the following outstanding foreign currency contracts that were entered into to hedge forecasted purchases and revenues, respectively: | |||||||||||||||||||||||||||||||||||||||||
(In thousands) | Currency denomination | ||||||||||||||||||||||||||||||||||||||||
as of December 31, | |||||||||||||||||||||||||||||||||||||||||
Foreign currency contract | 2013 | 2012 | |||||||||||||||||||||||||||||||||||||||
South Korean Won Forward | $ | 74,368 | $ | 55,546 | |||||||||||||||||||||||||||||||||||||
Mexican Peso Contracts | $ | 73,520 | $ | 66,674 | |||||||||||||||||||||||||||||||||||||
Brazilian Real Forward | $ | 11,427 | $ | 18,055 | |||||||||||||||||||||||||||||||||||||
Hungarian Forint Forward | € | 14,416 | € | 13,565 | |||||||||||||||||||||||||||||||||||||
Great Britain Pound Forward | £ | 3,735 | £ | 1,370 | |||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||
The following table discloses the fair values and balance sheet locations of our derivative instruments: | |||||||||||||||||||||||||||||||||||||||||
Asset derivatives | Liability derivatives | ||||||||||||||||||||||||||||||||||||||||
(In thousands) | Balance sheet location | December 31, 2013 | December 31, 2012 | Balance sheet location | December 31, 2013 | December 31, 2012 | |||||||||||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||
Commodity contracts | Prepaid expenses and other current assets | $ | 257 | $ | 427 | Other current liabilities and accrued expenses | $ | — | $ | 2,009 | |||||||||||||||||||||||||||||||
Commodity contracts | Other noncurrent assets | 195 | 267 | Other noncurrent liabilities | 1,785 | — | |||||||||||||||||||||||||||||||||||
Foreign currency contracts | Prepaid expenses and other current assets | 3,630 | 5,537 | Other current liabilities and accrued expenses | 141 | 26 | |||||||||||||||||||||||||||||||||||
Foreign currency contracts | Other noncurrent assets | 108 | 127 | Other noncurrent liabilities | 180 | 310 | |||||||||||||||||||||||||||||||||||
Interest rate swap contracts | Other noncurrent assets | 1,455 | — | Other noncurrent liabilities | — | — | |||||||||||||||||||||||||||||||||||
Total derivatives designated as hedging instruments | $ | 5,645 | $ | 6,358 | $ | 2,106 | $ | 2,345 | |||||||||||||||||||||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest rate swap contracts | Prepaid expenses and other current assets | $ | — | $ | — | Other current liabilities and accrued expenses | $ | — | $ | 2,218 | |||||||||||||||||||||||||||||||
Interest rate swap contracts | Other noncurrent assets | — | — | Other noncurrent liabilities | 728 | — | |||||||||||||||||||||||||||||||||||
Total derivatives not designated as hedging instruments | $ | — | $ | — | $ | 728 | $ | 2,218 | |||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||
The following tables disclose the effect of our derivative instruments on the accompanying consolidated statement of operations for the year ended December 31, 2013 (in thousands): | The following tables disclose the effect of our derivative instruments on the accompanying consolidated statement of operations for the year ended December 31, 2012 (in thousands): | The following tables disclose the effect of our derivative instruments on the accompanying consolidated statement of operations for the year ended December 31, 2011 (in thousands): | |||||||||||||||||||||||||||||||||||||||
Derivatives designated as cash | Amount of gain (loss) recognized in OCI on derivatives (effective portion) | Location of gain (loss) reclassified from AOCI into income (effective portion) | Amount of gain (loss) reclassified from AOCI into income (effective portion) | Location of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | Amount of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | Derivatives designated as | Amount of | Location of gain | Amount of | Location of gain | Amount of gain | Derivatives designated as | Amount of | Location of gain | Amount of | Location of gain | Amount of gain | ||||||||||||||||||||||||
flow hedging instruments | cash flow hedging | gain (loss) | (loss) reclassified from | gain | (loss) recognized in | (loss) | cash flow hedging | gain (loss) | (loss) reclassified from | gain | (loss) recognized in | (loss) | |||||||||||||||||||||||||||||
Commodity contracts | $ | (3,987 | ) | Cost of goods sold | $ | (3,956 | ) | Cost of goods sold | $ | (54 | ) | instruments | recognized | AOCI into income | (loss) | income on derivatives | recognized | instruments | recognized | AOCI into income | (loss) | income on derivatives | recognized | ||||||||||||||||||
Foreign currency contracts | 4,594 | Cost of goods sold | 5,751 | Cost of goods sold | — | in | (effective portion) | reclassified | (ineffective portion | in income on | in | (effective portion) | reclassified | (ineffective portion | in income on | ||||||||||||||||||||||||||
OCI on | from AOCI | and amount excluded | derivatives | OCI on | from AOCI | and amount excluded | derivatives | ||||||||||||||||||||||||||||||||||
Interest rate swap contracts | 1,455 | Interest expense–net | — | Interest expense–net | — | derivatives | into | from effectiveness | (ineffective | derivatives | into | from effectiveness | (ineffective | ||||||||||||||||||||||||||||
(effective | income | testing) | portion and | (effective | income | testing) | portion and | ||||||||||||||||||||||||||||||||||
$ | 2,062 | $ | 1,795 | $ | (54 | ) | portion) | (effective | amount | portion) | (effective | amount | |||||||||||||||||||||||||||||
portion) | excluded from | portion) | excluded from | ||||||||||||||||||||||||||||||||||||||
effectiveness | effectiveness | ||||||||||||||||||||||||||||||||||||||||
testing) | testing) | ||||||||||||||||||||||||||||||||||||||||
Commodity contracts | $ | (5 | ) | Cost of goods sold | $ | (4,043 | ) | Cost of goods sold | $ | (7 | ) | Commodity contracts | $ | (7,722 | ) | Cost of goods sold | $ | 6,742 | Cost of goods sold | $ | (91 | ) | |||||||||||||||||||
Derivatives not designated as hedging instruments | Location of gain (loss) recognized in income on derivatives | Amount of gain (loss) recognized in income on derivatives | Foreign currency | 12,809 | Cost of goods sold | (2,965 | ) | Cost of goods sold | — | ||||||||||||||||||||||||||||||||
contracts | Foreign currency | (7,567 | ) | Cost of goods sold | 2,658 | Cost of goods sold | — | ||||||||||||||||||||||||||||||||||
Interest rate swap | Interest expense–net | $ | 1,490 | $ | 12,804 | $ | (7,008 | ) | $ | (7 | ) | contracts | |||||||||||||||||||||||||||||
$ | (15,289 | ) | $ | 9,400 | $ | (91 | ) | ||||||||||||||||||||||||||||||||||
Derivatives not designated as hedging instruments | Location of gain | Amount of gain | |||||||||||||||||||||||||||||||||||||||
(loss) recognized in | (loss) recognized | Derivatives not designated as hedging instruments | Location of gain | Amount of gain | |||||||||||||||||||||||||||||||||||||
income on | in income on | (loss) recognized in | (loss) recognized | ||||||||||||||||||||||||||||||||||||||
derivatives | derivatives | income on | in income on | ||||||||||||||||||||||||||||||||||||||
Interest rate swap contracts | Interest expense–net | $ | (466 | ) | derivatives | derivatives | |||||||||||||||||||||||||||||||||||
Foreign currency contracts | Cost of goods sold | $ | (2,213 | ) | |||||||||||||||||||||||||||||||||||||
Interest rate swap contracts | Interest expense–net | $ | (1,659 | ) |
Inventory_Tables
Inventory (Tables) | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Inventory [Abstract] | ' | ||||||
Schedule of Inventory, Current | ' | ||||||
Net inventories consisted of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Raw materials | $ | 42,322 | $ | 47,972 | |||
Core inventory | 36,581 | 31,191 | |||||
Work-in-process | 8,398 | 9,934 | |||||
Finished goods | 72,039 | 69,839 | |||||
$ | 159,340 | $ | 158,936 | ||||
PPE_Tables
PP&E (Tables) | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
PP&E [Abstract] | ' | ||||||
Property, Plant and Equipment | ' | ||||||
Property, plant and equipment consisted of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Land and buildings | $ | 44,762 | $ | 43,272 | |||
Machinery and equipment | 204,564 | 184,683 | |||||
$ | 249,326 | $ | 227,955 | ||||
Goodwill_and_Other_Intangible_1
Goodwill and Other Intangible Assets (Tables) | 12 Months Ended | ||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||
Goodwill and other intangible assets [Abstract] | ' | ||||||||||||||||||
Schedule of Intangible Assets and Goodwill | ' | ||||||||||||||||||
The following table represents the carrying value of other intangible assets: | |||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | ||||||||||||||||||
(In thousands) | Carrying | Accumulated | Net | Carrying | Accumulated | Net | |||||||||||||
value | amortization | value | amortization | ||||||||||||||||
Definite-life intangibles: | |||||||||||||||||||
Intellectual property | $ | 16,810 | $ | 4,583 | $ | 12,227 | $ | 14,370 | $ | 4,082 | $ | 10,288 | |||||||
Customer relationships | 35,500 | 17,746 | 17,754 | 35,500 | 15,150 | 20,350 | |||||||||||||
Customer contract | 97,789 | 86,061 | 11,728 | 95,389 | 74,898 | 20,491 | |||||||||||||
Total | 150,099 | 108,390 | 41,709 | 145,259 | 94,130 | 51,129 | |||||||||||||
Indefinite-life intangibles: | |||||||||||||||||||
Trade names | 48,200 | — | 48,200 | 48,200 | — | 48,200 | |||||||||||||
Intangible assets, net | $ | 198,299 | $ | 108,390 | $ | 89,909 | $ | 193,459 | $ | 94,130 | $ | 99,329 | |||||||
Goodwill | $ | 271,418 | $ | — | $ | 271,418 | $ | 271,418 | $ | — | $ | 271,418 | |||||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | ' | ||||||||||||||||||
Estimated future amortization, in thousands, for intangibles with definite lives at December 31, 2013, is: | |||||||||||||||||||
2014 | $ | 12,125 | |||||||||||||||||
2015 | 7,315 | ||||||||||||||||||
2016 | 8,092 | ||||||||||||||||||
2017 | 9,665 | ||||||||||||||||||
2018 | 521 | ||||||||||||||||||
Other_Current_Liabilities_and_1
Other Current Liabilities and Accrued Expenses (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Other current liabilities and accrued expenses [Abstract] | ' | |||||||||
Schedule of Accrued Liabilities | ' | |||||||||
Other current liabilities and accrued expenses consist of the following: | ||||||||||
As of December 31, | ||||||||||
(In thousands) | 2013 | 2012 | ||||||||
Accrued warranty | $ | 27,083 | $ | 23,374 | ||||||
Accrued wages and benefits | 20,016 | 18,531 | ||||||||
Current portion of customer obligations | 4,560 | 9,326 | ||||||||
Rebates, stocklifts, discounts and returns | 18,922 | 15,865 | ||||||||
Current deferred revenue | 2,270 | 2,882 | ||||||||
Other | 37,328 | 38,179 | ||||||||
$ | 110,179 | $ | 108,157 | |||||||
Schedule of Product Warranty Liability | ' | |||||||||
Changes to our current and noncurrent accrued warranty were as follows: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Balance at beginning of period | $ | 27,194 | $ | 30,278 | $ | 32,510 | ||||
Provision for warranty | 44,215 | 36,281 | 45,597 | |||||||
Payments and charges against the accrual | (40,628 | ) | (39,365 | ) | (47,829 | ) | ||||
Balance at end of period | $ | 30,781 | $ | 27,194 | $ | 30,278 | ||||
Other_Noncurrent_Liabilities_T
Other Noncurrent Liabilities (Tables) | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Other noncurrent liabilities [Abstract] | ' | ||||||
Other Noncurrent Liabilities | ' | ||||||
Other noncurrent liabilities consist of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Customer obligations, net of current portion | $ | — | $ | 3,689 | |||
Noncurrent deferred revenue | 4,755 | 5,755 | |||||
Other | 20,028 | 19,744 | |||||
$ | 24,783 | $ | 29,188 | ||||
Debt_Tables
Debt (Tables) | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Debt [Abstract] | ' | ||||||
Schedule of Debt | ' | ||||||
Borrowings under long-term debt arrangements, net of discounts, consisted of the following: | |||||||
As of December 31, | |||||||
(In thousands) | 2013 | 2012 | |||||
Asset-Based Revolving Credit Facility, First Amendment- Maturity date of September 5, 2018 | $ | — | $ | — | |||
Term B Loan- Maturity date of December 17, 2016 | — | 284,892 | |||||
Amended and Restated Term B Loan- Maturity date of March 5, 2020 | 295,001 | — | |||||
Total Senior Credit Facility and Notes | 295,001 | 284,892 | |||||
Capital leases | 2,226 | 3,053 | |||||
Less current maturities | (3,392 | ) | (3,470 | ) | |||
Long-term debt less current maturities | $ | 293,835 | $ | 284,475 | |||
Schedule of Maturities of Long-term Debt | ' | ||||||
Future maturities of long-term debt outstanding at December 31, 2013, including capital lease obligations, and excluding original issue discount, in thousands, consist of the following: | |||||||
2014 | $ | 3,392 | |||||
2015 | 3,407 | ||||||
2016 | 3,421 | ||||||
2017 | 3,353 | ||||||
2018 | 3,255 | ||||||
Thereafter | 282,398 | ||||||
Accumulated_Other_Comprehensiv1
Accumulated Other Comprehensive Income (Loss) (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
Accumulated other comprehansive income (loss) [Abstract] | ' | ||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) | ' | ||||||||||||||||||||||||
The following table discloses the changes in each component of accumulated other comprehensive income (loss), net of tax for the year ended December 31, 2013, 2012 and 2011 (in thousands): | |||||||||||||||||||||||||
Foreign currency translation adjustment | Unrealized gains (losses) on currency hedges | Unrealized gains (losses) on commodity hedges | Interest rate swaps | Employee benefit plan adjustment | Accumulated other comprehensive income (loss) | ||||||||||||||||||||
Balances at December 31, 2010 | $ | (17,942 | ) | $ | 712 | $ | 5,606 | $ | (1,574 | ) | $ | (8,159 | ) | $ | (21,357 | ) | |||||||||
Other comprehensive income (loss) before reclassifications | (4,682 | ) | (8,014 | ) | (7,813 | ) | — | (12,682 | ) | (33,191 | ) | ||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | — | (2,211 | ) | (6,651 | ) | — | (2,320 | ) | (11,182 | ) | |||||||||||||||
Other comprehensive income (loss) | (4,682 | ) | (10,225 | ) | (14,464 | ) | — | (15,002 | ) | (44,373 | ) | ||||||||||||||
Balances at December 31, 2011 | (22,624 | ) | (9,513 | ) | (8,858 | ) | (1,574 | ) | (23,161 | ) | (65,730 | ) | |||||||||||||
Other comprehensive income (loss) before reclassifications | 2,764 | 10,277 | 76 | — | (2,304 | ) | 10,813 | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | — | 2,662 | 2,466 | — | (518 | ) | 4,610 | ||||||||||||||||||
Other comprehensive income (loss) | 2,764 | 12,939 | 2,542 | — | (2,822 | ) | 15,423 | ||||||||||||||||||
Balances at December 31, 2012 | (19,860 | ) | 3,426 | (6,316 | ) | (1,574 | ) | (25,983 | ) | (50,307 | ) | ||||||||||||||
Other comprehensive income (loss) before reclassifications | 1,755 | 3,495 | (2,458 | ) | 886 | 6,284 | 9,962 | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | — | (4,401 | ) | 2,442 | — | 830 | (1,129 | ) | |||||||||||||||||
Other comprehensive income (loss) | 1,755 | (906 | ) | (16 | ) | 886 | 7,114 | 8,833 | |||||||||||||||||
Balances at December 31, 2013 | $ | (18,105 | ) | $ | 2,520 | $ | (6,332 | ) | $ | (688 | ) | $ | (18,869 | ) | $ | (41,474 | ) | ||||||||
Disclosure of Reclassification Amount | ' | ||||||||||||||||||||||||
The following table discloses the effect of reclassifications of accumulated other comprehensive income on the accompanying consolidated statement of operations (in thousands): | |||||||||||||||||||||||||
Details about Accumulated Other Comprehensive Income (Loss) Components | Years ended December 31, | Affected Line Item in the Statement Where Net Income is Presented | |||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Gains (losses) on cash flow hedges: | |||||||||||||||||||||||||
Foreign currency contracts | $ | 5,751 | $ | (2,965 | ) | $ | 2,658 | Cost of goods sold | |||||||||||||||||
Commodity contracts | (4,010 | ) | (4,050 | ) | 6,651 | Cost of goods sold | |||||||||||||||||||
1,741 | (7,015 | ) | 9,309 | Total before tax | |||||||||||||||||||||
218 | 1,887 | (447 | ) | Tax benefit (expense) | |||||||||||||||||||||
1,959 | (5,128 | ) | 8,862 | Net of tax | |||||||||||||||||||||
Amortization of employee benefit plan costs: | |||||||||||||||||||||||||
Prior service costs | $ | 1,816 | $ | 1,674 | $ | 7,928 | Selling, general and administrative expenses | ||||||||||||||||||
Net actuarial loss | (3,187 | ) | (795 | ) | (5,608 | ) | Selling, general and administrative expenses | ||||||||||||||||||
(1,371 | ) | 879 | 2,320 | Total before tax | |||||||||||||||||||||
541 | (361 | ) | — | Tax benefit (expense) | |||||||||||||||||||||
(830 | ) | 518 | 2,320 | Net of tax | |||||||||||||||||||||
Total reclassifications for the period | $ | 1,129 | $ | (4,610 | ) | $ | 11,182 | Net of tax | |||||||||||||||||
Restructuring_and_Other_Charge1
Restructuring and Other Charges (Tables) | 12 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||
Restructuring and other charges [Abstract] | ' | |||||||||||||||||||
Schedule of Restructuring and Related Costs | ' | |||||||||||||||||||
Significant components of restructuring and other charges for the approved activities are (in thousands): | ||||||||||||||||||||
Total | Expense incurred in | Estimated | ||||||||||||||||||
expected | Year ended December 31, 2013 | Year ended December 31, 2012 | Year ended December 31, 2011 | future | ||||||||||||||||
costs | expense | |||||||||||||||||||
2013 Activities | ||||||||||||||||||||
Severance | $ | 1,756 | $ | 1,756 | $ | — | $ | — | $ | — | ||||||||||
Exit costs | 692 | 692 | — | — | — | |||||||||||||||
$ | 2,448 | $ | 2,448 | $ | — | $ | — | $ | — | |||||||||||
2012 Activities | ||||||||||||||||||||
Severance | $ | 4,533 | $ | 795 | $ | 3,738 | $ | — | $ | — | ||||||||||
Exit costs | 1,479 | 823 | 410 | — | 246 | |||||||||||||||
Other charges | 1,687 | — | 1,687 | — | — | |||||||||||||||
$ | 7,699 | $ | 1,618 | $ | 5,835 | $ | — | $ | 246 | |||||||||||
2011 Activities | ||||||||||||||||||||
Severance | $ | 4,518 | $ | — | $ | 1,635 | $ | 2,883 | $ | — | ||||||||||
Exit costs | 801 | — | 241 | 560 | — | |||||||||||||||
$ | 5,319 | $ | — | $ | 1,876 | $ | 3,443 | $ | — | |||||||||||
Restructuring charges and asset impairments are as follows: | ||||||||||||||||||||
Years ended December 31, | ||||||||||||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||||||||||||
Severance and termination benefits | $ | 2,551 | $ | 5,373 | $ | 2,995 | ||||||||||||||
Exit costs | 1,515 | 651 | 577 | |||||||||||||||||
Other charges | — | 1,687 | — | |||||||||||||||||
Asset impairments | — | 2,560 | — | |||||||||||||||||
Total restructuring and other charges | $ | 4,066 | $ | 10,271 | $ | 3,572 | ||||||||||||||
Schedule of Restructuring Reserve by Type of Cost | ' | |||||||||||||||||||
The following table summarizes the activity in our restructuring accrual: | ||||||||||||||||||||
(In thousands) | Termination | Exit | Other charges | Total | ||||||||||||||||
benefits | costs | |||||||||||||||||||
Accrual at January 1, 2012 | $ | 2,539 | $ | 386 | $ | — | $ | 2,925 | ||||||||||||
Provision in 2012 | 5,373 | 651 | 1,687 | 7,711 | ||||||||||||||||
Payments in 2012 | (4,339 | ) | (931 | ) | (1,687 | ) | (6,957 | ) | ||||||||||||
Accrual at December 31, 2012 | 3,573 | 106 | — | 3,679 | ||||||||||||||||
Provision in 2013 | 2,551 | 1,515 | — | 4,066 | ||||||||||||||||
Payments in 2013 | (5,143 | ) | (1,576 | ) | — | (6,719 | ) | |||||||||||||
Accrual at December 31, 2013 | $ | 981 | $ | 45 | $ | — | $ | 1,026 | ||||||||||||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Income taxes [Abstract] | ' | |||||||||
Schedule of Income before Income Tax, Domestic and Foreign | ' | |||||||||
Income before income taxes was taxed in the following jurisdictions: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
U.S. | $ | 25,815 | $ | 46,078 | $ | 45,053 | ||||
Non-U.S. | 34,463 | 24,078 | 45,091 | |||||||
$ | 60,278 | $ | 70,156 | $ | 90,144 | |||||
Schedule of Components of Income Tax Expense (Benefit) | ' | |||||||||
The following is a summary of the components of the provision for income tax expense (benefit): | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Current: | ||||||||||
Federal | $ | 764 | $ | 5,637 | $ | 1,798 | ||||
State and local | (215 | ) | 1,078 | 804 | ||||||
Non-U.S. | 15,655 | 11,023 | 14,230 | |||||||
Deferred: | ||||||||||
Federal | 8,332 | (70,643 | ) | (1,527 | ) | |||||
State and local | 1,352 | (13,076 | ) | (179 | ) | |||||
Non-U.S. | (5,964 | ) | (5,248 | ) | (313 | ) | ||||
Income tax expense (benefit) | $ | 19,924 | $ | (71,229 | ) | $ | 14,813 | |||
Schedule of Effective Income Tax Rate Reconciliation | ' | |||||||||
A reconciliation of income taxes at the United States federal statutory rate to the effective income tax rate follows: | ||||||||||
Years ended December 31, | ||||||||||
2013 | 2012 | 2011 | ||||||||
Federal statutory income tax rate | 35 | % | 35 | % | 35 | % | ||||
State and local income taxes, net of Federal tax benefit, if applicable | (0.4 | ) | (0.2 | ) | 0.6 | |||||
Permanent items and other | 5.7 | 9.3 | 2.2 | |||||||
Non-U.S. operations | (1.7 | ) | 2.4 | 2.4 | ||||||
Goodwill | — | — | 0.7 | |||||||
Valuation allowance changes affecting the provision | (5.5 | ) | (148.0 | ) | (24.5 | ) | ||||
Effective income tax rate | 33.1 | % | (101.5 | )% | 16.4 | % | ||||
Schedule of Components of Income Tax Expense (Benefit), Including Other Comprehensive Income [Table Text Block] | ' | |||||||||
The following table summarizes the total provision for income taxes by component: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Income tax expense (benefit) | $ | 19,924 | $ | (71,229 | ) | $ | 14,813 | |||
Allocated to other comprehensive income (loss): | ||||||||||
Financial instruments | (303 | ) | 4,331 | (2,044 | ) | |||||
Pensions | (4,196 | ) | (599 | ) | — | |||||
Schedule of Deferred Tax Assets and Liabilities | ' | |||||||||
The following is a summary of the significant components of our deferred income tax assets and liabilities. | ||||||||||
As of December 31, | ||||||||||
(In thousands) | 2013 | 2012 | ||||||||
Deferred tax assets: | ||||||||||
Restructuring charges | $ | 289 | $ | 245 | ||||||
Employee benefits | 11,472 | 14,394 | ||||||||
Inventories | 2,875 | 2,042 | ||||||||
Warranty | 10,194 | 9,714 | ||||||||
Alternative minimum tax and other credits | 16,356 | 17,118 | ||||||||
Net operating loss carryforwards | 55,855 | 65,039 | ||||||||
Customer contracts & other intangibles | 1,428 | 388 | ||||||||
Rebates, stock, discounts and returns | 5,898 | 4,814 | ||||||||
Unrealized gain/(loss) on financial instruments | 1,150 | 1,382 | ||||||||
Other | 5,062 | 8,453 | ||||||||
Total deferred tax assets | 110,579 | 123,589 | ||||||||
Valuation allowance | (11,917 | ) | (16,044 | ) | ||||||
Deferred tax assets, net of valuation allowance | 98,662 | 107,545 | ||||||||
Deferred tax liabilities: | ||||||||||
Depreciation | (3,462 | ) | (2,088 | ) | ||||||
Goodwill and other intangibles | (8,371 | ) | (10,936 | ) | ||||||
Trade names | (18,846 | ) | (18,846 | ) | ||||||
Other | (10,704 | ) | (10,375 | ) | ||||||
Total deferred tax liabilities | (41,383 | ) | (42,245 | ) | ||||||
Net deferred tax asset | $ | 57,279 | $ | 65,300 | ||||||
Schedule of Unrecognized Tax Benefits Roll Forward | ' | |||||||||
reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Balance at January 1, | $ | 9,164 | $ | 4,592 | $ | 2,806 | ||||
Additions based on tax positions related to the current year | 987 | 2,697 | 672 | |||||||
Additions for tax positions of prior years | 457 | 1,875 | 1,561 | |||||||
Reductions for tax positions of prior years | (116 | ) | — | (447 | ) | |||||
Settlements | (654 | ) | — | — | ||||||
Balance at December 31, | $ | 9,838 | $ | 9,164 | $ | 4,592 | ||||
Employee_Benefit_Plan_Tables
Employee Benefit Plan (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Employee benefit plans [Abstract] | ' | ||||||||||
Postretirement Healthcare and Life Insurance | ' | ||||||||||
The changes in benefit obligations and plan assets, components of expense and assumptions for the postretirement healthcare and life insurance plans are as follows: | |||||||||||
Postretirement healthcare | |||||||||||
and life insurance plans | |||||||||||
Years ended December 31, | |||||||||||
(In thousands of dollars) | 2013 | 2012 | 2011 | ||||||||
Change in benefit obligations | |||||||||||
Benefit obligation at beginning of period | $ | 2,682 | $ | 2,897 | |||||||
Service cost | — | — | |||||||||
Interest cost | 77 | 97 | |||||||||
Amendments | — | — | |||||||||
Actuarial (gain) loss | (154 | ) | 22 | ||||||||
Benefits paid | (359 | ) | (334 | ) | |||||||
Benefit obligation at end of period | $ | 2,246 | $ | 2,682 | |||||||
Change in plan assets | |||||||||||
Fair value of plan assets at beginning of period | $ | — | $ | — | |||||||
Employer contributions | 359 | 334 | |||||||||
Benefits paid | (359 | ) | (334 | ) | |||||||
Fair value of plan assets at end of period | $ | — | $ | — | |||||||
Funded status | $ | (2,246 | ) | $ | (2,682 | ) | |||||
Amounts recognized in statement of financial position consist of: | |||||||||||
Current liabilities | $ | (618 | ) | $ | (713 | ) | |||||
Noncurrent liabilities | (1,628 | ) | (1,969 | ) | |||||||
Net amount recognized | $ | (2,246 | ) | $ | (2,682 | ) | |||||
Amounts recognized in accumulated other comprehensive | |||||||||||
income consist of: | |||||||||||
Net actuarial loss | $ | 3,669 | $ | 5,647 | |||||||
Prior service credit | (3,632 | ) | (5,448 | ) | |||||||
Accumulated other comprehensive loss | $ | 37 | $ | 199 | |||||||
Components of net periodic benefit cost and other amounts | |||||||||||
recognized in other comprehensive income | |||||||||||
Net Periodic Benefit Cost | |||||||||||
Service cost | $ | — | $ | — | $ | — | |||||
Interest cost | 77 | 97 | 99 | ||||||||
Amortization of prior service cost | (1,816 | ) | (1,674 | ) | (7,928 | ) | |||||
Recognized net actuarial loss | 1,824 | (492 | ) | 5,129 | |||||||
Settlement gain | — | — | — | ||||||||
Net periodic cost (benefit) | $ | 85 | $ | (2,069 | ) | $ | (2,700 | ) | |||
Other changes in plan assets and benefit obligations recognized in other comprehensive income | |||||||||||
Net actuarial (gain) loss | $ | (154 | ) | $ | 22 | $ | 68 | ||||
Prior service credit | — | — | 805 | ||||||||
Amortization of prior service cost | 1,816 | 1,674 | 7,928 | ||||||||
Recognized net actuarial (loss) gain | (1,824 | ) | 492 | (5,129 | ) | ||||||
Total recognized in other comprehensive loss (income) | (162 | ) | 2,188 | 3,672 | |||||||
Total recognized in net (benefit) cost and OCI | $ | (77 | ) | $ | 119 | $ | 972 | ||||
Weighted-average assumptions | |||||||||||
U.S. assumptions: | |||||||||||
Discount rate for benefit obligation | 4.73 | % | 3.85 | % | 4.28 | % | |||||
Discount rate for net periodic benefit cost | 3.85 | % | 4.28 | % | 5.41 | % | |||||
Rate of compensation increase | — | % | — | % | — | % | |||||
Pension Plans | ' | ||||||||||
The changes in benefit obligations and plan assets and components of expense for the pension plans are as follows: | |||||||||||
Pension benefits | |||||||||||
Years ended December 31, | |||||||||||
(In thousands of dollars) | 2013 | 2012 | 2011 | ||||||||
Change in benefit obligations | |||||||||||
Benefit obligation at beginning of period | $ | 79,477 | $ | 73,182 | |||||||
Service cost | 1,035 | 291 | |||||||||
Interest cost | 3,278 | 3,143 | |||||||||
Amendments | — | — | |||||||||
Korea benefit obligation | 4,965 | — | |||||||||
Actuarial (gain) loss | (6,207 | ) | 5,692 | ||||||||
Benefits paid | (3,070 | ) | (2,831 | ) | |||||||
Benefit obligation at end of period | $ | 79,478 | $ | 79,477 | |||||||
Change in plan assets | |||||||||||
Fair value of plan assets at beginning of period | $ | 47,349 | $ | 41,765 | |||||||
Actual return on plan assets | 7,081 | 5,650 | |||||||||
Korea plan assets | 4,642 | — | |||||||||
Employer contributions | 3,984 | 2,765 | |||||||||
Benefits paid | (3,070 | ) | (2,831 | ) | |||||||
Fair value of plan assets at end of period | $ | 59,986 | $ | 47,349 | |||||||
Funded status | $ | (19,492 | ) | $ | (32,128 | ) | |||||
Amounts recognized in statement of financial position consist of: | |||||||||||
Noncurrent assets | — | — | |||||||||
Current liabilities | (389 | ) | (366 | ) | |||||||
Noncurrent liabilities | (19,103 | ) | (31,762 | ) | |||||||
Net amount recognized | $ | (19,492 | ) | $ | (32,128 | ) | |||||
Amounts recognized in accumulated other comprehensive income consist of: | |||||||||||
Net actuarial loss | $ | 17,069 | $ | 28,379 | |||||||
Prior service cost | — | — | |||||||||
Accumulated other comprehensive loss | $ | 17,069 | $ | 28,379 | |||||||
Information for pension plans with an accumulated benefit obligation in excess of plan assets | |||||||||||
Projected benefit obligation | $ | 79,478 | $ | 79,477 | |||||||
Accumulated benefit obligation | 79,478 | 79,064 | |||||||||
Fair value of plan assets | 59,986 | 47,349 | |||||||||
Components of net periodic benefit cost and other amounts recognized in other comprehensive income | |||||||||||
Net Periodic Benefit Cost | |||||||||||
Service cost | $ | 1,035 | $ | 291 | $ | 263 | |||||
Interest cost | 3,278 | 3,143 | 3,342 | ||||||||
Expected return on plan assets | (3,341 | ) | (2,622 | ) | (2,690 | ) | |||||
Amortization of prior service cost | — | — | — | ||||||||
Recognized net actuarial loss | 1,363 | 1,287 | 479 | ||||||||
Net periodic pension cost | $ | 2,335 | $ | 2,099 | $ | 1,394 | |||||
Other changes in plan assets and benefit obligations recognized in other comprehensive income | |||||||||||
Net actuarial (gain) loss | $ | (9,947 | ) | $ | 2,520 | $ | 11,807 | ||||
Prior service cost | — | — | — | ||||||||
Amortization of prior service cost | — | — | — | ||||||||
Recognized net actuarial loss | (1,363 | ) | (1,287 | ) | (479 | ) | |||||
Total recognized in other comprehensive (income) loss | (11,310 | ) | 1,233 | 11,328 | |||||||
Total recognized in net (benefit) cost and OCI | $ | (8,975 | ) | $ | 3,332 | $ | 12,722 | ||||
The assumptions for the pension plans are as follows: | |||||||||||
Pension benefits | |||||||||||
Years ended December 31, | |||||||||||
2013 | 2012 | 2011 | |||||||||
Weighted-average assumptions | |||||||||||
U.S. assumptions: | |||||||||||
Discount rate for benefit obligation | 4.73 | % | 3.85 | % | 4.28 | % | |||||
Discount rate for net periodic benefit cost | 3.85 | % | 4.28 | % | 5.41 | % | |||||
Rate of compensation increase | — | % | 5 | % | 5 | % | |||||
Expected return on plan assets | 6.5 | % | 6.5 | % | 6.5 | % | |||||
Non U.S. assumptions: | |||||||||||
Discount rate for benefit obligation | 4.27 | % | 4.1 | % | 4.7 | % | |||||
Discount rate for net periodic cost | 4 | % | 4.7 | % | 5.4 | % | |||||
Rate of compensation increase | 3.81 | % | 3.1 | % | 3.35 | % | |||||
Expected return on plan assets | 5.13 | % | 4.99 | % | 5.18 | % | |||||
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block] | ' | ||||||||||
Amounts in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year: | |||||||||||
(In thousands) | Pension | Postretirement | |||||||||
healthcare | |||||||||||
Amortization of actuarial losses | $ | 649 | $ | 19 | |||||||
Amortization of prior service cost | — | — | |||||||||
Total | $ | 649 | $ | 19 | |||||||
Schedule of Allocation of Plan Assets | ' | ||||||||||
The 2014 target plan asset allocation is: | |||||||||||
Target allocation | |||||||||||
Equity Investments | 45% | - | 65% | ||||||||
Fixed Income Investments | 25% | - | 45% | ||||||||
Cash and Short Term Investments | 10% | - | 20% | ||||||||
The asset allocations were: | |||||||||||
As of December 31, | |||||||||||
(In thousands) | 2013 | 2012 | |||||||||
Asset Allocation for Plan Assets | |||||||||||
Interest-bearing cash | $ | 8,980 | 15 | % | $ | 2,418 | 5.1 | % | |||
Bond Mutual Funds | 18,408 | 30.7 | % | 16,630 | 35.1 | % | |||||
Equity Mutual Funds | 32,598 | 54.3 | % | 28,301 | 59.8 | % | |||||
Total plan assets | $ | 59,986 | 100 | % | $ | 47,349 | 100 | % | |||
Schedule of Assumptions Used [Table Text Block] | ' | ||||||||||
The assumptions used in deriving our postretirement costs and the sensitivity analysis thereon are: | |||||||||||
As of December 31, | |||||||||||
2013 | 2012 | ||||||||||
Assumed Health Care Cost Trend Rates | |||||||||||
Health care cost trend rate assumed for next year | 9 | % | 9 | % | |||||||
Rate to which the cost trend is expected to decline | 5 | % | 5 | % | |||||||
Year that the rate reaches the ultimate trend rate | 2017 | 2016 | |||||||||
Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] | ' | ||||||||||
An increase or decrease of one percentage point in the assumed health care trends would have the following approximate effects for the year ended December 31, 2013: | |||||||||||
(In thousands) | 1% Increase | 1% Decrease | |||||||||
Effect on total of service and interest cost components of net periodic postretirement health care benefit cost | $ | — | $ | — | |||||||
Effect on the health care component of the accumulated postretirement | $ | 7 | $ | (7 | ) | ||||||
benefit obligation | |||||||||||
Schedule of Expected Benefit Payments [Table Text Block] | ' | ||||||||||
The following reflects the estimated future benefit payments to be paid from the plans: | |||||||||||
(In thousands) | Pension | Postretirement | |||||||||
healthcare | |||||||||||
2014 | $ | 3,488 | $ | 618 | |||||||
2015 | 4,758 | 336 | |||||||||
2016 | 3,793 | 165 | |||||||||
2017 | 4,025 | 111 | |||||||||
2018 | 3,883 | 87 | |||||||||
Years 2019-2023 | 23,045 | 336 | |||||||||
Stock_Based_Compensation_Table
Stock Based Compensation (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Stock-based compensation [Abstract] | ' | |||||||||
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | ' | |||||||||
Noncash compensation expense related to the awards was recognized for the years ended December 31, as follows: | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Stock-based compensation | $ | 6,561 | $ | 7,261 | $ | 6,884 | ||||
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | ' | |||||||||
A summary of stock option activity as of December 31, 2013 and changes for the year ended December 31, 2013 is presented below: | ||||||||||
Stock option awards | Shares | Weighted- | Weighted-average remaining contractual term | Aggregate intrinsic value (1) | ||||||
average | ||||||||||
exercise price | ||||||||||
Outstanding at January 1, 2013 | — | $ | — | |||||||
Granted | 268,293 | 18.48 | ||||||||
Exercised | — | — | ||||||||
Forfeited/Cancelled | (17,798 | ) | 18.5 | |||||||
Outstanding and expected to vest at December 31, 2013 | 250,495 | $ | 18.48 | 5.8 years | $ | 1,213,515 | ||||
Exercisable at December 31, 2013 | 13,843 | $ | 18.5 | 0.25 years | $ | 66,723 | ||||
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | ' | |||||||||
A summary of the status of our nonvested restricted stock awards as of December 31, 2013, and changes during the year ended December 31, 2013, is presented below: | ||||||||||
Nonvested restricted stock awards | Shares/Units | Weighted- | ||||||||
average | ||||||||||
grant-date | ||||||||||
fair value | ||||||||||
Nonvested at January 1, 2013 | 1,124,952 | $ | 14.08 | |||||||
Granted | 256,671 | 18.48 | ||||||||
Vested | (566,027 | ) | 13.08 | |||||||
Forfeited | (67,783 | ) | 17.75 | |||||||
Nonvested at December 31, 2013 | 747,813 | $ | 15.92 | |||||||
Lease_Commitments_Tables
Lease Commitments (Tables) | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Lease commitments [Abstract] | ' | |||
Schedule of Future Minimum Rental Payments for Operating Leases | ' | |||
Rental commitments at December 31, 2013, for long-term non-cancellable operating leases consummated as of December 31, 2013 (not reflected as accrued restructuring) are as follows: | ||||
(In thousands) | ||||
2014 | $ | 4,902 | ||
2015 | 3,362 | |||
2016 | 2,762 | |||
2017 | 2,371 | |||
2018 | 979 | |||
Thereafter | 1,516 | |||
Business_Segment_Geographical_1
Business Segment & Geographical Information (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Business seg & geo information [Abstract] | ' | |||||||||
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas | ' | |||||||||
Information about our net sales and long-lived assets by geographic region is as follows: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Net sales to external customers: | ||||||||||
United States | $ | 735,939 | $ | 753,420 | $ | 756,824 | ||||
Europe | 89,181 | 103,303 | 115,901 | |||||||
Other Americas | 59,611 | 56,300 | 90,636 | |||||||
Asia Pacific | 233,849 | 220,524 | 231,592 | |||||||
Total net sales | $ | 1,118,580 | $ | 1,133,547 | $ | 1,194,953 | ||||
As of December 31, | ||||||||||
(In thousands) | 2013 | 2012 | ||||||||
Long-lived assets: | ||||||||||
United States | $ | 80,429 | $ | 81,451 | ||||||
Europe | 11,612 | 12,562 | ||||||||
Other Americas | 55,937 | 58,267 | ||||||||
Asia Pacific | 38,106 | 25,423 | ||||||||
Total long-lived assets | $ | 186,084 | $ | 177,703 | ||||||
Supplemental_Cash_Flow_Informa1
Supplemental Cash Flow Information (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Supplemental Cash Flow Information [Abstract] | ' | |||||||||
Schedule of Cash Flow, Supplemental Disclosures | ' | |||||||||
Supplemental cash flow information is as follows: | ||||||||||
Years ended December 31, | ||||||||||
(In thousands) | 2013 | 2012 | 2011 | |||||||
Cash paid for interest | $ | 21,479 | $ | 26,987 | $ | 29,753 | ||||
Cash paid for income taxes, net of refunds received | 7,355 | 13,019 | 17,778 | |||||||
Quarterly_Financial_Informatio1
Quarterly Financial Information (Tables) | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Quarterly financial information [Abstract] | ' | |||||||||||||||
Schedule of Quarterly Financial Information | ' | |||||||||||||||
(In thousands, except per share information) | ||||||||||||||||
Quarter ended | ||||||||||||||||
March 31, | June 30, | September 30, | December 31, | Total year | ||||||||||||
2013 | 2013 | 2013 | 2013 | 2013 | ||||||||||||
Net sales | $ | 281,726 | $ | 282,349 | $ | 262,832 | $ | 291,673 | $ | 1,118,580 | ||||||
Gross profit | 54,979 | 54,701 | 52,232 | 61,058 | 222,970 | |||||||||||
Restructuring and other charges | 681 | 2,128 | 1,454 | (197 | ) | 4,066 | ||||||||||
Net income | 1,843 | 11,464 | 10,356 | 16,691 | 40,354 | |||||||||||
Net income attributable to common stockholders | 1,280 | 11,368 | 10,356 | 16,691 | 39,695 | |||||||||||
Basic earnings per share | $ | 0.04 | $ | 0.36 | $ | 0.33 | $ | 0.53 | $ | 1.27 | ||||||
Diluted earnings per share | $ | 0.04 | $ | 0.36 | $ | 0.33 | $ | 0.53 | $ | 1.26 | ||||||
Quarter ended | ||||||||||||||||
March 31, | June 30, | September 30, | December 31, | Total year | ||||||||||||
2012 | 2012 | 2012 | 2012 | 2012 | ||||||||||||
Net sales | $ | 293,061 | $ | 294,819 | $ | 277,401 | $ | 268,266 | $ | 1,133,547 | ||||||
Gross profit | 62,036 | 61,494 | 54,809 | 59,365 | 237,704 | |||||||||||
Restructuring and other charges | 1,698 | 1,892 | 5,374 | 1,307 | 10,271 | |||||||||||
Net income | 9,524 | 17,964 | 97,359 | 16,538 | 141,385 | |||||||||||
Net income attributable to common stockholders | 8,711 | 17,441 | 96,532 | 15,927 | 138,611 | |||||||||||
Basic earnings per share | $ | 0.29 | $ | 0.57 | $ | 3.15 | $ | 0.52 | $ | 4.53 | ||||||
Diluted earning per share | $ | 0.28 | $ | 0.56 | $ | 3.11 | $ | 0.51 | $ | 4.47 | ||||||
Description_of_the_Business_De
Description of the Business (Details) (USD $) | 12 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 |
Majority Shareholder | ' | ' | ' |
Significant Investor's Ownership Percentage | 47.00% | 51.00% | 51.00% |
Shares held by majority stakeholder | 14,805,195 | 16,342,508 | 16,342,508 |
Debt held by majority stakeholder | $29,700 | $29,700 | $28,698 |
Shares Acquired from Rights Offering | 9,870,130 | ' | ' |
Conversion of Stock, Shares Converted | 42,359 | ' | ' |
Board of Directors | ' | ' | ' |
Conversion of Stock, Shares Converted | 565 | ' | ' |
Stock Repurchased and Retired During Period, Shares | 435 | ' | ' |
Significant_Accounting_Policie3
Significant Accounting Policies Basis of Presentation (Details) | Dec. 31, 2013 |
Minimum | ' |
Consolidation, Ownership Percentage | 50.00% |
Equity Method Investment, Ownership Percentage | 20.00% |
Maximum | ' |
Equity Method Investment, Ownership Percentage | 50.00% |
Cost Basis, Ownership Percentage | 20.00% |
Significant_Accounting_Policie4
Significant Accounting Policies Accounting for remanufacturing operations (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Summary of significant accounting policies [Abstract] | ' | ' | ' |
Core Deposits Charged | $91,318 | $87,866 | $113,670 |
Significant_Accounting_Policie5
Significant Accounting Policies Research and development (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Summary of significant accounting policies [Abstract] | ' | ' | ' |
Research and Development Expense | $15,543 | $26,004 | $26,548 |
Research and Development Arrangement, Customer Funding to Offset Costs Incurred | $969 | $967 | $405 |
Significant_Accounting_Policie6
Significant Accounting Policies Government Grants (Details) (Government Grant, USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Government Grant | ' | ' | ' |
Government Grant Awarded | ' | $60,200 | ' |
Government Grants Received | ' | 36,000 | ' |
Reduction of Cost of Goods Sold | 2,427 | 4,820 | 5,529 |
Reduction of Selling, General, and Administrative Expenses | 743 | 6,491 | 7,691 |
Deferred Revenue | $6,283 | $7,414 | ' |
Significant_Accounting_Policie7
Significant Accounting Policies Trade accounts receivable and allowance for doubtful accounts (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Summary of significant accounting policies [Abstract] | ' | ' |
Notes Receivable | $27,154 | $29,091 |
Significant_Accounting_Policie8
Significant Accounting Policies Property, Plant and Equipment (Details) | 12 Months Ended |
Dec. 31, 2013 | |
Minimum | ' |
Core Inventory Useful Life | '4 years |
Maximum | ' |
Core Inventory Useful Life | '30 years |
Land, Buildings and Improvements | Minimum | ' |
Property, Plant and Equipment, Useful Life | '15 years |
Land, Buildings and Improvements | Maximum | ' |
Property, Plant and Equipment, Useful Life | '40 years |
Machinery and Equipment | Minimum | ' |
Property, Plant and Equipment, Useful Life | '3 years |
Machinery and Equipment | Maximum | ' |
Property, Plant and Equipment, Useful Life | '15 years |
Significant_Accounting_Policie9
Significant Accounting Policies Earnings per share (Details) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Summary of significant accounting policies [Abstract] | ' | ' | ' |
Weighted Average Number of Shares | 181,603 | 374,288 | 578,288 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 218,050 | ' | ' |
Fair_Value_Measurement_Details
Fair Value Measurement (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Interest Rate Swap | ' | ' |
Assets/(Liabilities) | ' | ' |
Derivative Assets (Liabilities), at Fair Value, Net | $727 | ($2,218) |
Interest Rate Swap | Fair Value, Inputs, Level 2 | ' | ' |
Assets/(Liabilities) | ' | ' |
Derivative Assets (Liabilities), at Fair Value, Net | 727 | -2,218 |
Foreign Exchange Contract | ' | ' |
Assets/(Liabilities) | ' | ' |
Derivative Assets (Liabilities), at Fair Value, Net | 3,417 | 5,328 |
Foreign Exchange Contract | Fair Value, Inputs, Level 2 | ' | ' |
Assets/(Liabilities) | ' | ' |
Derivative Assets (Liabilities), at Fair Value, Net | 3,417 | 5,328 |
Commodity Contract | ' | ' |
Assets/(Liabilities) | ' | ' |
Derivative Assets (Liabilities), at Fair Value, Net | -1,333 | -1,315 |
Commodity Contract | Fair Value, Inputs, Level 2 | ' | ' |
Assets/(Liabilities) | ' | ' |
Derivative Assets (Liabilities), at Fair Value, Net | ($1,333) | ($1,315) |
Fair_Value_Measurement_Pension
Fair Value Measurement Pension (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Non U.S. | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | $17,075 | $9,450 | ' |
Pension Plans, Defined Benefit | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 59,986 | 47,349 | 41,765 |
Pension Plans, Defined Benefit | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 59,986 | 47,349 | ' |
Pension Plans, Defined Benefit | United States | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 42,911 | 37,899 | ' |
Pension Plans, Defined Benefit | United States | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 42,911 | 37,899 | ' |
Pension Plans, Defined Benefit | Non U.S. | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 17,075 | 9,450 | ' |
Pension Plans, Defined Benefit | Non U.S. | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 17,075 | 9,450 | ' |
Pension Plans, Defined Benefit | Cash and Cash Equivalents | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 8,980 | 2,418 | ' |
Pension Plans, Defined Benefit | Cash and Cash Equivalents | United States | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 2,563 | 2,329 | ' |
Pension Plans, Defined Benefit | Cash and Cash Equivalents | United States | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 2,563 | 2,329 | ' |
Pension Plans, Defined Benefit | Cash and Cash Equivalents | Non U.S. | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 6,417 | 89 | ' |
Pension Plans, Defined Benefit | Cash and Cash Equivalents | Non U.S. | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 6,417 | 89 | ' |
Pension Plans, Defined Benefit | Fixed Income Funds | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 18,408 | 16,630 | ' |
Pension Plans, Defined Benefit | Fixed Income Funds | United States | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 14,550 | 12,838 | ' |
Pension Plans, Defined Benefit | Fixed Income Funds | United States | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 14,550 | 12,838 | ' |
Pension Plans, Defined Benefit | Fixed Income Funds | Non U.S. | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 3,858 | 3,792 | ' |
Pension Plans, Defined Benefit | Fixed Income Funds | Non U.S. | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 3,858 | 3,792 | ' |
Pension Plans, Defined Benefit | Equity Funds | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 32,598 | 28,301 | ' |
Pension Plans, Defined Benefit | Equity Funds | United States | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 25,798 | 22,732 | ' |
Pension Plans, Defined Benefit | Equity Funds | United States | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 25,798 | 22,732 | ' |
Pension Plans, Defined Benefit | Equity Funds | Non U.S. | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 6,800 | 5,569 | ' |
Pension Plans, Defined Benefit | Equity Funds | Non U.S. | Fair Value, Inputs, Level 1 | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | $6,800 | $5,569 | ' |
Financial_Instruments_Foreign_
Financial Instruments Foreign Currency Risk (Details) (Foreign Exchange Contract) | 12 Months Ended | |||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 |
USD ($) | USD ($) | South Korean Won | South Korean Won | Mexican Peso | Mexican Peso | Brazilian Real | Brazilian Real | Hungarian Forint | Hungarian Forint | Great Britain Pound | Great Britain Pound | |
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | EUR (€) | EUR (€) | GBP (£) | GBP (£) | |||
Derivative | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Maximum Term of Credit Risk Derivatives | '18 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Derivative, Notional Amount | ' | ' | $74,368 | $55,546 | $73,520 | $66,674 | $11,427 | $18,055 | € 14,416 | € 13,565 | £ 3,735 | £ 1,370 |
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax | 2,520 | 3,426 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | $2,562 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Financial_Instruments_Interest
Financial Instruments Interest Rate Risk (Details) (Interest Rate Swap, USD $) | Dec. 31, 2010 | Dec. 31, 2016 | Dec. 31, 2013 | Dec. 31, 2016 | Dec. 31, 2013 | Dec. 31, 2012 |
Prior Contract | Not Designated as Hedging Instrument | Not Designated as Hedging Instrument | Designated as Hedging Instrument | Designated as Hedging Instrument | Designated as Hedging Instrument | |
Derivative | ' | ' | ' | ' | ' | ' |
Percentage of Debt Hedged by Interest Rate Derivatives | 50.00% | ' | ' | ' | ' | ' |
Lower Variable Interest Rate Range | 1.75% | ' | 1.25% | ' | 1.25% | ' |
Fixed Interest Rate | 3.35% | ' | 4.05% | ' | 2.75% | ' |
Derivative, Amount of Hedged Item | ' | ' | $72,000,000 | ' | $72,000,000 | ' |
Derivative, Notional Amount | ' | ' | 72,000,000 | ' | 72,000,000 | ' |
Quarterly Notional Reduction, Derivatives | ' | 187,500 | ' | 187,500 | ' | ' |
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, before Tax | ' | ' | ' | ' | 1,455,000 | 0 |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | ' | ' | ' | ' | $0 | ' |
Financial_Instruments_Commodit
Financial Instruments Commodity Price Risk (Details) (Commodity Contract, USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Commodity Contract | ' | ' |
Derivative | ' | ' |
Number of Instruments Held | 32 | 36 |
Investment Contract Weight | 6,368 | 6,566 |
Maximum Term of Credit Risk Derivatives | '18 months | ' |
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, before Tax | ($1,319) | ($1,288) |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | ($1,511) | ' |
Financial_Instruments_Balance_
Financial Instruments Balance Sheet Locations (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Designated as Hedging Instrument | ' | ' |
Derivatives, Fair Value | ' | ' |
Total derivative assets | $5,645 | $6,358 |
Total derivative liabilities | 2,106 | 2,345 |
Not Designated as Hedging Instrument | ' | ' |
Derivatives, Fair Value | ' | ' |
Total derivative assets | 0 | 0 |
Total derivative liabilities | 728 | 2,218 |
Commodity Contract | Designated as Hedging Instrument | ' | ' |
Derivatives, Fair Value | ' | ' |
Prepaid expenses and other current assets | 257 | 427 |
Other current liabilities and accrued expenses | 0 | 2,009 |
Other noncurrent assets | 195 | 267 |
Other noncurrent liabilities | 1,785 | 0 |
Foreign Exchange Contract | Designated as Hedging Instrument | ' | ' |
Derivatives, Fair Value | ' | ' |
Prepaid expenses and other current assets | 3,630 | 5,537 |
Other current liabilities and accrued expenses | 141 | 26 |
Other noncurrent assets | 108 | 127 |
Other noncurrent liabilities | 180 | 310 |
Interest Rate Swap | Designated as Hedging Instrument | ' | ' |
Derivatives, Fair Value | ' | ' |
Other noncurrent assets | 1,455 | 0 |
Other noncurrent liabilities | 0 | 0 |
Interest Rate Swap | Not Designated as Hedging Instrument | ' | ' |
Derivatives, Fair Value | ' | ' |
Prepaid expenses and other current assets | 0 | 0 |
Other current liabilities and accrued expenses | 0 | 2,218 |
Other noncurrent assets | 0 | 0 |
Other noncurrent liabilities | $728 | $0 |
Financial_Instruments_Income_S
Financial Instruments Income Statement (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Designated as Hedging Instrument | ' | ' | ' |
Derivative Instruments, Gain (Loss) | ' | ' | ' |
Amount of gain (loss) recognized in OCI on derivatives (effective portion) | $2,062 | $12,804 | ($15,289) |
Amount of gain (loss) reclassified from AOCI into income (effective portion) | 1,795 | -7,008 | 9,400 |
Amount of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | -54 | -7 | -91 |
Designated as Hedging Instrument | Commodity Contract | ' | ' | ' |
Derivative Instruments, Gain (Loss) | ' | ' | ' |
Amount of gain (loss) recognized in OCI on derivatives (effective portion) | -3,987 | -5 | -7,722 |
Amount of gain (loss) reclassified from AOCI into income (effective portion) | -3,956 | -4,043 | 6,742 |
Amount of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | -54 | -7 | -91 |
Designated as Hedging Instrument | Foreign Exchange Contract | ' | ' | ' |
Derivative Instruments, Gain (Loss) | ' | ' | ' |
Amount of gain (loss) recognized in OCI on derivatives (effective portion) | 4,594 | 12,809 | -7,567 |
Amount of gain (loss) reclassified from AOCI into income (effective portion) | 5,751 | -2,965 | 2,658 |
Amount of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | 0 | 0 | 0 |
Designated as Hedging Instrument | Interest Rate Swap | ' | ' | ' |
Derivative Instruments, Gain (Loss) | ' | ' | ' |
Amount of gain (loss) recognized in OCI on derivatives (effective portion) | 1,455 | ' | ' |
Amount of gain (loss) reclassified from AOCI into income (effective portion) | 0 | ' | ' |
Amount of gain (loss) recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing) | 0 | ' | ' |
Not Designated as Hedging Instrument | Foreign Exchange Contract | ' | ' | ' |
Derivative Instruments, Gain (Loss) | ' | ' | ' |
Amount of gain (loss) recognized in income on derivatives | ' | ' | -2,213 |
Not Designated as Hedging Instrument | Interest Rate Swap | ' | ' | ' |
Derivative Instruments, Gain (Loss) | ' | ' | ' |
Amount of gain (loss) recognized in income on derivatives | $1,490 | ($466) | ($1,659) |
Financial_Instruments_Concentr
Financial Instruments Concentrations of Credit Risk (Details) (Sales Revenue, Goods, Net) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Significant Customers Concentration Risks | ' | ' | ' |
Concentration Risk | ' | ' | ' |
Concentration Risk, Percentage | 48.30% | 50.10% | 49.10% |
General Motors | ' | ' | ' |
Concentration Risk | ' | ' | ' |
Concentration Risk, Percentage | 16.20% | 20.70% | 20.70% |
Hyundai Motor Company | ' | ' | ' |
Concentration Risk | ' | ' | ' |
Concentration Risk, Percentage | 10.40% | 8.80% | 7.90% |
Financial_Instruments_Factorin
Financial Instruments Factoring Accounts Receivable (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Derivative Instruments and Hedging Activities [Abstract] | ' | ' | ' |
Gain (Loss) on Sale of Accounts Receivable | $5,710 | $5,472 | $6,501 |
Accounts Receivable Factored, Gross | $244,940 | $183,547 | ' |
Inventory_Details
Inventory (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Inventory [Abstract] | ' | ' |
Raw materials | $42,322 | $47,972 |
Core inventory | 36,581 | 31,191 |
Work-in-process | 8,398 | 9,934 |
Finished goods | 72,039 | 69,839 |
Inventories | $159,340 | $158,936 |
PPE_Details
PP&E (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
PP&E [Abstract] | ' | ' | ' |
Land and buildings | $44,762 | $43,272 | ' |
Machinery and equipment | 204,564 | 184,683 | ' |
Property, plant and equipment | 249,326 | 227,955 | ' |
Depreciation expense | $19,107 | $19,161 | $19,110 |
Goodwill_and_Other_Intangible_2
Goodwill and Other Intangible Assets Intangible Assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2010 | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | Trade Names | Trade Names | Intellectual Property | Intellectual Property | Customer Relationships | Customer Relationships | Customer Contracts | Customer Contracts | Trade Names | Total definite-life intangible assets | Total definite-life intangible assets | ||
Intangible Assets and Goodwill | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Finite-Lived Intangible Assets, Gross | ' | ' | ' | ' | $16,810 | $14,370 | $35,500 | $35,500 | $97,789 | $95,389 | $6,000 | $150,099 | $145,259 |
Indefinite-Lived Intangible Assets, Gross | ' | ' | 48,200 | 48,200 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intangible Assets, Gross (Excluding Goodwill) | 198,299 | 193,459 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Goodwill | 271,418 | 271,418 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Finite-Lived Intangible Assets, Accumulated Amortization | ' | ' | ' | ' | 4,583 | 4,082 | 17,746 | 15,150 | 86,061 | 74,898 | ' | 108,390 | 94,130 |
Indefinite-Lived Intangible Assets, Accumulated Amortization | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intangible Assets, Accumulated Amortization | 108,390 | 94,130 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Goodwill Amortization | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Finite-Lived Intangible Assets, Net | ' | ' | ' | ' | 12,227 | 10,288 | 17,754 | 20,350 | 11,728 | 20,491 | ' | 41,709 | 51,129 |
Indefinite-Lived Intangible Assets, Net | ' | ' | 48,200 | 48,200 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intangible Assets, Net (Excluding Goodwill) | 89,909 | 99,329 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Goodwill | $271,418 | $271,418 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Goodwill_and_Other_Intangible_3
Goodwill and Other Intangible Assets Definited Lived Intangible Assets (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Goodwill and other intangible assets [Abstract] | ' | ' | ' |
Amortization of Intangible Assets | $14,663 | $18,899 | $22,448 |
Estimated future amortization for intangibles with definite lives | ' | ' | ' |
2014 | 12,125 | ' | ' |
2015 | 7,315 | ' | ' |
2016 | 8,092 | ' | ' |
2017 | 9,665 | ' | ' |
2018 | $521 | ' | ' |
Goodwill_and_Other_Intangible_4
Goodwill and Other Intangible Assets Other Intangible Assets (Details) (USD $) | Jul. 31, 2004 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2011 | Dec. 31, 2010 | Dec. 31, 2007 | Dec. 31, 2007 | Dec. 31, 2007 | Dec. 31, 2007 |
In Thousands, unless otherwise specified | Trade Names | Trade Names | Intellectual Property | Intellectual Property | Customer Relationships | Customer Relationships | Customer Contracts | Customer Contracts | Trade Names | Trade Names | Revaluation of Assets | Revaluation of Assets | Revaluation of Assets | Revaluation of Assets | |
Trade Names | Intellectual Property | Customer Relationships | Customer Contracts | ||||||||||||
Finite-Lived Intangible Assets, Gross | ' | ' | ' | $16,810 | $14,370 | $35,500 | $35,500 | $97,789 | $95,389 | ' | $6,000 | ' | $9,000 | $35,500 | $29,800 |
Finite-lived Intangible Assets Acquired | ' | ' | ' | 2,440 | 1,665 | ' | ' | 2,741 | 4,985 | ' | ' | ' | ' | ' | ' |
Indefinite-Lived Intangible Assets, Gross | ' | 48,200 | 48,200 | ' | ' | ' | ' | ' | ' | ' | ' | 59,700 | ' | ' | ' |
Impairment of Intangible Assets, Finite-lived | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,600 | ' | ' | ' | ' | ' |
Finite-Lived Intangible Asset, Weighted Average Useful Life | ' | ' | ' | '12 years 3 months | ' | ' | ' | '4 years | ' | ' | '10 years | ' | ' | '10 years | ' |
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | ' | ' | ' | '15 years | '15 years | ' | ' | '4 years | '4 years | ' | ' | ' | ' | ' | ' |
Indefinite-Lived Intangible Assets, Annual Cost to Extend Indefinitely | $100 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other_Noncurrent_Assets_Detail
Other Noncurrent Assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Other noncurrent assets [Abstract] | ' | ' |
Noncurrent core return rights | $37,250 | $33,908 |
Noncurrent deferred tax assets | $22,113 | $32,907 |
Other_Current_Liabilities_and_2
Other Current Liabilities and Accrued Expenses (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Other current liabilities and accrued expenses [Abstract] | ' | ' |
Accrued warranty | $27,083 | $23,374 |
Accrued wages and benefits | 20,016 | 18,531 |
Current portion of customer obligations | 4,560 | 9,326 |
Rebates, stocklifts, discounts and returns | 18,922 | 15,865 |
Current deferred revenue | 2,270 | 2,882 |
Other current liabilities and accrued expenses | 37,328 | 38,179 |
Total current other liabilities | $110,179 | $108,157 |
Other_Current_Liabilities_and_3
Other Current Liabilities and Accrued Expenses Warranty (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Other current liabilities and accrued expenses [Abstract] | ' | ' | ' |
Balance at beginning of period | $27,194 | $30,278 | $32,510 |
Provision for warranty | 44,215 | 36,281 | 45,597 |
Payments and charges against the accrual | -40,628 | -39,365 | -47,829 |
Balance at end of period | $30,781 | $27,194 | $30,278 |
Other_Noncurrent_Liabilities_D
Other Noncurrent Liabilities (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Other noncurrent liabilities [Abstract] | ' | ' |
Customer obligations, net of current portion | $0 | $3,689 |
Noncurrent deferred revenue | 4,755 | 5,755 |
Other | 20,028 | 19,744 |
Total other noncurrent liabilities | $24,783 | $29,188 |
Debt_Long_Term_Debt_Table_Deta
Debt Long Term Debt Table (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Long-term debt | $295,001 | $284,892 |
Capital leases | 2,226 | 3,053 |
Less current maturities | -3,392 | -3,470 |
Long-term debt less current maturities | 293,835 | 284,475 |
Asset-Based Revolving Credit Facility, First Amendment | ' | ' |
Long-term debt | 0 | 0 |
Term B Loan Facility | ' | ' |
Long-term debt | 0 | 284,892 |
Amended and Restated Term B Loan Facility | ' | ' |
Long-term debt | $295,001 | $0 |
Debt_Future_Maturities_of_Long
Debt Future Maturities of Long Term Debt (Details) (USD $) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Debt Disclosure [Abstract] | ' |
2014 | $3,392 |
2015 | 3,407 |
2016 | 3,421 |
2017 | 3,353 |
2018 | 3,255 |
Thereafter | $282,398 |
Debt_AssetBased_Revolving_Cred
Debt Asset-Based Revolving Credit Facility, First Amendment (Details) (Asset-Based Revolving Credit Facility, First Amendment, USD $) | 12 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Debt Instrument [Line Items] | ' |
Line of credit facility, maximum borrowing capacity | $95,000 |
Line of credit facility, additional borrowing capacity | 20,000 |
Line of credit facility, amount outstanding | 0 |
Letters of credit outstanding, amount | 2,535 |
Line of credit facility, current borrowing capacity | $72,521 |
Line of credit facility, unused capacity, commitment fee percentage | 0.38% |
Minimum | ' |
Debt Instrument [Line Items] | ' |
Debt instrument, basis spread on fixed rate | 0.50% |
Debt instrument, basis spread on variable rate | 1.50% |
Maximum | ' |
Debt Instrument [Line Items] | ' |
Debt instrument, basis spread on fixed rate | 1.00% |
Debt instrument, basis spread on variable rate | 2.00% |
Debt_Amended_and_Restated_Term
Debt Amended and Restated Term B Credit Facility (Details) (USD $) | 12 Months Ended | 12 Months Ended | |||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Mar. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Mar. 31, 2013 |
Term B Loan Facility | Term B Loan Facility | Amended and Restated Term B Loan Facility | Amended and Restated Term B Loan Facility | ||||
Line of Credit Facility [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Debt instrument, face amount | ' | ' | ' | $286,978 | ' | ' | $300,000 |
Debt instrument, unamortized discount | ' | ' | ' | ' | ' | ' | 750 |
Debt instrument, interest rate, stated percentage rate range, minimum | ' | ' | ' | ' | ' | 1.25% | ' |
Debt instrument, basis spread on variable rate | ' | ' | ' | ' | ' | 3.00% | ' |
Debt instrument, periodic payment, principal | ' | ' | ' | ' | ' | 750 | ' |
Excess Cash Flow Calculation Amount | ' | ' | ' | ' | ' | 0 | ' |
Debt instrument, weighted average interest rate | ' | ' | ' | ' | ' | 4.25% | ' |
Loss on extinguishment of debt and refinancing fees | 4,256 | 0 | 0 | ' | ' | ' | ' |
Long-term debt, fair value | ' | ' | ' | ' | 290,029 | 300,157 | ' |
Fair Value Aggregate Differences, Long-term Debt Instruments | ' | ' | ' | ' | 5,137 | 5,156 | ' |
Covenant Agreement, Minimum Payment Missed To Fall Into Default | ' | ' | ' | ' | ' | $5,000 | ' |
Debt_Short_Term_Debt_Details
Debt Short Term Debt (Details) (USD $) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
South Korea | ' |
Short-term Debt [Line Items] | ' |
Short-term debt, number of lenders | 4 |
Short-term debt, maximum borrowing capacity | $17,057 |
Short-term debt, amount outstanding | 2,369 |
Short-term debt, weighted average interest rate | 3.46% |
Hungary | ' |
Short-term Debt [Line Items] | ' |
Short-term debt, number of lenders | 2 |
Short-term debt, maximum borrowing capacity | 4,316 |
Short-term debt, amount outstanding | $0 |
Debt_Capital_Leases_Details
Debt Capital Leases (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Debt Disclosure [Abstract] | ' | ' |
Capitalization Rate Lower Bound | 4.00% | ' |
Capitalization Rate Higher Bound | 15.10% | ' |
Balance Sheet, Assets by Major Class, Net | $3,050 | $3,883 |
Redeemable_Preferred_Stock_Det
Redeemable Preferred Stock (Details) (USD $) | 3 Months Ended | 12 Months Ended | ||||||
In Thousands, except Share data, unless otherwise specified | Mar. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2011 | Dec. 31, 2010 |
Series A Preferred Stock | Series A Preferred Stock | Series B Preferred Stock | Series B Preferred Stock | |||||
Preferred Stock, Shares Outstanding | ' | 0 | ' | ' | ' | 27,000 | ' | 60,000 |
Preferred Stock, par value | ' | ' | $0.00 | ' | ' | $0.00 | ' | $0.00 |
Preferred Stock Value, Outstanding | ' | ' | ' | ' | ' | $27,000 | ' | $60,000 |
Backstop Fees | 1,700 | ' | ' | ' | ' | 500 | ' | 1,200 |
Amount of Preferred Dividends in Arrears | 153 | ' | ' | ' | 739 | ' | 1,375 | ' |
Dividend Rate, Percentage | ' | ' | ' | ' | ' | 20.00% | ' | 20.00% |
Common Stockholder Vote for Amendment to Amended and Restated Certificate of Incorporation | 67.00% | ' | ' | ' | ' | ' | ' | ' |
Loss on extinguishment of preferred stock | -7,572 | 0 | 0 | -7,572 | ' | ' | ' | ' |
Preferred Stock Redemption Price | 115.00% | ' | ' | ' | ' | ' | ' | ' |
Dividends, Preferred Stock | 37,246 | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock, Redemption Amount | 45,022 | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock Redemption Premium | $5,872 | ' | ' | ' | ' | ' | ' | ' |
Stockholders_Equity_Details
Stockholders' Equity (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||
In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Stockholders' Equity Attributable to Parent [Abstract] | ' | ' | ' | ' | ' |
Total Shares Authorized | ' | ' | ' | 280,000,000 | ' |
Common Stock, Shares Authorized | ' | ' | ' | 240,000,000 | ' |
Common Stock, par value | ' | $0.00 | $0.00 | $0.00 | ' |
Preferred Stock, Shares Authorized | ' | ' | ' | 40,000,000 | ' |
Preferred Stock, par value | ' | ' | ' | $0.00 | ' |
Common Stock, Shares, Outstanding | ' | 31,981,544 | 31,981,544 | 31,865,008 | ' |
Preferred Stock, Shares Outstanding | ' | 0 | 0 | ' | ' |
Treasury Stock, Shares, Acquired | ' | ' | 67,087 | 15,276 | ' |
Acquisition of treasury shares | ' | ' | $1,248 | $229 | ' |
Common Stock, Dividends, Per Share, Declared | $0.10 | $0.10 | $0.40 | $0.30 | $0 |
Dividend payments on common stock | ' | ' | 12,669 | 9,226 | 0 |
Dividends Payable | ' | $425 | $425 | $335 | ' |
Stockholders_Equity_Employee_S
Stockholders' Equity Employee Stock Purchase Plan (Details) (Employee Stock Purchase Plan, USD $) | Dec. 31, 2012 |
Common Stock, Shares, Issued | 11,107 |
Sale of Stock, Price Per Share | $17 |
Additional Consideration for Employee Stock Purchase | 15 |
Number of Shares for Employee Stock Purchase Plan | 100 |
Minimum | ' |
Number of Shares for Employee Stock Purchase Plan | 100 |
Maximum | ' |
Number of Shares for Employee Stock Purchase Plan | 200 |
Stockholders_Equity_Common_Sto
Stockholders' Equity Common Stock Rights Offering (Details) (USD $) | 12 Months Ended | 3 Months Ended | ||||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Mar. 31, 2011 | Mar. 31, 2011 | Dec. 31, 2011 |
Rights Exercised | Rights Exercised | |||||
Common Stockholder Vote for Amendment to Amended and Restated Certificate of Incorporation | ' | ' | ' | 67.00% | 67.00% | ' |
Sale of Stock, Price Per Share | ' | ' | ' | ' | $11 | ' |
Common Stock, Shares, Issued | ' | ' | ' | ' | 19,723,786 | 31,467,367 |
Proceeds from Issuance of Common Stock; Total Value | ' | ' | ' | ' | $216,961 | ' |
Proceeds from Issuance of Common Stock | 0 | 0 | 122,177 | ' | 123,426 | ' |
Preferred Stock Cancelled | ' | ' | ' | ' | 48,004 | ' |
Preferred Shares Cancelled Value | ' | ' | ' | ' | $93,535 | ' |
Accumulated_Other_Comprehensiv2
Accumulated Other Comprehensive Income (Loss) Changes in Accumulated Other Comprehensive Income (Loss) (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Beginning Balance | ($50,307) | ($65,730) | ($21,357) |
Other comprehensive income (loss) before reclassifications | 9,962 | 10,813 | -33,191 |
Amounts reclassified from accumulated other comprehensive income (loss) | -1,129 | 4,610 | -11,182 |
Total other comprehensive income (loss), net of tax | 8,833 | 15,423 | -44,373 |
Ending Balance | -41,474 | -50,307 | -65,730 |
Accumulated Translation Adjustment | ' | ' | ' |
Beginning Balance | -19,860 | -22,624 | -17,942 |
Other comprehensive income (loss) before reclassifications | 1,755 | 2,764 | -4,682 |
Amounts reclassified from accumulated other comprehensive income (loss) | 0 | 0 | 0 |
Total other comprehensive income (loss), net of tax | 1,755 | 2,764 | -4,682 |
Ending Balance | -18,105 | -19,860 | -22,624 |
Accumulated Defined Benefit Plans Adjustment | ' | ' | ' |
Beginning Balance | -25,983 | -23,161 | -8,159 |
Other comprehensive income (loss) before reclassifications | 6,284 | -2,304 | -12,682 |
Amounts reclassified from accumulated other comprehensive income (loss) | 830 | -518 | -2,320 |
Total other comprehensive income (loss), net of tax | 7,114 | -2,822 | -15,002 |
Ending Balance | -18,869 | -25,983 | -23,161 |
Foreign Exchange Contract | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | ' | ' | ' |
Beginning Balance | 3,426 | -9,513 | 712 |
Other comprehensive income (loss) before reclassifications | 3,495 | 10,277 | -8,014 |
Amounts reclassified from accumulated other comprehensive income (loss) | -4,401 | 2,662 | -2,211 |
Total other comprehensive income (loss), net of tax | -906 | 12,939 | -10,225 |
Ending Balance | 2,520 | 3,426 | -9,513 |
Commodity Contract | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | ' | ' | ' |
Beginning Balance | -6,316 | -8,858 | 5,606 |
Other comprehensive income (loss) before reclassifications | -2,458 | 76 | -7,813 |
Amounts reclassified from accumulated other comprehensive income (loss) | 2,442 | 2,466 | -6,651 |
Total other comprehensive income (loss), net of tax | -16 | 2,542 | -14,464 |
Ending Balance | -6,332 | -6,316 | -8,858 |
Interest Rate Swap | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | ' | ' | ' |
Beginning Balance | -1,574 | -1,574 | -1,574 |
Other comprehensive income (loss) before reclassifications | 886 | 0 | 0 |
Amounts reclassified from accumulated other comprehensive income (loss) | 0 | 0 | 0 |
Total other comprehensive income (loss), net of tax | 886 | 0 | 0 |
Ending Balance | ($688) | ($1,574) | ($1,574) |
Accumulated_Other_Comprehensiv3
Accumulated Other Comprehensive Income (Loss) Reclassifications Out of Accumulated Other Comprehensive Income (Loss) (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cost of goods sold | $895,610 | $895,843 | $925,052 |
Income before income taxes | 60,278 | 70,156 | 90,144 |
Income tax expense (benefit) | 19,924 | -71,229 | 14,813 |
Net income attributable to common stockholders | 39,695 | 138,611 | 62,200 |
Reclassification out of Accumulated Other Comprehensive Income | ' | ' | ' |
Net income attributable to common stockholders | 1,129 | -4,610 | 11,182 |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | ' | ' | ' |
Income before income taxes | 1,741 | -7,015 | 9,309 |
Income tax expense (benefit) | 218 | 1,887 | -447 |
Net income attributable to common stockholders | 1,959 | -5,128 | 8,862 |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Foreign Exchange Contract | ' | ' | ' |
Cost of goods sold | 5,751 | -2,965 | 2,658 |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Commodity Contract | ' | ' | ' |
Cost of goods sold | -4,010 | -4,050 | 6,651 |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | ' | ' | ' |
Prior service cost | 1,816 | 1,674 | 7,928 |
Actuarial losses | -3,187 | -795 | -5,608 |
Income before income taxes | -1,371 | 879 | 2,320 |
Income tax expense (benefit) | 541 | -361 | 0 |
Net income attributable to common stockholders | ($830) | $518 | $2,320 |
Restructuring_and_Other_Charge2
Restructuring and Other Charges (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring and other charges | $4,066 | $10,271 | $3,572 |
2013 | Total Expected Costs | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 1,756 | ' | ' |
Business Exit Costs | 692 | ' | ' |
Restructuring and other charges | 2,448 | ' | ' |
2013 | Restructuring Charges | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 1,756 | 0 | 0 |
Business Exit Costs | 692 | 0 | 0 |
Restructuring and other charges | 2,448 | 0 | 0 |
2013 | Estimated Future Expense | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 0 | ' | ' |
Business Exit Costs | 0 | ' | ' |
Restructuring and other charges | 0 | ' | ' |
2012 | Total Expected Costs | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 4,533 | ' | ' |
Business Exit Costs | 1,479 | ' | ' |
Other Restructuring Costs | 1,687 | ' | ' |
Restructuring and other charges | 7,699 | ' | ' |
2012 | Restructuring Charges | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 795 | 3,738 | 0 |
Business Exit Costs | 823 | 410 | 0 |
Other Restructuring Costs | 0 | 1,687 | 0 |
Restructuring and other charges | 1,618 | 5,835 | 0 |
2012 | Estimated Future Expense | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 0 | ' | ' |
Business Exit Costs | 246 | ' | ' |
Other Restructuring Costs | 0 | ' | ' |
Restructuring and other charges | 246 | ' | ' |
2011 | Total Expected Costs | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 4,518 | ' | ' |
Business Exit Costs | 801 | ' | ' |
Restructuring and other charges | 5,319 | ' | ' |
2011 | Restructuring Charges | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 0 | 1,635 | 2,883 |
Business Exit Costs | 0 | 241 | 560 |
Restructuring and other charges | 0 | 1,876 | 3,443 |
2011 | Estimated Future Expense | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 0 | ' | ' |
Business Exit Costs | 0 | ' | ' |
Restructuring and other charges | $0 | ' | ' |
Restructuring_and_Other_Charge3
Restructuring and Other Charges Restructure Charges (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring and other charges | $4,066 | $10,271 | $3,572 |
Total Restructure Charges | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Severance Costs | 2,551 | 5,373 | 2,995 |
Business Exit Costs | 1,515 | 651 | 577 |
Other Restructuring Costs | 0 | 1,687 | 0 |
Asset Impairments Related to Restructuring | 0 | 2,560 | 0 |
Restructuring and other charges | $4,066 | $10,271 | $3,572 |
Restructuring_and_Other_Charge4
Restructuring and Other Charges Restructuring Charges Rollforward (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring and other charges | $4,066 | $10,271 | $3,572 |
Payments for Restructuring | -6,719 | -6,957 | -1,237 |
Employee Severance | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring Reserve | 3,573 | 2,539 | ' |
Restructuring and other charges | 2,551 | 5,373 | ' |
Payments for Restructuring | -5,143 | -4,339 | ' |
Restructuring Reserve | 981 | 3,573 | ' |
Business Exit Costs | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring Reserve | 106 | 386 | ' |
Restructuring and other charges | 1,515 | 651 | ' |
Payments for Restructuring | -1,576 | -931 | ' |
Restructuring Reserve | 45 | 106 | ' |
Other Restructuring | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring Reserve | 0 | 0 | ' |
Restructuring and other charges | 0 | 1,687 | ' |
Payments for Restructuring | 0 | -1,687 | ' |
Restructuring Reserve | 0 | 0 | ' |
Total Restructuring | ' | ' | ' |
Restructuring Cost and Reserve | ' | ' | ' |
Restructuring Reserve | 3,679 | 2,925 | ' |
Restructuring and other charges | 4,066 | 7,711 | ' |
Payments for Restructuring | -6,719 | -6,957 | ' |
Restructuring Reserve | $1,026 | $3,679 | ' |
Income_Taxes_Income_before_inc
Income Taxes Income before income taxes (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income taxes [Abstract] | ' | ' | ' |
Domestic | $25,815 | $46,078 | $45,053 |
Foreign | 34,463 | 24,078 | 45,091 |
Income before income taxes | $60,278 | $70,156 | $90,144 |
Income_Taxes_Income_Taxes_Deta
Income Taxes Income Taxes (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Current: | ' | ' | ' |
Federal | $764 | $5,637 | $1,798 |
State and Local | -215 | 1,078 | 804 |
Foreign | 15,655 | 11,023 | 14,230 |
Deferred | ' | ' | ' |
Federal | 8,332 | -70,643 | -1,527 |
State and Local | 1,352 | -13,076 | -179 |
Foreign | -5,964 | -5,248 | -313 |
Income tax expense (benefit) | $19,924 | ($71,229) | $14,813 |
Income_Taxes_Federal_Tax_Rate_
Income Taxes Federal Tax Rate Reconciliation (Details) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Income taxes [Abstract] | ' | ' | ' |
Federal statutory income tax rate | 35.00% | 35.00% | 35.00% |
State and local income taxes, net of Federal tax benefit, if applicable | -0.40% | -0.20% | 0.60% |
Permanent items and other | 5.70% | 9.30% | 2.20% |
Non-U.S. operations | -1.70% | 2.40% | 2.40% |
Goodwill | 0.00% | 0.00% | 0.70% |
Valuation allowance changes affecting the provision | -5.50% | -148.00% | -24.50% |
Effective income tax rate | 33.10% | -101.50% | 16.40% |
Income_Taxes_Income_Taxes_and_
Income Taxes Income Taxes and Other Comprehensive Income (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income taxes [Abstract] | ' | ' | ' |
Income tax expense (benefit) | $19,924 | ($71,229) | $14,813 |
Allocated to other comprehensive income (loss): | ' | ' | ' |
Financial instruments | -303 | 4,331 | -2,044 |
Pensions | ($4,196) | ($599) | $0 |
Income_Taxes_Deferred_Taxes_De
Income Taxes Deferred Taxes (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Deferred tax assets: | ' | ' |
Restructuring charges | $289 | $245 |
Employee benefits | 11,472 | 14,394 |
Inventories | 2,875 | 2,042 |
Warranty | 10,194 | 9,714 |
Alternative minimum tax and other credits | 16,356 | 17,118 |
Net operating loss carryforwards | 55,855 | 65,039 |
Customer contracts & other intangibles | 1,428 | 388 |
Rebates, stock, discounts and returns | 5,898 | 4,814 |
Unrealized gain/loss on financial instruments | 1,150 | 1,382 |
Other | 5,062 | 8,453 |
Total deferred tax assets | 110,579 | 123,589 |
Valuation allowance | -11,917 | -16,044 |
Deferred tax assets net of valuation allowance | 98,662 | 107,545 |
Deferred Tax Liabilities | ' | ' |
Depreciation | -3,462 | -2,088 |
Goodwill and other intangibles | -8,371 | -10,936 |
Trade names | -18,846 | -18,846 |
Other | -10,704 | -10,375 |
Total deferred tax liabilities | -41,383 | -42,245 |
Net deferred tax asset | $57,279 | $65,300 |
Income_Taxes_Unrecognized_Tax_
Income Taxes Unrecognized Tax Benefits (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income taxes [Abstract] | ' | ' | ' |
Balance at January 1, | $9,164 | $4,592 | $2,806 |
Additions based on tax positions related to the current year | 987 | 2,697 | 672 |
Additions for tax positions of prior years | 457 | 1,875 | 1,561 |
Reductions for tax positions of prior years | -116 | 0 | -447 |
Settlements | -654 | 0 | 0 |
Balance at December 31, | $9,838 | $9,164 | $4,592 |
Income_Taxes_Other_Details_Det
Income Taxes Other Details (Details) (USD $) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Valuation Allowance, Deferred Tax Asset, Change in Amount | ($84,705,000) | ' | ' | ' |
Income Tax Expense (Benefit) | ' | ' | 1,068,000 | ' |
Valuation allowance | ' | 11,917,000 | 16,044,000 | ' |
Cash paid for income taxes, net of refunds received | ' | 7,355,000 | 13,019,000 | 17,778,000 |
Unrecognized Tax Benefits | ' | 11,456,000 | 10,350,000 | ' |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | ' | 1,618,000 | 1,186,000 | ' |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | ' | 432,000 | 398,000 | 79,000 |
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations | ' | 4,738,000 | ' | ' |
Undistributed Earnings of Foreign Subsidiaries | ' | 172,901,000 | ' | ' |
Internal Revenue Service (IRS) | ' | ' | ' | ' |
Operating Loss Carryforwards | ' | 101,500,000 | ' | ' |
Operating Loss Carryforwards, per year limitation | ' | 10,555,000 | ' | ' |
Valuation Allowance, Deferred Tax Asset, Change in Amount | 84,705,000 | ' | ' | ' |
Valuation allowance | ' | 4,997,000 | 5,598,000 | ' |
Foreign Tax Authority | ' | ' | ' | ' |
Operating Loss Carryforwards | ' | 63,728,000 | 54,576,000 | ' |
Operating Loss Carryforwards, next year limitation | ' | 0 | ' | ' |
Operating Loss Carryforwards, after next year limitation | ' | 11,867,000 | ' | ' |
Operating Loss Carryforwards, Indefinitely | ' | 51,861,000 | ' | ' |
Valuation Allowance, Deferred Tax Asset, Change in Amount | ' | 2,733,000 | 4,708,000 | ' |
Alternative Minimum Tax Credit Carryforward | ' | ' | ' | ' |
Tax Credit Carryforward, Amount | ' | 3,256,000 | ' | ' |
Research Tax Credit Carryforward | ' | ' | ' | ' |
Tax Credit Carryforward, Amount | ' | 12,893,000 | ' | ' |
Expiration of Capital Loss | Internal Revenue Service (IRS) | ' | ' | ' | ' |
Valuation Allowance, Deferred Tax Asset, Change in Amount | ' | 2,703,000 | ' | ' |
Utilization of state tax credits | Internal Revenue Service (IRS) | ' | ' | ' | ' |
Valuation Allowance, Deferred Tax Asset, Change in Amount | ' | $2,102,000 | ' | ' |
Employee_Benefit_Plan_Postreti
Employee Benefit Plan Postretirement Healthcare and Life Insurance Plans (Details) (Postretirement Healthcare Benefit Plans, Defined Benefit, USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Postretirement Healthcare Benefit Plans, Defined Benefit | ' | ' | ' |
Change in benefit obligations | ' | ' | ' |
Benefit obligation at beginning of period | $2,682 | $2,897 | ' |
Service cost | 0 | 0 | 0 |
Interest cost | 77 | 97 | 99 |
Amendments | 0 | 0 | ' |
Actuarial loss | -154 | 22 | ' |
Benefits paid | -359 | -334 | ' |
Benefit obligation at end of period | 2,246 | 2,682 | 2,897 |
Change in plan assets | ' | ' | ' |
Fair value of plan assets at beginning of period | 0 | 0 | ' |
Employer contributions | 359 | 334 | ' |
Benefits paid | -359 | -334 | ' |
Fair value of plan assets at end of period | 0 | 0 | 0 |
Funded status | -2,246 | -2,682 | ' |
Amounts recognized in statement of financial position consist of | ' | ' | ' |
Current liabilities | -618 | -713 | ' |
Noncurrent Liabilities | -1,628 | -1,969 | ' |
Net amount recognized | -2,246 | -2,682 | ' |
Amounts recognized in accumulated other comprehensive income consist of: | ' | ' | ' |
Net actuarial loss | 3,669 | 5,647 | ' |
Prior service cost | -3,632 | -5,448 | ' |
Accumulated other comprehensive loss (income) | 37 | 199 | ' |
Net Periodic Benefit Cost | ' | ' | ' |
Service cost | 0 | 0 | 0 |
Interest cost | 77 | 97 | 99 |
Amortization of prior service cost | -1,816 | -1,674 | -7,928 |
Recognized net actuarial loss (gain) | 1,824 | -492 | 5,129 |
Settlement gain | 0 | 0 | 0 |
Net periodic pension cost (benefit) | 85 | -2,069 | -2,700 |
Other changes in plan assets and benefit obligations recognized in other comprehensive income | ' | ' | ' |
Net actuarial loss (gain) | -154 | 22 | 68 |
Prior service cost | 0 | 0 | 805 |
Amortization of prior service cost | 1,816 | 1,674 | 7,928 |
Recognized net actuarial (loss) gain | -1,824 | 492 | -5,129 |
Total recognized in other comprehensive loss (income) | -162 | 2,188 | 3,672 |
Total recognized in net (benefit) cost and OCI | ($77) | $119 | $972 |
Weighted-average assumptions | ' | ' | ' |
Discount rate for benefit obligation | 4.73% | 3.85% | 4.28% |
Discount rate for net periodic benefit cost | 3.85% | 4.28% | 5.41% |
Rate of compensation increase | 0.00% | 0.00% | 0.00% |
Employee_Benefit_Plan_Pension_
Employee Benefit Plan Pension Plan Disclosure (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Non U.S. | ' | ' | ' |
Change in benefit obligations | ' | ' | ' |
Benefit obligation at end of period | $19,477 | $12,557 | ' |
Change in plan assets | ' | ' | ' |
Fair value of plan assets at end of period | 17,075 | 9,450 | ' |
Pension Plans, Defined Benefit | ' | ' | ' |
Change in benefit obligations | ' | ' | ' |
Benefit obligation at beginning of period | 79,477 | 73,182 | ' |
Service cost | 1,035 | 291 | 263 |
Interest cost | 3,278 | 3,143 | 3,342 |
Amendments | 0 | 0 | ' |
Korea benefit obligation | 4,965 | 0 | ' |
Actuarial loss | -6,207 | 5,692 | ' |
Benefits paid | -3,070 | -2,831 | ' |
Benefit obligation at end of period | 79,478 | 79,477 | 73,182 |
Change in plan assets | ' | ' | ' |
Fair value of plan assets at beginning of period | 47,349 | 41,765 | ' |
Actual Return on Plan Assets | 7,081 | 5,650 | ' |
Korea plan assets | 4,642 | 0 | ' |
Employer contributions | 3,984 | 2,765 | ' |
Benefits paid | -3,070 | -2,831 | ' |
Fair value of plan assets at end of period | 59,986 | 47,349 | 41,765 |
Funded status | -19,492 | -32,128 | ' |
Amounts recognized in statement of financial position consist of | ' | ' | ' |
Noncurrent assets | 0 | 0 | ' |
Current liabilities | -389 | -366 | ' |
Noncurrent Liabilities | -19,103 | -31,762 | ' |
Net amount recognized | -19,492 | -32,128 | ' |
Amounts recognized in accumulated other comprehensive income consist of: | ' | ' | ' |
Net actuarial loss (gain) | 17,069 | 28,379 | ' |
Prior service cost | 0 | 0 | ' |
Accumulated other comprehensive loss (income) | 17,069 | 28,379 | ' |
Information for pension plans with an accumulated benefit obligation in excess of plan assets | ' | ' | ' |
Projected benefit obligation | 79,478 | 79,477 | ' |
Accumulated benefit obligation | 79,478 | 79,064 | ' |
Fair value of plan assets | 59,986 | 47,349 | ' |
Net Periodic Benefit Cost | ' | ' | ' |
Service cost | 1,035 | 291 | 263 |
Interest cost | 3,278 | 3,143 | 3,342 |
Expected return on plan assets | -3,341 | -2,622 | -2,690 |
Amortization of prior service cost | 0 | 0 | 0 |
Recognized net actuarial loss (gain) | 1,363 | 1,287 | 479 |
Net periodic pension cost (benefit) | 2,335 | 2,099 | 1,394 |
Other changes in plan assets and benefit obligations recognized in other comprehensive income | ' | ' | ' |
Net actuarial loss (gain) | -9,947 | 2,520 | 11,807 |
Prior service cost | 0 | 0 | 0 |
Amortization of prior service cost | 0 | 0 | 0 |
Recognized net actuarial (loss) gain | -1,363 | -1,287 | -479 |
Total recognized in other comprehensive loss (income) | -11,310 | 1,233 | 11,328 |
Total recognized in net (benefit) cost and OCI | -8,975 | 3,332 | 12,722 |
Pension Plans, Defined Benefit | United States | ' | ' | ' |
Change in plan assets | ' | ' | ' |
Fair value of plan assets at beginning of period | 37,899 | ' | ' |
Fair value of plan assets at end of period | 42,911 | 37,899 | ' |
Weighted-average assumptions | ' | ' | ' |
Discount rate for benefit obligation | 4.73% | 3.85% | 4.28% |
Discount rate for net periodic benefit cost | 3.85% | 4.28% | 5.41% |
Rate of compensation increase | 0.00% | 5.00% | 5.00% |
Expected return on plan assets | 6.50% | 6.50% | 6.50% |
Pension Plans, Defined Benefit | Non U.S. | ' | ' | ' |
Change in plan assets | ' | ' | ' |
Fair value of plan assets at beginning of period | 9,450 | ' | ' |
Fair value of plan assets at end of period | $17,075 | $9,450 | ' |
Weighted-average assumptions | ' | ' | ' |
Discount rate for benefit obligation | 4.27% | 4.10% | 4.70% |
Discount rate for net periodic benefit cost | 4.00% | 4.70% | 5.40% |
Rate of compensation increase | 3.81% | 3.10% | 3.35% |
Expected return on plan assets | 5.13% | 4.99% | 5.18% |
Employee_Benefit_Plan_Accumula
Employee Benefit Plan Accumulated Other Comprehensive Income (Details) (USD $) | 12 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Pension Plans, Defined Benefit | ' |
Defined Benefit Plan Disclosure | ' |
Amortization of actuarial losses | $649 |
Amortization of prior service cost | 0 |
Total | 649 |
Postretirement Healthcare Benefit Plans, Defined Benefit | ' |
Defined Benefit Plan Disclosure | ' |
Amortization of actuarial losses | 19 |
Amortization of prior service cost | 0 |
Total | $19 |
Employee_Benefit_Plan_Target_A
Employee Benefit Plan Target Allocations (Details) (Pension Plans, Defined Benefit) | 12 Months Ended |
Dec. 31, 2013 | |
Equity Funds | ' |
Defined Benefit Plan Disclosure | ' |
Defined Benefit Plan, Target Plan Asset Allocations Range Minimum | 45.00% |
Defined Benefit Plan, Target Plan Asset Allocations Range Maximum | 65.00% |
Fixed Income Funds | ' |
Defined Benefit Plan Disclosure | ' |
Defined Benefit Plan, Target Plan Asset Allocations Range Minimum | 25.00% |
Defined Benefit Plan, Target Plan Asset Allocations Range Maximum | 45.00% |
Cash and Cash Equivalents | ' |
Defined Benefit Plan Disclosure | ' |
Defined Benefit Plan, Target Plan Asset Allocations Range Minimum | 10.00% |
Defined Benefit Plan, Target Plan Asset Allocations Range Maximum | 20.00% |
Employee_Benefit_Plan_Asset_Al
Employee Benefit Plan Asset Allocation (Details) (Pension Plans, Defined Benefit, USD $) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Defined Benefit Plan Disclosure | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | $59,986 | $47,349 | $41,765 |
Defined Benefit Plan, Actual Plan Asset Allocations | 100.00% | 100.00% | ' |
Cash and Cash Equivalents | ' | ' | ' |
Defined Benefit Plan Disclosure | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 8,980 | 2,418 | ' |
Defined Benefit Plan, Actual Plan Asset Allocations | 15.00% | 5.10% | ' |
Fixed Income Funds | ' | ' | ' |
Defined Benefit Plan Disclosure | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | 18,408 | 16,630 | ' |
Defined Benefit Plan, Actual Plan Asset Allocations | 30.70% | 35.10% | ' |
Equity Funds | ' | ' | ' |
Defined Benefit Plan Disclosure | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | $32,598 | $28,301 | ' |
Defined Benefit Plan, Actual Plan Asset Allocations | 54.30% | 59.80% | ' |
Employee_Benefit_Plan_Healthca
Employee Benefit Plan Healthcare Cost Trend Rate (Details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Employee benefit plans [Abstract] | ' | ' |
Health care cost trend rate assumed for next year | 9.00% | 9.00% |
Rate to which the cost trend is expected to decline | 5.00% | 5.00% |
Year that the rate reaches the ultimate trend rate | '2017 | '2016 |
Employee_Benefit_Plan_Sensitiv
Employee Benefit Plan Sensitivity Analysis (Details) (USD $) | 12 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Employee benefit plans [Abstract] | ' |
Effect on total of service and interest cost components of net periodic postretirement health care benefit cost, 1% Increase | $0 |
Effect on total of service and interest cost components of net periodic postretirement health care benefit cost, 1% Decrease | 0 |
Effect on the health care component of the accumulated postretirement benefit obligation, 1% Increase | 7 |
Effect on the health care component of the accumulated postretirement benefit obligation, 1% Decrease | ($7) |
Employee_Benefit_Plan_Future_p
Employee Benefit Plan Future payments to pension and postretirement healthcare plans (Details) (USD $) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Pension Plans, Defined Benefit | ' |
Defined Benefit Plan Disclosure | ' |
2014 | $3,488 |
2015 | 4,758 |
2016 | 3,793 |
2017 | 4,025 |
2018 | 3,883 |
Years 2019-2023 | 23,045 |
Postretirement Healthcare Benefit Plans, Defined Benefit | ' |
Defined Benefit Plan Disclosure | ' |
2014 | 618 |
2015 | 336 |
2016 | 165 |
2017 | 111 |
2018 | 87 |
Years 2019-2023 | $336 |
Employee_Benefit_Plan_Details
Employee Benefit Plan (Details) (USD $) | 12 Months Ended | 12 Months Ended | |||||||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2009 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
United States | Non U.S. | Non U.S. | Non U.S. | GM Agreement | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | Pension Plans, Defined Benefit | ||||
United States | United States | United States | Non U.S. | Non U.S. | Non U.S. | ||||||||||||
Line Items | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Defined Benefit Plan, Benefit Obligation | ' | ' | ' | ' | ' | $19,477 | $12,557 | ' | $79,478 | $79,477 | $73,182 | ' | ' | ' | ' | ' | ' |
Defined Benefit Plan, Fair Value of Plan Assets | ' | ' | ' | ' | ' | 17,075 | 9,450 | ' | 59,986 | 47,349 | 41,765 | 42,911 | 37,899 | ' | 17,075 | 9,450 | ' |
Expected return on plan assets | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6.50% | 6.50% | 6.50% | 5.13% | 4.99% | 5.18% |
Defined Contribution Plan, Cost Recognized | 1,594 | 1,640 | 1,442 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employer contributions | ' | ' | ' | ' | ' | ' | ' | ' | 3,984 | 2,765 | ' | ' | ' | ' | ' | ' | ' |
Estimated Future Employer Contributions in Next Fiscal Year | ' | ' | ' | 3,272 | 1,497 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Percentage of Supplemental Executive Retirement Pension Plan Participant's Average Salary, Minimum | 30.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Percentage of Supplemental Executive Retirement Pension Plan Participant's Average Salary, Maximum | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of Years Used to Determine Pension Benefit, Supplemental Executive Retirement Pension Plan | 5 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of Participants in Supplemental Executive Retirement Pension Plan, Total | 5 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of Participants in Supplemental Executive Retirement Pension Plan, Active Employees | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Defined Benefit Plan, Benefit Obligation, Period Increase (Decrease) | ' | ' | ' | ' | ' | ' | ' | 2,570 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax | ' | ' | ' | ' | ' | ' | ' | $10,170 | ($11,310) | $1,233 | $11,328 | ' | ' | ' | ' | ' | ' |
Stock_Based_Compensation_Detai
Stock Based Compensation (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Jun. 30, 2008 | Dec. 31, 2007 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2008 | Mar. 31, 2008 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Executive Officers and Key Employees | Executive Officers and Key Employees | Executive Officers and Key Employees | Executive Officers and Key Employees | Executive Officers and Key Employees | Executive Officers and Key Employees | Board of Directors | Board of Directors | Board of Directors | Board of Directors | Board of Directors | Board of Directors | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $9,972,000 | $8,653,000 | $1,394,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employee Service Share-based Compensation, Cash Flow Effect, Cash Used to Settle Awards | 231,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | ' | ' | ' | 108,335 | 524,737 | 173,568 | 224,507 | 490,573 | 744,089 | 20,000 | 140,000 | 27,072 | 32,164 | 45,713 | 340,455 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $18.48 | ' | ' | $8 | $11.55 | $21.98 | $18.47 | $17.50 | $11 | $3 | $11.55 | $21.98 | $18.50 | $17.50 | $11 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 268,293 | ' | ' | ' | ' | 231,360 | 234,675 | ' | ' | ' | ' | 36,083 | 33,618 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $18.48 | $0 | ' | ' | ' | $21.98 | $18.47 | ' | ' | ' | ' | $21.98 | $18.50 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | ' | ' | ' | ' | ' | '7 years | '7 years | ' | ' | ' | ' | '7 years | '7 years | ' | ' |
Award Allocation Percentage, Time Based | ' | ' | ' | ' | ' | 50.00% | 50.00% | 50.00% | 50.00% | ' | ' | ' | ' | ' | ' |
Award Allocation Percentage, Performance Based | ' | ' | ' | ' | ' | 50.00% | 50.00% | 50.00% | 50.00% | ' | ' | ' | ' | ' | ' |
Annual Vesting Percentage, years one, two and three | ' | ' | ' | 12.00% | 12.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Annual Vesting Percentage, years four and five | ' | ' | ' | 32.00% | 32.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Annual Vesting Percentage, Time Based | ' | ' | ' | ' | ' | 33.00% | 33.00% | 33.00% | 33.00% | ' | ' | ' | ' | ' | ' |
Annual Vesting Percentage, Performance Based | ' | ' | ' | ' | ' | 33.00% | 33.00% | 33.00% | 33.00% | ' | ' | ' | ' | ' | ' |
Annual Vesting Percentage, years one and two | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | 50.00% | 50.00% | 50.00% | 50.00% | 50.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | ' | ' | ' | ' | ' | $7.07 | $7.58 | ' | ' | ' | ' | $7.07 | $7.58 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | ' | ' | ' | 3.00% | 3.00% | 1.53% | 0.86% | ' | ' | 3.00% | 3.00% | 1.53% | 0.86% | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | ' | ' | ' | 0.00% | 0.00% | 1.82% | 2.16% | ' | ' | 0.00% | 0.00% | 1.82% | 2.16% | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | ' | ' | ' | 39.10% | 39.10% | 43.20% | 56.70% | ' | ' | 39.10% | 39.10% | 43.20% | 56.70% | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | ' | ' | ' | ' | ' | '4 years 6 months | '5 years | ' | ' | ' | ' | '4 years 6 months | '5 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 5,500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 3,466,039 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Allocated Share-based Compensation Expense | 6,561,000 | 7,261,000 | 6,884,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized | $5,561,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | '2 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock_Based_Compensation_Nonve
Stock Based Compensation Nonvest Restricted Stock Awards (Details) (USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Restricted stock awards | ' |
Nonvested at January 1, 2012 | 1,124,952 |
Granted | 256,671 |
Vested | -566,027 |
Forfeited | -67,783 |
Nonvested at December 31, 2012 | 747,813 |
Weighted-average grant-date fair value | ' |
Nonvested at January 1, 2012 | $14.08 |
Granted | $18.48 |
Vested | $13.08 |
Forfeited | $17.75 |
Nonvested at December 31, 2012 | $15.92 |
Stock_Based_Compensation_Stock
Stock Based Compensation Stock Option Activity (Details) (USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 268,293 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | -17,798 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 250,495 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $0 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $18.48 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $18.50 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $18.48 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | '5 years 10 months |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $1,213,515 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | 13,843 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $18.50 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term | '3 months |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $66,723 |
Share Price | $23.32 |
Lease_Commitments_Details
Lease Commitments (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Lease commitments [Abstract] | ' | ' | ' |
2014 | $4,902 | ' | ' |
2015 | 3,362 | ' | ' |
2016 | 2,762 | ' | ' |
2017 | 2,371 | ' | ' |
2018 | 979 | ' | ' |
Thereafter | 1,516 | ' | ' |
Operating Leases, Rent Expense, Net | $6,790 | $5,599 | $6,858 |
Business_Segment_Geographical_2
Business Segment & Geographical Information Net sales to external customers (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Net sales to external customers | ' | ' | ' |
Net sales | $1,118,580 | $1,133,547 | $1,194,953 |
United States | ' | ' | ' |
Net sales to external customers | ' | ' | ' |
Net sales | 735,939 | 753,420 | 756,824 |
Europe | ' | ' | ' |
Net sales to external customers | ' | ' | ' |
Net sales | 89,181 | 103,303 | 115,901 |
Other Americas | ' | ' | ' |
Net sales to external customers | ' | ' | ' |
Net sales | 59,611 | 56,300 | 90,636 |
Asia Pacific | ' | ' | ' |
Net sales to external customers | ' | ' | ' |
Net sales | $233,849 | $220,524 | $231,592 |
Business_Segment_Geographical_3
Business Segment & Geographical Information Long-lived assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Long-lived assets | ' | ' |
Long-lived assets | $186,084 | $177,703 |
United States | ' | ' |
Long-lived assets | ' | ' |
Long-lived assets | 80,429 | 81,451 |
Europe | ' | ' |
Long-lived assets | ' | ' |
Long-lived assets | 11,612 | 12,562 |
Other Americas | ' | ' |
Long-lived assets | ' | ' |
Long-lived assets | 55,937 | 58,267 |
Asia Pacific | ' | ' |
Long-lived assets | ' | ' |
Long-lived assets | $38,106 | $25,423 |
Other_Commitments_and_Continge1
Other Commitments and Contingencies (Details) (USD $) | 12 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Other commitments and contingencies [Abstract] | ' |
Counterclaim Damages Sought, Value | $111 |
Damages Sought, Value | 110,000 |
Loss Contingency Accrual | $0 |
Supplemental_Cash_Flow_Informa2
Supplemental Cash Flow Information (Details) (USD $) | 12 Months Ended | |||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2009 |
Cash paid for interest | $21,479 | $26,987 | $29,753 | ' |
Cash paid for income taxes, net of refunds received | 7,355 | 13,019 | 17,778 | ' |
Customer Obligations, Extinguished | ' | ' | ' | 23,038 |
Deferred Gain, Customer Obligations | ' | ' | ' | 8,152 |
Deferred Gain Recognized, Customer Obligations | 1,193 | 1,671 | 1,465 | ' |
Customer Contracts | ' | ' | ' | ' |
Finite-Lived Intangible Assets, Gross | 97,789 | 95,389 | ' | ' |
New Customer Agreements | ' | ' | ' | ' |
Customer Obligations | ' | 13,623 | ' | ' |
New Customer Agreements | Customer Contracts | ' | ' | ' | ' |
Finite-Lived Intangible Assets, Gross | ' | $13,623 | ' | ' |
Executive_officer_separation_D
Executive officer separation (Details) (USD $) | 3 Months Ended | 12 Months Ended |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2013 | Dec. 31, 2013 |
Executive officer separation [Abstract] | ' | ' |
Executive Officer Separation, Payment | $7,000 | ' |
Executive Officer Separation, Diluted Earnings Per Share Impact | ' | $0.14 |
Purchase_of_noncontrolling_int1
Purchase of noncontrolling interest (Details) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Jun. 30, 2013 |
Purchase of noncontrolling interest [Abstract] | ' |
Noncontrolling Interest, Ownership Percentage by Parent | 51.00% |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 49.00% |
Noncontrolling Interest, Acquisition Value | $14,628 |
Payments to Noncontrolling Interests | 8,107 |
Noncontrolling Interest Dividends in Excess of Ownership Percentage | 6,521 |
Adjustments to Additional Paid in Capital, Other | $9,188 |
Subsequent_Event_Details
Subsequent Event (Details) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2014 |
Subsequent Events [Abstract] | ' |
Payments to Acquire Businesses, Gross | $40.50 |
Quarterly_Financial_Informatio2
Quarterly Financial Information Quarterly Financial Data (Details) (USD $) | 12 Months Ended | 3 Months Ended | |||||||||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 |
2013 | 2013 | 2013 | 2013 | 2012 | 2012 | 2012 | 2012 | ||||
Net sales | $1,118,580 | $1,133,547 | $1,194,953 | $291,673 | $262,832 | $282,349 | $281,726 | $268,266 | $277,401 | $294,819 | $293,061 |
Gross Profit | 222,970 | 237,704 | 269,901 | 61,058 | 52,232 | 54,701 | 54,979 | 59,365 | 54,809 | 61,494 | 62,036 |
Restructuring and other charges | 4,066 | 10,271 | 3,572 | -197 | 1,454 | 2,128 | 681 | 1,307 | 5,374 | 1,892 | 1,698 |
Net income | 40,354 | 141,385 | 75,331 | 16,691 | 10,356 | 11,464 | 1,843 | 16,538 | 97,359 | 17,964 | 9,524 |
Net income attributable to common stockholders | $39,695 | $138,611 | $62,200 | $16,691 | $10,356 | $11,368 | $1,280 | $15,927 | $96,532 | $17,441 | $8,711 |
Basic earnings per share | $1.27 | $4.53 | $2.14 | $0.53 | $0.33 | $0.36 | $0.04 | $0.52 | $3.15 | $0.57 | $0.29 |
Diluted earnings per share | $1.26 | $4.47 | $2.10 | $0.53 | $0.33 | $0.36 | $0.04 | $0.51 | $3.11 | $0.56 | $0.28 |
Quarterly_Financial_Informatio3
Quarterly Financial Information Quarterly Financial Disclosures (Details) (USD $) | 3 Months Ended | 12 Months Ended | ||||
Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 49.00% | ' | ' | ' | ' | ' |
Noncontrolling Interest, Acquisition Value | $14,628,000 | ' | ' | ' | ' | ' |
Payments to Noncontrolling Interests | 8,107,000 | ' | ' | ' | ' | ' |
Noncontrolling Interest Dividends in Excess of Ownership Percentage | 6,521,000 | ' | ' | ' | ' | ' |
Executive Officer Separation, Payment | ' | 7,000,000 | ' | ' | ' | ' |
Loss on extinguishment of debt and refinancing fees | ' | ' | ' | -4,256,000 | 0 | 0 |
Valuation Allowance, Deferred Tax Asset, Change in Amount | ' | ' | -84,705,000 | ' | ' | ' |
Asset Impairments Related to Restructuring | ' | ' | $2,279,000 | ' | ' | ' |
Valuation_and_Qualifying_Accou1
Valuation and Qualifying Accounts (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Allowance for doubtful accounts | ' | ' | ' |
Valuation and Qualifying Accounts Disclosure | ' | ' | ' |
Balance at Beginning of Period | $1,931 | $1,612 | $2,364 |
Charged to Costs and Expenses | 356 | 814 | 77 |
Charged (Credited) to Other Accounts | 6 | -9 | -11 |
Deductions | -710 | -486 | -818 |
Balance at End of Period | 1,583 | 1,931 | 1,612 |
Allowance for excess and obsolete inventory | ' | ' | ' |
Valuation and Qualifying Accounts Disclosure | ' | ' | ' |
Balance at Beginning of Period | 5,582 | 6,708 | 8,054 |
Charged to Costs and Expenses | 4,114 | 5,115 | 4,611 |
Charged (Credited) to Other Accounts | 61 | 86 | -74 |
Deductions | -2,100 | -6,327 | -5,883 |
Balance at End of Period | 7,657 | 5,582 | 6,708 |
Deferred tax asset valuation allowance | ' | ' | ' |
Valuation and Qualifying Accounts Disclosure | ' | ' | ' |
Balance at Beginning of Period | 16,044 | 112,277 | 133,824 |
Charged to Costs and Expenses | -3,334 | -103,805 | -29,521 |
Charged (Credited) to Other Accounts | -793 | 7,572 | 7,974 |
Deductions | 0 | 0 | 0 |
Balance at End of Period | $11,917 | $16,044 | $112,277 |